data_2k58_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k58 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.455 HG21 ' N ' ' B' ' 13' ' ' ILE . 8.0 tp . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 111.988 0.366 . . . . 1.26 111.988 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.49 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 78.3 mt -55.99 -61.98 5.49 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 111.767 0.284 . . . . 1.4 111.767 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.49 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.9 Cg_endo -55.23 -40.5 85.36 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 122.153 1.902 . . . . 0.62 111.852 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 t -59.76 -47.47 85.56 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.455 -0.339 . . . . 0.65 110.911 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.5 t -63.93 -46.88 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 116.555 -0.293 . . . . 1.29 110.895 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.653 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 9.4 mp -59.22 -50.56 73.56 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.455 -0.338 . . . . 1.33 111.125 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.6 mt -59.97 -44.68 95.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.567 0.222 . . . . 1.19 110.699 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.425 ' O ' HG12 ' B' ' 23' ' ' ILE . 51.3 m -60.63 -45.72 92.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.845 0.355 . . . . 1.17 110.339 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 43.3 t -58.82 -50.71 72.94 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.09 -0.505 . . . . 0.68 110.954 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 58.7 mt -60.0 -45.55 92.39 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.69 0.281 . . . . 0.83 110.793 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.24 -58.18 9.6 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 116.39 -0.368 . . . . 1.08 110.784 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.425 HG12 ' O ' ' B' ' 19' ' ' THR . 52.0 mm -55.13 -39.56 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.39 0.138 . . . . 1.17 110.907 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 54.7 tp -57.78 -45.95 85.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.932 0.396 . . . . 1.29 110.504 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 78.6 t -78.76 -46.68 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.467 0.651 . . . . 1.3 111.639 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 . . . . . 0 C--N 1.325 -0.484 0 C-N-CA 124.28 1.032 . . . . 0.96 113.171 -178.9 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.569 HG22 ' N ' ' B' ' 13' ' ' ILE . 10.9 tp . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 113.044 0.757 . . . . 1.17 113.044 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.569 ' N ' HG22 ' B' ' 12' ' ' ILE . 68.8 mt -59.34 -61.17 8.38 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.315 0.487 . . . . 1.13 112.315 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.421 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.1 Cg_endo -54.48 -40.03 85.29 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.864 1.709 . . . . 0.46 111.485 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.8 t -60.1 -51.93 67.51 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.22 -0.446 . . . . 1.16 111.671 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 34.7 m -65.22 -38.89 83.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 112.296 0.48 . . . . 1.1 112.296 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 pp -69.97 -43.35 71.67 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 119.624 -0.83 . . . . 1.15 111.651 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -66.5 -38.04 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.276 -0.57 . . . . 1.14 110.312 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.469 ' O ' HG12 ' B' ' 23' ' ' ILE . 87.5 m -64.59 -47.22 79.49 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.126 -0.324 . . . . 1.11 110.126 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.47 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 48.7 m -59.17 -51.48 69.83 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.19 -0.459 . . . . 0.4 110.618 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.429 ' N ' HD12 ' B' ' 21' ' ' LEU . 8.6 mp -57.97 -45.22 87.05 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.63 -0.259 . . . . 1.19 110.847 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.95 -57.26 13.31 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 116.489 -0.323 . . . . 0.48 110.855 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.469 HG12 ' O ' ' B' ' 19' ' ' THR . 45.9 mm -55.3 -40.75 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 117.521 0.146 . . . . 1.15 111.208 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' B' ' 20' ' ' SER . 84.4 mt -58.31 -42.57 87.01 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.868 0.366 . . . . 1.13 110.485 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 76.9 t -80.61 -46.3 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.472 0.653 . . . . 1.12 111.667 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 . . . . . 0 N--CA 1.469 0.479 0 C-N-CA 124.412 1.085 . . . . 0.74 113.134 -178.873 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.416 HG23 ' N ' ' B' ' 13' ' ' ILE . 8.1 tp . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 111.974 0.361 . . . . 1.47 111.974 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.638 ' O ' HG13 ' B' ' 16' ' ' VAL . 71.6 mt -61.72 -63.07 4.7 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 111.889 0.329 . . . . 1.3 111.889 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.495 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.4 Cg_endo -54.76 -40.48 84.58 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.863 1.709 . . . . 0.86 111.461 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 52.0 t -62.43 -48.66 78.71 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.093 -0.503 . . . . 1.4 111.564 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.638 HG13 ' O ' ' B' ' 13' ' ' ILE . 7.5 p -64.76 -39.45 85.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.029 0.381 . . . . 1.18 112.029 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.549 HD12 HG21 ' B' ' 18' ' ' ILE . 3.0 pp -70.65 -42.8 70.33 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 119.842 -0.743 . . . . 1.2 111.561 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.549 HG21 HD12 ' B' ' 17' ' ' LEU . 2.6 pp -65.9 -37.11 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 120.067 -0.653 . . . . 1.21 110.188 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.407 ' N ' HD12 ' B' ' 18' ' ' ILE . 89.0 m -65.83 -46.26 79.24 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.805 0.336 . . . . 1.19 110.145 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -60.56 -51.51 69.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.124 -0.489 . . . . 0.38 110.904 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.479 HD22 ' O ' ' B' ' 17' ' ' LEU . 4.1 mm? -59.89 -45.74 91.56 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.588 -0.278 . . . . 1.16 111.075 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 -57.98 10.15 Favored 'General case' 0 C--O 1.213 -0.862 0 C-N-CA 120.965 -0.294 . . . . 1.11 110.613 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 74.8 mt -54.55 -39.95 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.351 0.12 . . . . 1.24 110.979 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 49.8 tp -56.81 -47.17 80.86 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.987 0.423 . . . . 1.23 110.607 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 77.9 t -79.93 -44.31 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.51 0.671 . . . . 1.17 111.962 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 . . . . . 0 C--N 1.322 -0.625 0 N-CA-C 114.053 1.131 . . . . 0.73 114.053 -177.962 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.8 tp . . . . . 0 CA--C 1.543 0.692 0 N-CA-C 112.542 0.571 . . . . 1.38 112.542 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.53 ' O ' HD23 ' B' ' 17' ' ' LEU . 72.3 mt -59.78 -63.91 3.65 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 112.279 0.474 . . . . 1.21 112.279 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.487 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.4 Cg_endo -55.95 -37.71 95.65 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.689 1.593 . . . . 0.72 111.453 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 40.8 t -60.85 -53.4 57.79 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.092 -0.503 . . . . 1.47 111.742 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.527 HG13 ' O ' ' B' ' 13' ' ' ILE . 11.9 p -64.9 -40.68 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 120.824 -0.35 . . . . 1.24 111.509 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.53 HD23 ' O ' ' B' ' 13' ' ' ILE . 3.8 mm? -62.82 -51.83 65.53 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.42 -0.175 . . . . 1.24 111.152 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 63.7 mt -60.79 -44.8 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.552 0.215 . . . . 1.35 110.904 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 64.0 m -60.07 -46.98 87.77 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.663 0.268 . . . . 1.24 110.775 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.1 m -60.23 -50.55 73.22 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.288 -0.414 . . . . 0.6 110.725 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 8.8 mp -58.86 -45.18 90.71 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.44 -0.346 . . . . 1.34 110.68 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.58 -55.67 31.62 Favored 'General case' 0 C--O 1.208 -1.117 0 C-N-CA 120.894 -0.322 . . . . 1.18 110.329 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 74.1 mt -52.89 -41.68 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 122.967 0.167 . . . . 1.23 111.187 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.29 -46.96 87.14 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.927 0.394 . . . . 1.31 110.577 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.63 -36.32 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.474 0.654 . . . . 1.26 111.209 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 . . . . . 0 N--CA 1.447 -0.596 0 C-N-CA 124.107 0.963 . . . . 0.8 111.466 -179.249 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.2 tp . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 112.332 0.493 . . . . 1.34 112.332 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.48 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 78.3 mt -56.62 -61.5 6.7 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 111.982 0.364 . . . . 1.39 111.982 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.48 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 14.1 Cg_endo -56.56 -39.74 89.26 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.788 1.659 . . . . 0.65 111.742 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 41.2 t -60.26 -53.05 62.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.343 -0.39 . . . . 0.88 111.792 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.503 HG12 ' N ' ' B' ' 17' ' ' LEU . 14.0 p -65.49 -40.67 88.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 120.893 -0.323 . . . . 1.21 111.118 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.604 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 7.7 mp -60.89 -51.93 67.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.486 0.184 . . . . 1.32 110.776 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.5 mt -60.31 -44.0 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 120.699 0.285 . . . . 1.34 110.689 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 75.0 m -59.96 -45.23 93.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.423 -0.353 . . . . 0.67 110.48 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 40.9 t -60.3 -50.62 72.9 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.169 -0.469 . . . . 1.24 110.826 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 53.6 mt -59.23 -44.98 92.32 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.731 0.301 . . . . 1.39 110.844 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.27 -57.77 11.42 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 116.326 -0.397 . . . . 1.24 110.712 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.06 -36.56 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 121.415 -0.114 . . . . 0.81 110.978 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' B' ' 24' ' ' LEU . 1.5 tm? -59.83 -45.77 91.35 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.771 -0.455 . . . . 1.42 109.771 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.6 t -78.08 -46.28 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.424 0.631 . . . . 1.36 111.442 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 . . . . . 0 C--N 1.326 -0.447 0 C-N-CA 124.183 0.993 . . . . 1.05 112.478 -179.12 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 112.07 0.396 . . . . 1.31 112.07 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.55 HG23 HD21 ' B' ' 17' ' ' LEU . 72.3 mt -55.98 -62.89 3.9 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.123 0.416 . . . . 1.64 112.123 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.512 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.1 Cg_endo -54.48 -40.16 84.67 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.97 1.78 . . . . 1.2 111.603 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 46.7 t -60.13 -51.43 69.66 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.932 -0.576 . . . . 1.23 111.664 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.12 -38.96 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.482 0.549 . . . . 1.21 112.482 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.754 HD11 HG21 ' B' ' 18' ' ' ILE . 3.3 pp -69.1 -42.53 76.01 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 119.651 -0.82 . . . . 1.52 111.399 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.754 HG21 HD11 ' B' ' 17' ' ' LEU . 2.6 pp -66.76 -36.88 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 120.057 -0.657 . . . . 1.5 110.034 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.466 ' O ' HG12 ' B' ' 23' ' ' ILE . 86.5 m -65.51 -47.25 76.62 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.972 -0.381 . . . . 1.15 109.972 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 48.3 t -58.68 -49.72 76.52 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.073 -0.512 . . . . 1.13 110.757 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.473 HD12 ' O ' ' B' ' 17' ' ' LEU . 8.4 mp -60.51 -45.4 93.93 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.326 -0.397 . . . . 1.63 111.044 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.18 -56.51 21.1 Favored 'General case' 0 C--O 1.214 -0.802 0 C-N-CA 120.871 -0.332 . . . . 1.17 110.752 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.466 HG12 ' O ' ' B' ' 19' ' ' THR . 47.7 mm -56.63 -37.93 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 110.774 -0.084 . . . . 1.32 110.774 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -59.36 -46.63 88.11 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.886 -0.413 . . . . 1.49 109.886 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.1 t -76.51 -45.76 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.446 0.641 . . . . 1.35 111.591 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 . . . . . 0 C--N 1.325 -0.5 0 C-N-CA 124.121 0.968 . . . . 0.99 112.493 -179.115 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 50.7 mm . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 112.503 0.557 . . . . 1.18 112.503 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.502 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 72.8 mt -55.74 -63.12 3.5 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.233 0.457 . . . . 1.24 112.233 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.502 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.8 Cg_endo -55.47 -39.99 88.0 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.041 1.827 . . . . 0.63 111.899 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 50.2 t -59.65 -47.08 87.01 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.387 -0.369 . . . . 0.66 110.95 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 22.2 t -63.98 -47.57 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 116.617 -0.265 . . . . 1.15 111.133 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.408 ' HA ' HD12 ' B' ' 17' ' ' LEU . 4.2 mm? -59.46 -48.71 80.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.749 -0.205 . . . . 1.26 111.221 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.2 mt -61.24 -45.32 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.557 0.218 . . . . 1.24 110.757 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 38.4 m -61.43 -46.6 89.43 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.754 0.311 . . . . 0.46 110.796 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 48.0 t -59.83 -50.88 72.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.176 -0.465 . . . . 0.68 110.942 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.456 HD13 ' N ' ' B' ' 21' ' ' LEU . 9.1 mp -60.56 -44.35 96.26 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.63 0.252 . . . . 1.21 111.024 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.22 -59.6 5.05 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 116.566 -0.288 . . . . 1.08 110.604 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 77.3 mt -54.46 -39.3 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.353 0.121 . . . . 1.11 110.907 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.8 tp -57.47 -45.75 84.46 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.758 0.313 . . . . 1.16 110.631 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 72.4 t -80.87 -43.66 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.642 0.734 . . . . 1.13 111.88 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 . . . . . 0 C--N 1.321 -0.635 0 C-N-CA 124.281 1.032 . . . . 0.74 113.543 -178.321 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 45.7 mm . . . . . 0 N--CA 1.442 -0.83 0 CA-C-O 120.705 0.288 . . . . 1.23 111.524 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.472 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 80.6 mt -53.84 -60.74 6.54 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 116.151 -0.477 . . . . 1.39 112.177 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.472 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.0 Cg_endo -55.32 -40.69 84.3 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.928 1.752 . . . . 0.64 112.003 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 48.3 t -61.04 -53.33 58.54 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.299 -0.409 . . . . 0.73 111.911 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.407 HG22 ' O ' ' B' ' 13' ' ' ILE . 33.2 m -64.35 -38.03 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 120.701 -0.399 . . . . 1.16 111.191 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.427 HD11 ' N ' ' B' ' 17' ' ' LEU . 7.1 mp -61.92 -53.2 58.96 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.313 0.101 . . . . 1.31 111.204 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.97 -35.62 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 120.736 -0.386 . . . . 1.21 110.849 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 80.0 m -65.35 -47.0 77.97 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.97 -0.382 . . . . 1.19 109.97 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 39.9 t -59.83 -50.9 72.0 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.991 -0.55 . . . . 0.76 110.898 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.22 -44.87 94.81 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.651 -0.25 . . . . 1.27 111.099 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.54 -57.16 14.17 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 120.866 -0.333 . . . . 1.16 110.566 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.62 -37.1 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 121.49 -0.084 . . . . 1.22 110.957 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.5 tp -59.86 -45.65 91.78 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.011 0.434 . . . . 1.26 110.269 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 73.8 t -77.5 -47.24 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.461 0.648 . . . . 1.33 111.316 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 114.98 -1.009 . . . . 0.98 112.207 -179.427 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.7 tp . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 111.591 0.219 . . . . 1.33 111.591 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.548 ' O ' HG23 ' B' ' 16' ' ' VAL . 82.1 mt -57.15 -61.11 7.7 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 111.933 0.346 . . . . 1.41 111.933 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.471 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.1 Cg_endo -55.37 -38.91 93.47 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.727 1.618 . . . . 0.82 111.641 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 40.9 t -59.69 -54.5 45.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.042 -0.526 . . . . 0.98 111.796 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 13' ' ' ILE . 27.5 m -65.1 -40.91 90.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 121.021 -0.272 . . . . 1.26 111.665 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.651 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 3.9 mm? -60.75 -53.03 62.39 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 121.173 -0.211 . . . . 1.29 111.019 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 43.5 mm -60.09 -43.74 93.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.508 0.194 . . . . 1.28 110.64 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 91.5 m -60.0 -45.5 92.53 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.625 0.25 . . . . 1.22 110.374 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 47.7 t -60.09 -51.04 71.31 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.236 -0.438 . . . . 0.98 110.497 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 60.4 mt -58.11 -44.62 87.78 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 120.765 0.317 . . . . 1.26 110.48 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' B' ' 26' ' ' PHE . . . -59.0 -60.54 3.7 Favored 'General case' 0 C--O 1.204 -1.306 0 CA-C-N 116.296 -0.411 . . . . 1.12 110.237 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.445 HD13 HG22 ' B' ' 23' ' ' ILE . 71.8 mt -50.95 -39.79 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 120.572 0.225 . . . . 1.19 111.147 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 52.6 tp -58.31 -47.78 82.6 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.684 0.278 . . . . 1.32 110.929 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.11 -39.6 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.671 0.748 . . . . 1.23 111.295 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' B' ' 22' ' ' ALA . 3.3 m-85 . . . . . 0 C--N 1.324 -0.537 0 C-N-CA 124.693 1.197 . . . . 0.6 111.812 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.57 HG22 ' H ' ' B' ' 13' ' ' ILE . 5.7 tp . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 110.641 -0.133 . . . . 1.21 110.641 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.57 ' H ' HG22 ' B' ' 12' ' ' ILE . 87.5 mt -56.25 -55.09 45.78 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 110.63 -0.137 . . . . 1.33 110.63 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' B' ' 13' ' ' ILE . 19.7 Cg_endo -54.1 -44.82 45.85 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.882 2.388 . . . . 0.51 111.401 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.1 t -60.14 -43.73 95.47 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.965 -0.561 . . . . 0.71 110.856 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.28 -48.82 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 112.071 0.397 . . . . 1.21 112.071 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.526 ' O ' HD21 ' B' ' 21' ' ' LEU . 2.2 pp -66.55 -43.56 84.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.401 -0.52 . . . . 1.17 111.397 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 31.6 mm -60.52 -45.15 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.666 0.269 . . . . 1.21 110.517 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.458 ' O ' HG12 ' B' ' 23' ' ' ILE . 47.6 m -62.57 -45.73 91.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.501 -0.318 . . . . 1.23 110.387 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.497 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 49.9 m -58.89 -52.47 65.58 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.19 -0.459 . . . . 0.48 110.894 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.526 HD21 ' O ' ' B' ' 17' ' ' LEU . 4.1 mm? -58.72 -44.11 90.34 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.716 -0.22 . . . . 1.23 110.682 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.17 -56.13 26.05 Favored 'General case' 0 C--O 1.212 -0.893 0 C-N-CA 120.891 -0.324 . . . . 1.22 110.467 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.458 HG12 ' O ' ' B' ' 19' ' ' THR . 50.1 mm -55.06 -40.02 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 122.82 0.075 . . . . 1.24 111.15 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' ' 20' ' ' SER . 92.6 mt -60.11 -44.83 94.58 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.89 0.376 . . . . 1.21 110.795 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 92.3 t -77.69 -40.47 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.68 0.752 . . . . 1.19 111.649 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 115.022 -0.99 . . . . 0.91 113.345 -178.294 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.564 HG22 ' N ' ' B' ' 13' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.605 0 CA-C-O 120.312 0.101 . . . . 1.1 111.147 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.681 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 4.8 mp -57.93 -62.21 5.91 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 111.454 0.168 . . . . 1.15 111.454 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.479 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.7 Cg_endo -55.01 -39.63 89.97 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.89 1.726 . . . . 0.37 111.855 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 53.7 t -60.28 -49.85 75.99 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.201 -0.454 . . . . 0.95 111.511 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.462 HG12 ' N ' ' B' ' 17' ' ' LEU . 7.3 p -66.0 -41.2 89.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 120.761 -0.376 . . . . 1.1 111.074 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 58.7 mt -59.65 -52.85 63.74 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 121.23 -0.188 . . . . 1.11 110.576 178.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.403 HG12 ' O ' ' B' ' 14' ' ' PRO . 45.4 mm -59.65 -42.81 89.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.622 -0.263 . . . . 1.12 110.572 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.539 ' O ' HG12 ' B' ' 23' ' ' ILE . 76.4 m -60.6 -46.46 90.16 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.151 -0.314 . . . . 1.08 110.151 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 48.4 t -59.22 -51.56 69.44 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.322 -0.399 . . . . 0.99 110.883 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 58.8 mt -58.63 -44.82 90.12 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.715 0.293 . . . . 1.2 110.889 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.87 -55.74 31.21 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 116.441 -0.345 . . . . 1.1 110.756 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.539 HG12 ' O ' ' B' ' 19' ' ' THR . 43.9 mm -57.4 -37.39 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 121.266 -0.173 . . . . 1.16 110.724 179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 52.7 tp -59.78 -46.01 90.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.965 0.412 . . . . 1.16 110.311 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t -76.97 -46.36 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.401 0.619 . . . . 1.17 111.36 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 . . . . . 0 C--N 1.326 -0.451 0 C-N-CA 124.175 0.99 . . . . 0.85 112.303 -179.2 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 6.9 tp . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 111.636 0.236 . . . . 1.59 111.636 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.479 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 79.6 mt -57.14 -61.22 7.51 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 111.756 0.28 . . . . 1.8 111.756 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.479 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.9 Cg_endo -55.36 -40.31 86.27 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.841 1.694 . . . . 1.13 111.869 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 42.9 t -61.68 -53.24 58.78 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.285 -0.416 . . . . 1.02 111.901 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.531 HG12 HD12 ' B' ' 17' ' ' LEU . 12.5 p -63.82 -38.4 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 120.601 -0.439 . . . . 1.54 110.83 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.631 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 7.0 mp -61.66 -54.18 46.27 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.998 -0.092 . . . . 1.71 111.201 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.58 -35.83 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.838 -0.345 . . . . 1.29 110.882 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.427 ' O ' HG12 ' B' ' 23' ' ' ILE . 86.5 m -64.46 -45.77 85.99 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.841 -0.429 . . . . 1.33 109.841 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 48.4 t -60.23 -52.28 65.99 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.882 -0.599 . . . . 1.09 110.528 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 59.8 mt -57.16 -44.61 83.66 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.74 0.305 . . . . 1.41 110.812 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.28 -58.15 9.77 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 116.326 -0.397 . . . . 1.23 110.705 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.427 HG12 ' O ' ' B' ' 19' ' ' THR . 51.9 mm -54.61 -40.49 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 117.58 0.173 . . . . 1.41 111.113 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' B' ' 20' ' ' SER . 85.7 mt -58.99 -44.57 91.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 121.093 -0.243 . . . . 1.35 111.029 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -80.06 -43.26 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.67 0.748 . . . . 1.38 111.738 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 114.951 -1.022 . . . . 1.1 113.399 -178.488 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.436 HG21 ' N ' ' B' ' 13' ' ' ILE . 9.0 tp . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 120.331 0.11 . . . . 1.43 111.28 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.502 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 77.5 mt -60.29 -61.68 7.44 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 111.535 0.198 . . . . 1.49 111.535 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.502 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.4 Cg_endo -55.57 -39.39 91.33 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.853 1.702 . . . . 0.96 111.544 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . 0.402 ' O ' HG13 ' B' ' 18' ' ' ILE . 50.3 t -64.21 -51.68 62.56 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.146 -0.479 . . . . 0.88 112.012 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.599 HG13 HD12 ' B' ' 17' ' ' LEU . 10.0 p -62.43 -38.26 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 120.403 -0.519 . . . . 1.21 110.401 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.599 HD12 HG13 ' B' ' 16' ' ' VAL . 7.4 mp -62.32 -53.71 51.07 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.843 -0.162 . . . . 1.34 111.089 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.402 HG13 ' O ' ' B' ' 15' ' ' CYS . 2.6 pp -63.42 -35.36 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 120.782 -0.367 . . . . 1.32 111.189 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.438 ' O ' HG12 ' B' ' 23' ' ' ILE . 37.0 m -66.03 -44.09 85.68 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.563 -0.532 . . . . 1.18 109.563 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 46.6 t -61.16 -51.27 69.75 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.776 -0.647 . . . . 0.97 111.631 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.412 HD13 ' N ' ' B' ' 22' ' ' ALA . 3.2 pp -64.93 -38.86 92.35 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.45 -0.5 . . . . 0.92 111.039 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.412 ' N ' HD13 ' B' ' 21' ' ' LEU . . . -59.93 -57.7 11.75 Favored 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 120.554 -0.458 . . . . 1.15 110.121 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.438 HG12 ' O ' ' B' ' 19' ' ' THR . 51.3 mm -56.32 -39.11 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 122.967 0.167 . . . . 1.14 110.756 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.58 -45.15 85.57 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.865 0.364 . . . . 1.29 110.462 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 69.8 t -79.44 -45.15 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.457 0.646 . . . . 1.24 111.576 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 114.908 -1.042 . . . . 0.76 113.012 -178.877 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 39.9 mm . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 112.408 0.522 . . . . 1.45 112.408 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.697 ' H ' HD13 ' B' ' 13' ' ' ILE . 3.1 mp -54.21 -59.98 8.68 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 111.905 0.335 . . . . 1.31 111.905 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.408 ' O ' HG12 ' B' ' 18' ' ' ILE . 12.1 Cg_endo -56.29 -41.31 77.79 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 121.967 1.778 . . . . 0.94 112.065 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.1 t -58.75 -48.08 82.44 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.733 0.301 . . . . 1.71 110.868 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.03 -47.14 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 116.37 -0.377 . . . . 1.51 110.967 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.407 HD11 ' O ' ' B' ' 13' ' ' ILE . 8.6 mp -58.54 -50.68 72.9 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.661 -0.245 . . . . 1.68 111.417 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.408 HG12 ' O ' ' B' ' 14' ' ' PRO . 46.4 mm -61.36 -44.89 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 120.448 0.166 . . . . 1.72 110.835 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 44.7 m -60.87 -47.19 87.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.715 0.293 . . . . 1.38 110.69 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 44.4 t -60.38 -50.98 71.46 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.272 -0.422 . . . . 1.58 110.929 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 8.8 mp -59.03 -45.82 89.76 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 116.553 -0.294 . . . . 1.93 110.768 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' B' ' 26' ' ' PHE . . . -58.64 -57.57 12.4 Favored 'General case' 0 C--O 1.207 -1.174 0 N-CA-C 110.044 -0.354 . . . . 1.45 110.044 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 30.7 mm -53.21 -38.35 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.481 0.181 . . . . 1.27 111.458 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.9 tp -60.67 -45.86 92.55 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.836 0.35 . . . . 1.98 110.654 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -80.58 -37.92 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.547 0.689 . . . . 1.86 111.392 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' B' ' 22' ' ' ALA . 2.8 m-85 . . . . . 0 C--N 1.324 -0.522 0 C-N-CA 124.401 1.08 . . . . 1.73 111.913 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.413 HG22 ' N ' ' B' ' 13' ' ' ILE . 7.4 tp . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 111.875 0.324 . . . . 1.37 111.875 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.708 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 74.4 mt -58.38 -62.48 5.53 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 111.854 0.316 . . . . 1.35 111.854 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.505 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.4 Cg_endo -54.42 -40.13 84.5 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 121.882 1.722 . . . . 0.64 111.834 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 t -61.93 -50.29 72.75 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.014 -0.539 . . . . 1.3 111.558 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.533 HG11 ' N ' ' B' ' 17' ' ' LEU . 7.2 p -64.14 -39.0 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.6 -0.44 . . . . 1.06 110.947 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 60.3 mt -62.78 -53.39 54.99 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 122.451 -0.156 . . . . 1.2 111.275 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.83 -36.69 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 120.762 -0.375 . . . . 1.19 111.15 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 88.1 m -64.78 -46.38 82.32 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.826 0.346 . . . . 0.96 110.126 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.5 m -60.14 -50.96 71.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.051 -0.522 . . . . 0.46 110.626 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -59.62 -44.46 93.45 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 116.592 -0.276 . . . . 1.12 110.629 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.549 ' O ' ' HB2' ' B' ' 26' ' ' PHE . . . -59.16 -60.57 3.66 Favored 'General case' 0 C--O 1.205 -1.287 0 CA-C-O 119.259 -0.401 . . . . 1.13 110.131 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' B' ' 23' ' ' ILE . 36.6 mm -51.04 -38.67 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 117.817 0.281 . . . . 1.22 111.289 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 53.7 tp -59.54 -47.54 85.14 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.755 0.312 . . . . 1.34 110.927 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 60.8 t -83.37 -39.94 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.771 0.796 . . . . 1.35 111.373 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . 0.549 ' HB2' ' O ' ' B' ' 22' ' ' ALA . 3.9 m-85 . . . . . 0 C--N 1.324 -0.523 0 C-N-CA 124.895 1.278 . . . . 0.86 111.947 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . 0.482 HG22 ' N ' ' B' ' 13' ' ' ILE . 7.7 tp . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 112.089 0.403 . . . . 1.38 112.089 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.661 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 73.9 mt -59.49 -62.71 5.32 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 111.709 0.263 . . . . 1.5 111.709 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.509 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.2 Cg_endo -54.51 -37.2 90.11 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.735 1.623 . . . . 0.72 111.604 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 41.3 t -61.24 -51.3 69.51 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.198 -0.455 . . . . 0.9 111.56 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 35.5 m -65.77 -39.08 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 120.684 -0.406 . . . . 1.26 111.225 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 57.3 mt -61.84 -53.97 48.5 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 121.165 -0.214 . . . . 1.34 110.73 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 45.0 mm -60.15 -43.36 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.642 -0.254 . . . . 1.29 111.085 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.4 HG22 HD13 ' B' ' 23' ' ' ILE . 58.4 m -60.44 -44.37 95.88 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.653 0.263 . . . . 1.26 110.423 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -61.53 -50.61 72.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.241 -0.436 . . . . 0.71 110.818 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 60.6 mt -58.28 -44.89 88.67 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.781 0.324 . . . . 1.49 110.534 179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.01 -57.65 11.87 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 116.222 -0.445 . . . . 1.35 110.59 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.4 HD13 HG22 ' B' ' 19' ' ' THR . 71.6 mt -56.23 -37.96 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 122.821 0.076 . . . . 1.38 110.915 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 54.8 tp -58.9 -45.34 90.54 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.042 0.449 . . . . 1.54 110.281 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 70.7 t -78.62 -46.3 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.447 0.641 . . . . 1.63 111.34 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.009 -0.996 . . . . 1.54 112.69 -179.146 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 3.8 mm . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.562 0.22 . . . . 1.28 111.564 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.698 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 73.8 mt -54.61 -62.63 3.79 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.857 0.318 . . . . 1.21 111.857 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.506 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.3 Cg_endo -55.53 -39.9 88.46 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 121.73 1.62 . . . . 0.44 111.723 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 40.8 t -60.96 -50.75 72.12 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.103 -0.499 . . . . 1.13 111.448 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.445 HG12 ' O ' ' B' ' 13' ' ' ILE . 8.4 p -64.73 -41.79 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.9 -0.32 . . . . 1.16 111.177 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 60.0 mt -60.19 -51.14 70.84 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 122.276 -0.265 . . . . 1.18 110.605 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.8 mt -60.02 -44.04 93.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.536 -0.302 . . . . 1.32 110.718 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.477 ' O ' HG12 ' B' ' 23' ' ' ILE . 67.6 m -60.54 -45.01 95.47 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.405 -0.361 . . . . 1.2 110.625 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.3 t -60.7 -49.64 76.71 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.245 -0.434 . . . . 0.83 110.647 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 60.4 mt -59.71 -44.6 93.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.721 0.296 . . . . 1.21 110.556 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.77 11.42 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 116.418 -0.356 . . . . 1.19 110.641 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.477 HG12 ' O ' ' B' ' 19' ' ' THR . 45.4 mm -56.8 -36.91 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.282 0.087 . . . . 1.28 110.956 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.6 -44.44 96.27 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.952 0.406 . . . . 1.82 110.162 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 79.6 t -78.51 -47.54 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 121.444 0.64 . . . . 1.32 111.138 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 114.898 -1.046 . . . . 1.04 112.405 -179.285 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.6 mm . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 111.763 0.283 . . . . 1.29 111.763 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.417 HD11 ' H ' ' B' ' 13' ' ' ILE . 3.6 mp -57.99 -62.44 5.48 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 116.646 -0.252 . . . . 1.17 111.591 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.404 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.5 Cg_endo -56.03 -38.07 95.3 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.642 1.561 . . . . 0.36 111.821 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . 0.427 ' O ' HG13 ' B' ' 18' ' ' ILE . 42.0 t -60.86 -53.78 53.19 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.316 -0.402 . . . . 0.67 111.551 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.568 HG12 HD11 ' B' ' 17' ' ' LEU . 12.1 p -63.96 -37.85 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 120.684 -0.406 . . . . 1.2 110.623 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.568 HD11 HG12 ' B' ' 16' ' ' VAL . 6.9 mp -61.5 -53.04 61.63 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.942 -0.117 . . . . 1.18 111.19 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.427 HG13 ' O ' ' B' ' 15' ' ' CYS . 2.6 pp -63.57 -34.27 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 120.707 -0.397 . . . . 1.13 110.831 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.464 ' O ' HG12 ' B' ' 23' ' ' ILE . 34.8 m -66.11 -48.07 72.1 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.811 0.338 . . . . 1.18 110.27 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -59.09 -48.53 81.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.012 -0.54 . . . . 0.87 110.504 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 9.1 mp -60.78 -45.55 93.93 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.26 -0.427 . . . . 1.18 110.937 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.36 -56.33 23.54 Favored 'General case' 0 C--O 1.215 -0.731 0 C-N-CA 120.822 -0.351 . . . . 1.13 110.608 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.464 HG12 ' O ' ' B' ' 19' ' ' THR . 46.4 mm -56.73 -37.64 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 122.835 0.085 . . . . 1.31 110.779 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.91 -45.31 92.97 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.971 0.415 . . . . 1.31 110.407 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -77.33 -45.93 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.444 0.64 . . . . 1.32 111.312 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 . . . . . 0 C--N 1.326 -0.424 0 C-N-CA 124.306 1.042 . . . . 1.02 112.573 -179.051 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 51.3 mm . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 112.479 0.548 . . . . 2.27 112.479 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.439 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 84.1 mt -54.01 -61.37 5.43 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 111.878 0.325 . . . . 2.29 111.878 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.439 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.3 Cg_endo -54.87 -41.25 80.2 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 122.088 1.858 . . . . 1.63 111.605 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 41.2 t -60.2 -48.48 81.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.364 -0.38 . . . . 2.11 110.817 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 t -62.06 -46.61 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 120.696 0.284 . . . . 1.85 110.762 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.56 ' O ' HD23 ' B' ' 21' ' ' LEU . 4.1 mm? -60.24 -51.49 69.35 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.456 -0.338 . . . . 1.89 111.816 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.37 -36.77 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 120.49 -0.484 . . . . 1.57 110.978 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.487 ' O ' HG12 ' B' ' 23' ' ' ILE . 80.4 m -65.9 -47.09 75.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.878 0.371 . . . . 1.38 110.039 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.508 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 41.0 t -58.81 -51.81 68.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.015 -0.539 . . . . 1.09 110.782 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.56 HD23 ' O ' ' B' ' 17' ' ' LEU . 4.1 mm? -59.01 -44.65 91.73 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.654 -0.248 . . . . 1.79 110.786 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.72 -56.29 23.88 Favored 'General case' 0 C--O 1.211 -0.928 0 C-N-CA 120.852 -0.339 . . . . 1.31 110.585 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.487 HG12 ' O ' ' B' ' 19' ' ' THR . 50.0 mm -55.61 -40.13 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.288 0.09 . . . . 1.22 111.144 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' B' ' 20' ' ' SER . 87.9 mt -59.23 -43.78 92.35 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.779 0.323 . . . . 1.49 110.6 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 73.5 t -78.83 -45.6 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.528 0.68 . . . . 1.46 111.652 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 . . . . . 0 C--N 1.325 -0.46 0 C-N-CA 124.277 1.031 . . . . 1.05 112.975 -178.83 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.6 tp . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 120.581 0.229 . . . . 1.32 110.981 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.568 ' O ' HD21 ' B' ' 17' ' ' LEU . 79.9 mt -58.18 -62.21 5.98 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 111.832 0.308 . . . . 1.29 111.832 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' PRO . . . . . 0.498 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.9 Cg_endo -55.91 -40.4 85.29 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 121.873 1.716 . . . . 0.59 111.671 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.3 t -59.76 -52.66 64.52 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.153 -0.476 . . . . 0.97 111.715 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.487 HG11 ' N ' ' B' ' 17' ' ' LEU . 11.8 p -64.84 -41.23 91.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 120.805 -0.358 . . . . 1.35 111.332 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' LEU . . . . . 0.568 HD21 ' O ' ' B' ' 13' ' ' ILE . 3.8 mm? -61.09 -52.16 66.07 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 121.144 -0.222 . . . . 1.39 111.023 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.403 HG12 ' O ' ' B' ' 14' ' ' PRO . 43.9 mm -60.16 -43.89 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.599 0.238 . . . . 1.28 110.675 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 75.5 m -60.6 -47.37 86.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.679 0.276 . . . . 0.88 110.669 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' SER . . . . . 0.498 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 48.1 t -59.44 -52.78 64.12 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.323 -0.399 . . . . 0.98 110.771 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -57.83 -45.58 85.98 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.576 -0.284 . . . . 1.59 110.918 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.99 -54.78 42.85 Favored 'General case' 0 C--O 1.212 -0.872 0 C-N-CA 120.922 -0.311 . . . . 1.28 110.164 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 34.2 mm -54.53 -45.88 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 122.932 0.145 . . . . 1.44 110.973 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' B' ' 20' ' ' SER . 93.3 mt -54.45 -41.55 69.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.821 0.343 . . . . 1.56 110.872 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 91.7 t -81.32 -36.02 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.374 0.607 . . . . 1.42 111.49 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 . . . . . 0 C--N 1.326 -0.44 0 C-N-CA 124.094 0.958 . . . . 1.03 113.389 -177.884 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.291 0.091 . . . . 1.35 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -88.31 -151.56 0.2 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.01 0.434 . . . . 1.38 110.697 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.556 ' H ' ' HD3' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -72.27 154.76 91.98 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.16 -0.473 . . . . 0.97 110.694 179.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.69 153.45 11.1 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.3 2.666 . . . . 1.06 113.857 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' B' ' 6' ' ' PHE . 3.9 mm? 68.1 97.31 0.06 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.608 -0.724 . . . . 1.48 111.541 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' B' ' 5' ' ' LEU . 5.2 m-85 72.18 108.49 0.07 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.572 -0.74 . . . . 1.27 111.718 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.98 -134.78 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.539 -0.755 . . . . 1.36 111.599 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 5.5 t -68.02 132.88 48.08 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.82 -0.55 . . . . 1.07 111.075 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 17.7 mm -77.3 59.12 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 112.681 0.623 . . . . 1.25 112.681 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -77.51 60.05 2.03 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.157 -0.339 . . . . 0.77 111.075 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 99.0 mt 59.8 35.71 22.04 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.962 -0.563 . . . . 1.26 111.004 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.455 HG21 ' N ' ' B' ' 13' ' ' ILE . 8.0 tp -68.15 -41.0 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.748 -0.66 . . . . 1.26 111.988 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.49 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 78.3 mt -55.99 -61.98 5.49 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 111.767 0.284 . . . . 1.4 111.767 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.49 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.9 Cg_endo -55.23 -40.5 85.36 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 122.153 1.902 . . . . 0.62 111.852 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 t -59.76 -47.47 85.56 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.455 -0.339 . . . . 0.65 110.911 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.5 t -63.93 -46.88 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 116.555 -0.293 . . . . 1.29 110.895 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.653 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 9.4 mp -59.22 -50.56 73.56 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.455 -0.338 . . . . 1.33 111.125 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.6 mt -59.97 -44.68 95.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.567 0.222 . . . . 1.19 110.699 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.425 ' O ' HG12 ' B' ' 23' ' ' ILE . 51.3 m -60.63 -45.72 92.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.845 0.355 . . . . 1.17 110.339 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 43.3 t -58.82 -50.71 72.94 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.09 -0.505 . . . . 0.68 110.954 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 58.7 mt -60.0 -45.55 92.39 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.69 0.281 . . . . 0.83 110.793 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.24 -58.18 9.6 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 116.39 -0.368 . . . . 1.08 110.784 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.425 HG12 ' O ' ' B' ' 19' ' ' THR . 52.0 mm -55.13 -39.56 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.39 0.138 . . . . 1.17 110.907 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 54.7 tp -57.78 -45.95 85.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.932 0.396 . . . . 1.29 110.504 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 78.6 t -78.76 -46.68 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.467 0.651 . . . . 1.3 111.639 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -61.63 -53.11 60.63 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.28 1.032 . . . . 0.96 113.171 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.415 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 2.7 m-85 -82.48 -36.81 26.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.477 -0.329 . . . . 1.02 111.493 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.527 ' O ' ' HE2' ' B' ' 35' ' ' LYS . 17.1 tp 57.82 68.0 2.09 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.086 -0.506 . . . . 1.3 112.15 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.05 55.51 1.82 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.761 2.307 . . . . 0.84 113.614 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 87.5 p -79.14 146.29 33.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.761 0.315 . . . . 0.69 111.524 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -72.29 59.79 0.42 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.13 0.491 . . . . 1.37 111.843 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 40.9 t -158.34 135.83 10.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.101 -0.5 . . . . 1.05 110.472 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.54 46.88 1.76 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 115.335 0.894 . . . . 1.42 115.335 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.4 -33.36 19.14 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.046 0.923 . . . . 1.96 109.783 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.527 ' HE2' ' O ' ' B' ' 28' ' ' LEU . 9.2 ptpp? . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.36 -0.829 . . . . 1.54 111.737 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 111.504 0.187 . . . . 1.2 111.504 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -71.29 136.23 47.8 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.555 -0.293 . . . . 1.26 110.739 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -67.16 138.9 94.86 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.81 0.338 . . . . 1.55 110.604 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.02 125.3 16.75 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.235 1.957 . . . . 0.53 112.525 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.51 59.55 1.12 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.089 -0.505 . . . . 1.36 110.721 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 66.1 45.81 2.28 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.35 -0.841 . . . . 0.9 110.959 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -63.15 -35.41 80.18 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.921 -0.582 . . . . 1.24 112.343 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.486 HG23 HD22 ' B' ' 10' ' ' ASN . 3.3 t -148.97 134.76 18.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.192 0.52 . . . . 1.19 111.822 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.709 HD11 HD12 ' B' ' 13' ' ' ILE . 5.4 tp -79.4 125.16 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.767 -0.651 . . . . 1.18 111.697 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.486 HD22 HG23 ' B' ' 8' ' ' THR . 11.0 p30 -173.64 -143.12 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.613 -0.722 . . . . 0.4 110.542 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.466 ' N ' HD23 ' B' ' 11' ' ' LEU . 3.6 mm? -78.95 -23.96 44.23 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.488 0.921 . . . . 1.29 113.488 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.569 HG22 ' N ' ' B' ' 13' ' ' ILE . 10.9 tp -63.25 -42.36 96.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 113.044 0.757 . . . . 1.17 113.044 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.709 HD12 HD11 ' B' ' 9' ' ' ILE . 68.8 mt -59.34 -61.17 8.38 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.315 0.487 . . . . 1.13 112.315 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.421 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.1 Cg_endo -54.48 -40.03 85.29 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.864 1.709 . . . . 0.46 111.485 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.8 t -60.1 -51.93 67.51 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.22 -0.446 . . . . 1.16 111.671 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 34.7 m -65.22 -38.89 83.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 112.296 0.48 . . . . 1.1 112.296 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 3.5 pp -69.97 -43.35 71.67 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 119.624 -0.83 . . . . 1.15 111.651 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -66.5 -38.04 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.276 -0.57 . . . . 1.14 110.312 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.469 ' O ' HG12 ' B' ' 23' ' ' ILE . 87.5 m -64.59 -47.22 79.49 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.126 -0.324 . . . . 1.11 110.126 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.47 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 48.7 m -59.17 -51.48 69.83 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.19 -0.459 . . . . 0.4 110.618 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.429 ' N ' HD12 ' B' ' 21' ' ' LEU . 8.6 mp -57.97 -45.22 87.05 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.63 -0.259 . . . . 1.19 110.847 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.95 -57.26 13.31 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 116.489 -0.323 . . . . 0.48 110.855 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.469 HG12 ' O ' ' B' ' 19' ' ' THR . 45.9 mm -55.3 -40.75 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 117.521 0.146 . . . . 1.15 111.208 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' B' ' 20' ' ' SER . 84.4 mt -58.31 -42.57 87.01 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.868 0.366 . . . . 1.13 110.485 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 76.9 t -80.61 -46.3 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.472 0.653 . . . . 1.12 111.667 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -62.39 -61.36 2.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.412 1.085 . . . . 0.74 113.134 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -73.59 -32.4 64.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.273 -0.421 . . . . 1.14 110.931 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.457 HD11 ' HZ2' ' B' ' 35' ' ' LYS . 13.6 tp 59.98 61.53 3.83 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.464 -0.789 . . . . 1.2 111.877 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' B' ' 28' ' ' LEU . 31.3 Cg_endo -85.63 41.67 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.517 2.145 . . . . 0.88 112.011 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 12.8 p -91.22 44.47 1.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.817 -0.628 . . . . 0.62 111.359 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -69.31 -49.09 59.06 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.223 -0.444 . . . . 1.26 111.674 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 41.2 t -64.19 -26.44 68.52 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.938 0.399 . . . . 1.48 111.33 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.27 126.89 1.39 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.034 -0.603 . . . . 0.91 112.463 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -74.24 64.04 1.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.114 0.783 . . . . 1.21 113.114 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.457 ' HZ2' HD11 ' B' ' 28' ' ' LEU . 3.9 mppt? . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.322 -0.847 . . . . 1.61 111.987 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 111.209 0.077 . . . . 3.26 111.209 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 56.48 -147.14 0.53 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.97 0.414 . . . . 2.18 111.703 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.505 ' HD2' ' HB2' ' B' ' 6' ' ' PHE . 59.2 pttt -169.82 146.9 2.81 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.617 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.506 ' HB2' ' H ' ' B' ' 5' ' ' LEU . 56.2 Cg_endo -72.04 -140.66 0.02 OUTLIER 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.761 2.307 . . . . 1.28 112.724 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.506 ' H ' ' HB2' ' B' ' 4' ' ' PRO . 3.5 mm? -72.89 43.17 0.11 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.433 0.531 . . . . 2.09 112.433 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.505 ' HB2' ' HD2' ' B' ' 3' ' ' LYS . 3.5 m-30 -86.82 53.64 2.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.966 0.412 . . . . 1.79 111.166 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -81.92 32.7 0.37 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.021 0.439 . . . . 1.93 111.966 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 63.3 p -79.0 56.87 2.06 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.296 -0.411 . . . . 1.62 111.908 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 8.4 tp -83.07 -32.55 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.33 0.492 . . . . 1.44 112.33 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -70.86 56.25 0.18 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.945 0.721 . . . . 0.96 112.945 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.53 -21.92 66.82 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.935 0.398 . . . . 1.59 111.843 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.416 HG23 ' N ' ' B' ' 13' ' ' ILE . 8.1 tp -61.95 -34.76 64.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.282 -0.417 . . . . 1.47 111.974 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.638 ' O ' HG13 ' B' ' 16' ' ' VAL . 71.6 mt -61.72 -63.07 4.7 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 111.889 0.329 . . . . 1.3 111.889 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.495 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.4 Cg_endo -54.76 -40.48 84.58 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.863 1.709 . . . . 0.86 111.461 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 52.0 t -62.43 -48.66 78.71 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.093 -0.503 . . . . 1.4 111.564 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.638 HG13 ' O ' ' B' ' 13' ' ' ILE . 7.5 p -64.76 -39.45 85.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.029 0.381 . . . . 1.18 112.029 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.549 HD12 HG21 ' B' ' 18' ' ' ILE . 3.0 pp -70.65 -42.8 70.33 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 119.842 -0.743 . . . . 1.2 111.561 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.549 HG21 HD12 ' B' ' 17' ' ' LEU . 2.6 pp -65.9 -37.11 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 120.067 -0.653 . . . . 1.21 110.188 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.407 ' N ' HD12 ' B' ' 18' ' ' ILE . 89.0 m -65.83 -46.26 79.24 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.805 0.336 . . . . 1.19 110.145 178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -60.56 -51.51 69.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.124 -0.489 . . . . 0.38 110.904 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.479 HD22 ' O ' ' B' ' 17' ' ' LEU . 4.1 mm? -59.89 -45.74 91.56 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.588 -0.278 . . . . 1.16 111.075 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 -57.98 10.15 Favored 'General case' 0 C--O 1.213 -0.862 0 C-N-CA 120.965 -0.294 . . . . 1.11 110.613 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.488 ' O ' ' HB2' ' B' ' 27' ' ' TYR . 74.8 mt -54.55 -39.95 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.351 0.12 . . . . 1.24 110.979 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.488 HD12 HD11 ' B' ' 28' ' ' LEU . 49.8 tp -56.81 -47.17 80.86 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.987 0.423 . . . . 1.23 110.607 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.471 HG11 ' HA ' ' B' ' 34' ' ' GLU . 77.9 t -79.93 -44.31 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.51 0.671 . . . . 1.17 111.962 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -64.62 -46.46 82.52 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.053 1.131 . . . . 0.73 114.053 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 3.8 m-85 -79.06 -41.94 27.6 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.211 0.819 . . . . 1.17 113.211 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.488 HD11 HD12 ' B' ' 24' ' ' LEU . 94.6 mt -82.61 116.03 61.57 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-O 121.144 0.497 . . . . 1.39 112.09 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.39 50.65 3.32 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.939 2.426 . . . . 1.21 113.184 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 79.9 p -80.13 -45.29 18.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.978 0.418 . . . . 1.06 111.804 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -159.24 -122.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.924 -0.58 . . . . 0.92 111.175 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 38.8 t -161.62 25.31 0.12 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 111.806 0.299 . . . . 0.8 111.806 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.11 60.53 3.09 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.958 -0.639 . . . . 0.7 112.865 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.471 ' HA ' HG11 ' B' ' 25' ' ' VAL . 13.2 pt-20 -71.76 143.01 49.73 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.793 0.664 . . . . 0.74 112.793 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 mptt . . . . . 0 C--O 1.251 1.164 0 CA-C-N 115.362 -0.835 . . . . 0.96 112.14 179.468 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 42.6 ptt85 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.534 0.207 . . . . 1.67 111.243 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -80.36 133.03 35.87 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.058 0.456 . . . . 2.22 111.828 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.526 ' HG2' ' HB3' ' B' ' 7' ' ' TYR . 25.4 tptp -169.66 128.17 0.86 Allowed Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 115.929 -0.578 . . . . 1.24 109.875 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 3' ' ' LYS . 18.2 Cg_exo -67.45 52.89 0.49 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.461 2.774 . . . . 1.24 114.188 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' B' ' 5' ' ' LEU . 62.5 mt 53.67 46.12 26.61 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.449 0.537 . . . . 2.17 112.449 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -145.2 49.18 1.27 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.167 0.508 . . . . 1.5 111.077 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.526 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 9.3 t80 -173.6 114.99 0.23 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.954 -0.566 . . . . 0.7 110.647 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.6 t -86.76 -175.17 5.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.944 -0.571 . . . . 1.42 111.641 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 6.2 tp -92.52 122.4 43.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.331 0.586 . . . . 1.23 111.153 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.491 ' O ' ' HD2' ' B' ' 14' ' ' PRO . 63.1 m-20 -73.25 129.52 38.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.59 110.521 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.619 ' H ' HD21 ' B' ' 11' ' ' LEU . 3.7 mm? -55.34 -31.69 61.91 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.566 0.58 . . . . 1.4 112.566 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.8 tp -63.0 -33.4 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.542 0.571 . . . . 1.38 112.542 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.53 ' O ' HD23 ' B' ' 17' ' ' LEU . 72.3 mt -59.78 -63.91 3.65 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 112.279 0.474 . . . . 1.21 112.279 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' B' ' 10' ' ' ASN . 12.4 Cg_endo -55.95 -37.71 95.65 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.689 1.593 . . . . 0.72 111.453 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 40.8 t -60.85 -53.4 57.79 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.092 -0.503 . . . . 1.47 111.742 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.527 HG13 ' O ' ' B' ' 13' ' ' ILE . 11.9 p -64.9 -40.68 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 120.824 -0.35 . . . . 1.24 111.509 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.53 HD23 ' O ' ' B' ' 13' ' ' ILE . 3.8 mm? -62.82 -51.83 65.53 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.42 -0.175 . . . . 1.24 111.152 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 63.7 mt -60.79 -44.8 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.552 0.215 . . . . 1.35 110.904 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 64.0 m -60.07 -46.98 87.77 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.663 0.268 . . . . 1.24 110.775 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.1 m -60.23 -50.55 73.22 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.288 -0.414 . . . . 0.6 110.725 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 8.8 mp -58.86 -45.18 90.71 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.44 -0.346 . . . . 1.34 110.68 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.58 -55.67 31.62 Favored 'General case' 0 C--O 1.208 -1.117 0 C-N-CA 120.894 -0.322 . . . . 1.18 110.329 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 74.1 mt -52.89 -41.68 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 122.967 0.167 . . . . 1.23 111.187 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.29 -46.96 87.14 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.927 0.394 . . . . 1.31 110.577 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.63 -36.32 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.474 0.654 . . . . 1.26 111.209 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.408 ' HB3' ' H ' ' B' ' 27' ' ' TYR . 3.2 m-30 -80.6 -132.14 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.107 0.963 . . . . 0.8 111.466 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.408 ' H ' ' HB3' ' B' ' 26' ' ' PHE . 3.3 m-85 34.03 47.8 0.21 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.42 -1.263 . . . . 1.3 113.585 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.94 127.93 93.47 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.342 -0.39 . . . . 1.49 111.314 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.25 45.05 0.75 Allowed 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.882 2.388 . . . . 0.87 113.29 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 90.8 p -79.65 54.59 1.82 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.992 0.425 . . . . 0.73 111.117 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -75.87 54.82 0.84 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.631 0.729 . . . . 1.03 111.299 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 28.3 p -129.86 127.92 41.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.049 -0.523 . . . . 0.77 110.912 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.16 -132.89 2.63 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.932 -0.652 . . . . 1.08 111.883 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mp0 -76.11 47.01 0.42 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.743 0.272 . . . . 2.06 111.347 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.455 -0.783 . . . . 1.61 111.35 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.235 0.064 . . . . 1.97 110.847 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 55.77 58.23 4.62 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.646 0.736 . . . . 1.28 111.141 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' B' ' 3' ' ' LYS . 31.3 mmtm -149.02 131.44 7.8 Favored Pre-proline 0 C--O 1.236 0.351 0 CA-C-N 115.582 -0.736 . . . . 0.78 111.022 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.89 119.31 6.31 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.498 2.132 . . . . 0.59 111.586 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.498 ' HA ' HD12 ' B' ' 5' ' ' LEU . 3.7 mm? 53.14 34.27 17.02 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.103 -0.499 . . . . 1.54 111.368 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 21.5 p90 43.67 39.65 2.54 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.834 0.854 . . . . 1.51 112.769 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -145.15 151.07 37.89 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.156 -0.474 . . . . 1.09 111.064 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 70.0 p -73.74 50.15 0.33 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.203 0.445 . . . . 1.35 112.203 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 8.4 tt -97.05 124.46 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.049 0.452 . . . . 1.09 111.45 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -82.66 44.34 0.89 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 111.956 0.354 . . . . 0.72 111.956 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 50.91 45.4 27.59 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.631 0.604 . . . . 1.15 112.631 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.2 tp -68.45 -40.7 82.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 112.332 0.493 . . . . 1.34 112.332 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.48 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 78.3 mt -56.62 -61.5 6.7 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 111.982 0.364 . . . . 1.39 111.982 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.48 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 14.1 Cg_endo -56.56 -39.74 89.26 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.788 1.659 . . . . 0.65 111.742 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 41.2 t -60.26 -53.05 62.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.343 -0.39 . . . . 0.88 111.792 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.503 HG12 ' N ' ' B' ' 17' ' ' LEU . 14.0 p -65.49 -40.67 88.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 120.893 -0.323 . . . . 1.21 111.118 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.604 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 7.7 mp -60.89 -51.93 67.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.486 0.184 . . . . 1.32 110.776 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.5 mt -60.31 -44.0 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 120.699 0.285 . . . . 1.34 110.689 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 75.0 m -59.96 -45.23 93.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.423 -0.353 . . . . 0.67 110.48 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 40.9 t -60.3 -50.62 72.9 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.169 -0.469 . . . . 1.24 110.826 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 53.6 mt -59.23 -44.98 92.32 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.731 0.301 . . . . 1.39 110.844 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.27 -57.77 11.42 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 116.326 -0.397 . . . . 1.24 110.712 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.06 -36.56 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 121.415 -0.114 . . . . 0.81 110.978 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' B' ' 24' ' ' LEU . 1.5 tm? -59.83 -45.77 91.35 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.771 -0.455 . . . . 1.42 109.771 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.6 t -78.08 -46.28 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.424 0.631 . . . . 1.36 111.442 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -62.54 -50.4 71.49 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.183 0.993 . . . . 1.05 112.478 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -93.99 38.83 1.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.301 -0.409 . . . . 1.12 110.798 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' B' ' 30' ' ' SER . 0.0 OUTLIER -65.04 140.95 98.23 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-O 121.223 0.535 . . . . 1.2 111.838 -179.398 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 28' ' ' LEU . 16.3 Cg_exo -68.3 68.39 1.02 Allowed 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.289 2.66 . . . . 1.04 113.151 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.55 ' HB2' HD21 ' B' ' 28' ' ' LEU . 37.6 t -66.36 117.59 8.82 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.782 0.325 . . . . 0.49 111.371 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.525 ' HA ' ' NZ ' ' B' ' 35' ' ' LYS . 13.4 t0 -165.17 111.31 0.94 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.779 0.323 . . . . 1.08 111.576 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 51.2 t -172.81 -40.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.2 -0.454 . . . . 2.01 111.384 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.64 36.26 0.02 OUTLIER Glycine 0 CA--C 1.519 0.333 0 C-N-CA 121.189 -0.529 . . . . 2.07 112.072 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.72 -41.84 4.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.839 0.352 . . . . 2.02 111.612 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.525 ' NZ ' ' HA ' ' B' ' 31' ' ' ASP . 33.4 mtmm . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.268 -0.872 . . . . 2.41 111.798 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.607 0.241 . . . . 2.45 111.393 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -77.13 139.3 39.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.762 0.315 . . . . 3.3 110.875 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.597 ' HD2' ' HD2' ' B' ' 4' ' ' PRO . 23.4 tptm -67.37 126.53 92.68 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.091 -0.504 . . . . 2.73 111.224 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.597 ' HD2' ' HD2' ' B' ' 3' ' ' LYS . 68.3 Cg_endo -73.27 53.6 2.59 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.139 2.559 . . . . 1.33 113.88 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 55.0 mt -79.18 47.35 0.78 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.412 0.523 . . . . 1.75 112.412 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.07 41.75 0.45 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.095 0.474 . . . . 1.05 111.979 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -164.15 143.25 7.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.178 -0.464 . . . . 1.19 110.393 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 80.4 p -73.85 41.8 0.13 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.586 0.587 . . . . 1.0 112.586 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 7.9 tp -71.6 -35.59 56.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.115 0.483 . . . . 1.36 110.747 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -64.33 -36.19 83.32 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.106 -0.497 . . . . 0.99 111.671 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 92.4 mt -65.8 -22.59 66.57 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.308 0.484 . . . . 1.53 112.308 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 43.5 mm -61.88 -41.92 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 112.07 0.396 . . . . 1.31 112.07 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.55 HG23 HD21 ' B' ' 17' ' ' LEU . 72.3 mt -55.98 -62.89 3.9 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.123 0.416 . . . . 1.64 112.123 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.512 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.1 Cg_endo -54.48 -40.16 84.67 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.97 1.78 . . . . 1.2 111.603 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 46.7 t -60.13 -51.43 69.66 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.932 -0.576 . . . . 1.23 111.664 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.12 -38.96 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.482 0.549 . . . . 1.21 112.482 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.754 HD11 HG21 ' B' ' 18' ' ' ILE . 3.3 pp -69.1 -42.53 76.01 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 119.651 -0.82 . . . . 1.52 111.399 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.754 HG21 HD11 ' B' ' 17' ' ' LEU . 2.6 pp -66.76 -36.88 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 120.057 -0.657 . . . . 1.5 110.034 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.466 ' O ' HG12 ' B' ' 23' ' ' ILE . 86.5 m -65.51 -47.25 76.62 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.972 -0.381 . . . . 1.15 109.972 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 48.3 t -58.68 -49.72 76.52 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.073 -0.512 . . . . 1.13 110.757 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.473 HD12 ' O ' ' B' ' 17' ' ' LEU . 8.4 mp -60.51 -45.4 93.93 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.326 -0.397 . . . . 1.63 111.044 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.18 -56.51 21.1 Favored 'General case' 0 C--O 1.214 -0.802 0 C-N-CA 120.871 -0.332 . . . . 1.17 110.752 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.466 HG12 ' O ' ' B' ' 19' ' ' THR . 47.7 mm -56.63 -37.93 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 110.774 -0.084 . . . . 1.32 110.774 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -59.36 -46.63 88.11 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.886 -0.413 . . . . 1.49 109.886 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.1 t -76.51 -45.76 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.446 0.641 . . . . 1.35 111.591 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -63.57 -50.92 67.56 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.121 0.968 . . . . 0.99 112.493 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -92.44 40.97 1.06 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.184 -0.462 . . . . 1.05 110.801 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.455 HD22 ' HB2' ' B' ' 30' ' ' SER . 0.0 OUTLIER -70.45 148.17 95.28 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.271 -0.422 . . . . 1.14 111.58 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -66.08 67.11 0.44 Allowed 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.35 2.7 . . . . 1.14 113.2 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.455 ' HB2' HD22 ' B' ' 28' ' ' LEU . 42.3 t -70.33 -50.97 33.69 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.358 -0.383 . . . . 0.71 111.186 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 55.62 -125.65 2.1 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.71 -0.677 . . . . 1.33 112.315 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 50.7 t -70.05 134.56 48.38 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.058 0.456 . . . . 2.14 111.88 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.13 128.07 1.28 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.118 -0.563 . . . . 1.5 113.362 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -69.2 71.32 0.26 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.995 0.518 . . . . 2.2 111.968 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.613 -0.708 . . . . 1.1 110.928 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 110.831 -0.062 . . . . 1.11 110.831 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 12.4 ptt85 -159.5 42.96 0.22 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.65 0.262 . . . . 0.81 111.221 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.646 ' HG3' ' HB2' ' B' ' 6' ' ' PHE . 23.7 ttmm 63.8 77.87 0.3 Allowed Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 121.318 0.58 . . . . 0.82 111.035 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.11 69.94 1.8 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.419 2.746 . . . . 0.64 112.402 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' B' ' 5' ' ' LEU . 3.9 mm? 69.84 24.56 5.25 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.68 -0.691 . . . . 1.19 111.053 -178.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.646 ' HB2' ' HG3' ' B' ' 3' ' ' LYS . 3.1 m-85 -82.01 50.81 1.63 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.822 -0.626 . . . . 1.13 110.507 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.494 ' HB2' ' HD3' ' B' ' 3' ' ' LYS . 4.6 t80 -178.41 -130.49 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.338 -0.846 . . . . 1.2 108.811 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 80.6 p -82.4 139.02 34.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 0.77 110.823 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 42.1 mt -68.98 -37.5 77.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 120.915 0.388 . . . . 1.26 110.888 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 62.57 49.48 3.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.727 -0.669 . . . . 0.5 112.369 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 93.9 mt -62.38 -23.33 66.75 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.883 0.373 . . . . 1.26 111.793 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 50.7 mm -60.75 -42.57 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 112.503 0.557 . . . . 1.18 112.503 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.502 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 72.8 mt -55.74 -63.12 3.5 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.233 0.457 . . . . 1.24 112.233 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.502 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.8 Cg_endo -55.47 -39.99 88.0 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.041 1.827 . . . . 0.63 111.899 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 50.2 t -59.65 -47.08 87.01 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.387 -0.369 . . . . 0.66 110.95 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 22.2 t -63.98 -47.57 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 116.617 -0.265 . . . . 1.15 111.133 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.408 ' HA ' HD12 ' B' ' 17' ' ' LEU . 4.2 mm? -59.46 -48.71 80.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.749 -0.205 . . . . 1.26 111.221 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.2 mt -61.24 -45.32 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.557 0.218 . . . . 1.24 110.757 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 38.4 m -61.43 -46.6 89.43 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.754 0.311 . . . . 0.46 110.796 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 48.0 t -59.83 -50.88 72.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.176 -0.465 . . . . 0.68 110.942 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.456 HD13 ' N ' ' B' ' 21' ' ' LEU . 9.1 mp -60.56 -44.35 96.26 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.63 0.252 . . . . 1.21 111.024 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.22 -59.6 5.05 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 116.566 -0.288 . . . . 1.08 110.604 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.424 ' O ' ' HB2' ' B' ' 27' ' ' TYR . 77.3 mt -54.46 -39.3 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.353 0.121 . . . . 1.11 110.907 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' B' ' 28' ' ' LEU . 55.8 tp -57.47 -45.75 84.46 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.758 0.313 . . . . 1.16 110.631 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 72.4 t -80.87 -43.66 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.642 0.734 . . . . 1.13 111.88 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -64.89 -46.57 81.17 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.281 1.032 . . . . 0.74 113.543 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 3.5 m-85 -86.67 -51.21 6.27 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.428 0.529 . . . . 0.72 112.428 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' B' ' 24' ' ' LEU . 6.7 mp -83.03 135.95 44.43 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-O 120.788 0.327 . . . . 1.17 111.383 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.65 53.07 1.36 Allowed 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.056 2.504 . . . . 0.58 113.403 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 86.8 p 56.62 -124.62 1.87 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.232 0.613 . . . . 0.45 112.188 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -141.9 -49.32 0.38 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.04 0.447 . . . . 0.65 111.473 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 29.3 m -63.74 -39.51 94.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.759 -0.655 . . . . 0.6 111.93 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.5 -55.02 0.09 OUTLIER Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.648 -0.787 . . . . 0.57 112.673 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.07 157.97 18.87 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.214 0.531 . . . . 0.61 111.449 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-N 115.288 -0.869 . . . . 0.63 111.765 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 120.547 0.213 . . . . 1.85 111.303 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -165.83 128.25 2.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.452 -0.34 . . . . 1.61 110.687 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp 66.23 111.53 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.606 0 O-C-N 123.748 0.655 . . . . 1.0 112.06 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.32 139.6 50.38 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.761 2.308 . . . . 0.63 113.033 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.51 HD22 ' N ' ' B' ' 5' ' ' LEU . 3.6 mm? -79.45 36.88 0.32 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.954 0.407 . . . . 1.24 111.787 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -87.17 55.03 3.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.98 0.419 . . . . 1.48 111.323 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -70.84 -50.54 34.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.94 111.658 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -176.35 -153.77 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.087 -0.506 . . . . 1.12 110.656 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 pt -73.91 50.31 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.366 0.603 . . . . 1.38 112.316 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -117.61 45.65 1.89 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.357 -0.383 . . . . 0.94 110.908 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.498 ' N ' HD21 ' B' ' 11' ' ' LEU . 3.4 mm? -75.3 45.27 0.28 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.937 0.399 . . . . 1.24 112.046 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 45.7 mm -72.58 -42.23 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 122.72 0.408 . . . . 1.23 111.524 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.472 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 80.6 mt -53.84 -60.74 6.54 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 116.151 -0.477 . . . . 1.39 112.177 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.472 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.0 Cg_endo -55.32 -40.69 84.3 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.928 1.752 . . . . 0.64 112.003 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 48.3 t -61.04 -53.33 58.54 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.299 -0.409 . . . . 0.73 111.911 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.407 HG22 ' O ' ' B' ' 13' ' ' ILE . 33.2 m -64.35 -38.03 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 120.701 -0.399 . . . . 1.16 111.191 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.427 HD11 ' N ' ' B' ' 17' ' ' LEU . 7.1 mp -61.92 -53.2 58.96 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.313 0.101 . . . . 1.31 111.204 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.97 -35.62 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 120.736 -0.386 . . . . 1.21 110.849 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 80.0 m -65.35 -47.0 77.97 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.97 -0.382 . . . . 1.19 109.97 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 39.9 t -59.83 -50.9 72.0 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.991 -0.55 . . . . 0.76 110.898 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.22 -44.87 94.81 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.651 -0.25 . . . . 1.27 111.099 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.54 -57.16 14.17 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 120.866 -0.333 . . . . 1.16 110.566 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' B' ' 27' ' ' TYR . 65.4 mt -56.62 -37.1 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 121.49 -0.084 . . . . 1.22 110.957 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.5 tp -59.86 -45.65 91.78 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.011 0.434 . . . . 1.26 110.269 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 73.8 t -77.5 -47.24 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.461 0.648 . . . . 1.33 111.316 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -61.71 -51.84 66.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.98 -1.009 . . . . 0.98 112.207 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.412 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 2.0 m-85 -92.01 55.08 2.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.059 -0.519 . . . . 1.5 110.562 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -53.72 131.97 56.24 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 121.342 0.591 . . . . 1.51 111.916 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.37 127.44 18.2 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.589 2.193 . . . . 0.59 112.829 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 48.3 t -78.9 -46.8 17.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.204 -0.453 . . . . 1.04 110.854 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -104.69 -173.61 2.34 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.15 0.5 . . . . 1.15 111.48 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 39.8 m -80.6 131.21 35.48 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.072 -0.513 . . . . 1.28 111.86 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.67 38.37 93.7 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 121.305 -0.474 . . . . 1.23 112.548 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -78.64 -49.06 13.85 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.175 0.435 . . . . 1.04 112.175 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 40.8 mttp . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.423 -0.799 . . . . 1.52 110.85 -179.929 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 120.427 0.156 . . . . 1.71 111.324 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.36 145.03 44.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.58 -0.282 . . . . 2.66 110.778 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -54.0 131.84 58.71 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 116.191 -0.458 . . . . 2.03 112.208 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.39 46.85 0.78 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.058 2.505 . . . . 1.33 113.492 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.506 ' HA ' HD22 ' B' ' 5' ' ' LEU . 69.9 mt -81.19 50.87 1.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.816 0.341 . . . . 1.57 111.72 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.02 31.31 0.55 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.064 0.459 . . . . 1.48 111.931 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -87.45 -38.16 16.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 2.03 111.076 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -167.48 -147.43 0.08 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.178 -0.465 . . . . 1.38 110.849 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 35.6 pt -65.07 144.03 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 121.213 0.53 . . . . 1.66 112.353 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -66.91 -40.69 87.75 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.03 -0.532 . . . . 0.9 111.439 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.87 44.46 0.75 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.006 0.432 . . . . 1.48 111.814 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.7 tp -71.17 -37.37 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.402 -0.363 . . . . 1.33 111.591 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.548 ' O ' HG23 ' B' ' 16' ' ' VAL . 82.1 mt -57.15 -61.11 7.7 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 111.933 0.346 . . . . 1.41 111.933 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.471 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.1 Cg_endo -55.37 -38.91 93.47 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.727 1.618 . . . . 0.82 111.641 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 40.9 t -59.69 -54.5 45.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.042 -0.526 . . . . 0.98 111.796 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 13' ' ' ILE . 27.5 m -65.1 -40.91 90.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 121.021 -0.272 . . . . 1.26 111.665 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.651 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 3.9 mm? -60.75 -53.03 62.39 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 121.173 -0.211 . . . . 1.29 111.019 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 43.5 mm -60.09 -43.74 93.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.508 0.194 . . . . 1.28 110.64 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 91.5 m -60.0 -45.5 92.53 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.625 0.25 . . . . 1.22 110.374 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 47.7 t -60.09 -51.04 71.31 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.236 -0.438 . . . . 0.98 110.497 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 60.4 mt -58.11 -44.62 87.78 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 120.765 0.317 . . . . 1.26 110.48 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' B' ' 26' ' ' PHE . . . -59.0 -60.54 3.7 Favored 'General case' 0 C--O 1.204 -1.306 0 CA-C-N 116.296 -0.411 . . . . 1.12 110.237 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.597 ' O ' ' HB2' ' B' ' 27' ' ' TYR . 71.8 mt -50.95 -39.79 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 120.572 0.225 . . . . 1.19 111.147 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 52.6 tp -58.31 -47.78 82.6 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.684 0.278 . . . . 1.32 110.929 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.11 -39.6 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.671 0.748 . . . . 1.23 111.295 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' B' ' 22' ' ' ALA . 3.3 m-85 -79.73 -117.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.693 1.197 . . . . 0.6 111.812 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.597 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 0.4 OUTLIER 51.98 43.7 30.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 114.511 -1.222 . . . . 0.79 112.696 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.94 113.15 45.88 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.439 -0.346 . . . . 1.64 111.128 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.14 50.46 2.86 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.637 2.225 . . . . 1.25 112.607 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 54.6 p -75.16 -61.11 2.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.983 0.421 . . . . 2.04 111.975 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.28 -143.94 0.08 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.904 -0.589 . . . . 2.5 111.761 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 25.8 p -77.13 118.6 19.83 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.921 0.391 . . . . 2.31 111.514 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 167.11 128.81 1.01 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.866 -0.683 . . . . 1.52 112.654 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 39.72 58.61 2.02 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.718 0.807 . . . . 1.39 113.079 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.558 -0.734 . . . . 1.65 110.658 179.793 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 87.1 mtm-85 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.612 0.244 . . . . 1.77 111.408 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -75.96 60.04 1.34 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.265 0.469 . . . . 1.67 112.265 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.424 ' N ' ' HD3' ' B' ' 4' ' ' PRO . 19.0 ptpt 41.08 62.83 6.36 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.668 0.988 . . . . 2.09 113.668 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.424 ' HD3' ' N ' ' B' ' 3' ' ' LYS . 4.5 Cg_exo -73.08 136.87 25.45 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.974 2.449 . . . . 1.13 112.197 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.461 ' HA ' HD12 ' B' ' 5' ' ' LEU . 3.7 mm? -73.63 51.92 0.38 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.205 0.446 . . . . 1.81 112.205 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.99 42.51 0.32 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.094 0.473 . . . . 0.9 112.091 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -76.59 -35.71 57.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.123 -0.49 . . . . 1.78 111.402 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 42.3 p -76.41 -30.8 57.6 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.546 0.573 . . . . 1.37 112.546 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 15.2 tt -156.28 138.34 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.111 0.411 . . . . 1.68 112.111 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 t30 62.88 52.18 2.74 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.441 -0.8 . . . . 0.6 111.783 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.77 -65.4 0.7 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.814 -0.63 . . . . 2.06 112.109 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.57 HG22 ' H ' ' B' ' 13' ' ' ILE . 5.7 tp -159.78 -53.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.261 -0.427 . . . . 1.21 110.641 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.57 ' H ' HG22 ' B' ' 12' ' ' ILE . 87.5 mt -56.25 -55.09 45.78 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 110.63 -0.137 . . . . 1.33 110.63 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' B' ' 13' ' ' ILE . 19.7 Cg_endo -54.1 -44.82 45.85 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.882 2.388 . . . . 0.51 111.401 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.1 t -60.14 -43.73 95.47 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.965 -0.561 . . . . 0.71 110.856 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.28 -48.82 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 112.071 0.397 . . . . 1.21 112.071 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.526 ' O ' HD21 ' B' ' 21' ' ' LEU . 2.2 pp -66.55 -43.56 84.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.401 -0.52 . . . . 1.17 111.397 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 31.6 mm -60.52 -45.15 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.666 0.269 . . . . 1.21 110.517 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.458 ' O ' HG12 ' B' ' 23' ' ' ILE . 47.6 m -62.57 -45.73 91.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.501 -0.318 . . . . 1.23 110.387 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.497 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 49.9 m -58.89 -52.47 65.58 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.19 -0.459 . . . . 0.48 110.894 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.526 HD21 ' O ' ' B' ' 17' ' ' LEU . 4.1 mm? -58.72 -44.11 90.34 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.716 -0.22 . . . . 1.23 110.682 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.17 -56.13 26.05 Favored 'General case' 0 C--O 1.212 -0.893 0 C-N-CA 120.891 -0.324 . . . . 1.22 110.467 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.458 HG12 ' O ' ' B' ' 19' ' ' THR . 50.1 mm -55.06 -40.02 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 122.82 0.075 . . . . 1.24 111.15 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' B' ' 20' ' ' SER . 92.6 mt -60.11 -44.83 94.58 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.89 0.376 . . . . 1.21 110.795 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 92.3 t -77.69 -40.47 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.68 0.752 . . . . 1.19 111.649 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -70.34 -51.71 28.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.022 -0.99 . . . . 0.91 113.345 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 3.1 m-85 -80.65 49.01 1.12 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.571 0.952 . . . . 0.85 113.571 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' B' ' 28' ' ' LEU . 76.6 mt -82.58 127.49 70.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 O-C-N 122.184 -0.322 . . . . 1.23 110.836 178.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.78 36.88 0.44 Allowed 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.798 2.332 . . . . 0.77 113.286 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 39.5 t -178.87 134.77 0.13 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.021 -0.536 . . . . 0.74 110.64 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 58.56 33.64 23.26 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.61 0.596 . . . . 0.8 112.61 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 46.2 t -174.46 -54.89 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.777 0.322 . . . . 0.51 111.367 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.87 61.39 2.1 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.242 -0.504 . . . . 0.7 114.166 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 1.023 ' HB2' ' HE2' ' B' ' 35' ' ' LYS . 27.1 mt-10 -63.04 -35.96 81.97 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.259 0.552 . . . . 0.94 111.145 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 1.023 ' HE2' ' HB2' ' B' ' 34' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.278 0 CA-C-O 118.079 -0.962 . . . . 1.22 110.863 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . 0.493 ' HG3' ' SG ' ' B' ' 15' ' ' CYS . 73.8 mtp180 . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 111.504 0.187 . . . . 0.5 111.504 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -81.99 47.85 1.16 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.687 0.28 . . . . 0.63 111.663 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' B' ' 3' ' ' LYS . 31.5 mmtm -155.1 133.99 7.4 Favored Pre-proline 0 N--CA 1.468 0.457 0 CA-C-N 116.329 -0.396 . . . . 0.76 110.808 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.22 48.88 1.26 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.916 2.411 . . . . 0.75 112.873 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 43.4 mt -145.15 62.38 1.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.505 . . . . 1.32 111.191 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -76.45 50.27 0.65 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.392 0.516 . . . . 0.71 112.392 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -67.4 -25.25 65.86 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.995 0.368 . . . . 0.6 111.995 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 18.1 p -75.98 105.83 7.24 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.805 0.336 . . . . 1.17 111.709 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.402 HD11 HG22 ' B' ' 9' ' ' ILE . 14.5 tt -74.22 -30.0 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.107 -0.497 . . . . 1.3 111.36 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -57.62 113.19 1.7 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.356 -0.383 . . . . 0.71 111.428 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 97.1 mt 57.47 35.1 25.5 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.782 -0.645 . . . . 1.26 112.146 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.564 HG22 ' N ' ' B' ' 13' ' ' ILE . 0.0 OUTLIER -68.73 -38.39 78.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.612 -0.267 . . . . 1.1 111.147 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.681 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 4.8 mp -57.93 -62.21 5.91 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 111.454 0.168 . . . . 1.15 111.454 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.479 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.7 Cg_endo -55.01 -39.63 89.97 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.89 1.726 . . . . 0.37 111.855 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.493 ' SG ' ' HG3' ' B' ' 1' ' ' ARG . 53.7 t -60.28 -49.85 75.99 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.201 -0.454 . . . . 0.95 111.511 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.462 HG12 ' N ' ' B' ' 17' ' ' LEU . 7.3 p -66.0 -41.2 89.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 120.761 -0.376 . . . . 1.1 111.074 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.681 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 58.7 mt -59.65 -52.85 63.74 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 121.23 -0.188 . . . . 1.11 110.576 178.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.403 HG12 ' O ' ' B' ' 14' ' ' PRO . 45.4 mm -59.65 -42.81 89.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.622 -0.263 . . . . 1.12 110.572 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.539 ' O ' HG12 ' B' ' 23' ' ' ILE . 76.4 m -60.6 -46.46 90.16 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.151 -0.314 . . . . 1.08 110.151 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 48.4 t -59.22 -51.56 69.44 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.322 -0.399 . . . . 0.99 110.883 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 58.8 mt -58.63 -44.82 90.12 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.715 0.293 . . . . 1.2 110.889 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.87 -55.74 31.21 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 116.441 -0.345 . . . . 1.1 110.756 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.539 HG12 ' O ' ' B' ' 19' ' ' THR . 43.9 mm -57.4 -37.39 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 121.266 -0.173 . . . . 1.16 110.724 179.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 52.7 tp -59.78 -46.01 90.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.965 0.412 . . . . 1.16 110.311 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.444 ' O ' HD21 ' B' ' 28' ' ' LEU . 68.9 t -76.97 -46.36 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.401 0.619 . . . . 1.17 111.36 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -63.17 -52.3 62.96 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.175 0.99 . . . . 0.85 112.303 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -93.44 39.53 1.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.016 -0.538 . . . . 0.7 110.357 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.444 HD21 ' O ' ' B' ' 25' ' ' VAL . 2.4 pt? -65.25 143.28 98.75 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 1.14 111.742 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.444 ' HB2' ' H ' ' B' ' 30' ' ' SER . 71.1 Cg_endo -74.86 -136.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.487 2.125 . . . . 0.68 112.367 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.444 ' H ' ' HB2' ' B' ' 29' ' ' PRO . 96.7 p 54.97 34.43 22.35 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.511 0.725 . . . . 0.6 112.742 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 51.22 59.68 4.42 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.58 0.585 . . . . 0.74 112.58 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 12.8 p -71.99 51.78 0.23 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.643 0.609 . . . . 0.54 112.643 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.39 130.13 10.52 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.98 -0.628 . . . . 0.66 112.917 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.78 -160.42 0.68 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.862 0.363 . . . . 1.97 111.054 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.348 -0.834 . . . . 2.13 111.477 179.741 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 111.981 0.363 . . . . 1.75 111.981 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -76.6 121.93 23.9 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.52 0.2 . . . . 2.47 110.888 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.488 ' HE2' HD21 ' B' ' 5' ' ' LEU . 14.3 mmmm 55.89 66.88 3.26 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-N 116.106 -0.497 . . . . 2.51 111.664 -179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -79.42 47.4 2.5 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.456 2.104 . . . . 1.23 113.363 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.492 HD22 ' N ' ' B' ' 5' ' ' LEU . 3.9 mm? -84.0 51.71 2.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.058 0.456 . . . . 1.64 111.351 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -148.55 36.15 0.8 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.046 0.45 . . . . 1.18 111.896 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.405 ' OH ' ' HA ' ' B' ' 10' ' ' ASN . 33.5 t80 -75.8 143.06 42.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.011 0.434 . . . . 0.8 111.17 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -162.47 -52.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 1.34 112.081 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.509 HG21 HD11 ' B' ' 12' ' ' ILE . 58.8 mt -81.0 115.63 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 1.49 111.149 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . 0.405 ' HA ' ' OH ' ' B' ' 7' ' ' TYR . 77.0 m-20 -73.17 133.93 44.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.363 -0.38 . . . . 1.08 111.656 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 97.6 mt 59.67 37.49 22.33 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.682 -0.69 . . . . 1.61 111.649 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.509 HD11 HG21 ' B' ' 9' ' ' ILE . 6.9 tp -68.51 -40.6 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.106 -0.497 . . . . 1.59 111.636 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.479 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 79.6 mt -57.14 -61.22 7.51 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 111.756 0.28 . . . . 1.8 111.756 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.479 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.9 Cg_endo -55.36 -40.31 86.27 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.841 1.694 . . . . 1.13 111.869 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 42.9 t -61.68 -53.24 58.78 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.285 -0.416 . . . . 1.02 111.901 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.531 HG12 HD12 ' B' ' 17' ' ' LEU . 12.5 p -63.82 -38.4 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 120.601 -0.439 . . . . 1.54 110.83 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.631 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 7.0 mp -61.66 -54.18 46.27 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.998 -0.092 . . . . 1.71 111.201 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.58 -35.83 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.838 -0.345 . . . . 1.29 110.882 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.427 ' O ' HG12 ' B' ' 23' ' ' ILE . 86.5 m -64.46 -45.77 85.99 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.841 -0.429 . . . . 1.33 109.841 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 48.4 t -60.23 -52.28 65.99 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.882 -0.599 . . . . 1.09 110.528 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 59.8 mt -57.16 -44.61 83.66 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.74 0.305 . . . . 1.41 110.812 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.28 -58.15 9.77 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 116.326 -0.397 . . . . 1.23 110.705 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.428 ' O ' ' HB2' ' B' ' 27' ' ' TYR . 51.9 mm -54.61 -40.49 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 117.58 0.173 . . . . 1.41 111.113 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' B' ' 20' ' ' SER . 85.7 mt -58.99 -44.57 91.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 121.093 -0.243 . . . . 1.35 111.029 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -80.06 -43.26 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.67 0.748 . . . . 1.38 111.738 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -65.73 -48.64 71.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.951 -1.022 . . . . 1.1 113.399 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 3.0 m-85 -85.15 -50.15 7.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.368 0.507 . . . . 1.65 112.368 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 83.4 mt -92.66 137.41 24.26 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.743 0.306 . . . . 1.42 111.469 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.17 48.45 0.9 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.811 2.341 . . . . 0.71 113.226 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 38.2 t -85.0 157.17 20.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.966 0.412 . . . . 0.66 111.867 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.431 ' HA ' ' HE3' ' B' ' 35' ' ' LYS . 3.4 m-20 57.39 50.3 11.6 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.661 -0.699 . . . . 1.08 112.515 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 42.7 t -76.81 52.87 0.87 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.509 0.671 . . . . 2.13 110.947 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.64 152.19 7.98 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.564 -0.744 . . . . 2.07 111.357 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.54 102.87 5.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.126 0.463 . . . . 3.01 111.571 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' B' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.614 -0.708 . . . . 1.78 110.5 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.584 0.23 . . . . 3.92 111.196 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -99.43 56.53 1.01 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.346 0.593 . . . . 0.93 112.067 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -160.34 133.36 4.66 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 0.99 111.226 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.51 -154.89 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.578 2.185 . . . . 0.86 112.569 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' B' ' 5' ' ' LEU . 67.5 mt -90.82 -125.08 0.07 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.69 0.757 . . . . 2.11 111.86 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -80.61 54.19 2.04 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.963 -1.017 . . . . 2.03 111.893 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -129.78 -55.7 1.14 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.723 0.296 . . . . 2.35 111.468 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 26.5 p -143.95 157.33 44.41 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.421 -0.354 . . . . 1.76 111.308 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 33.3 pt -74.43 -166.5 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.082 0.468 . . . . 2.11 111.551 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -70.97 127.61 33.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.984 0.421 . . . . 0.88 110.441 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt -75.15 14.08 0.61 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.669 0.618 . . . . 2.05 112.669 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.436 HG21 ' N ' ' B' ' 13' ' ' ILE . 9.0 tp -70.07 -39.83 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.331 0.11 . . . . 1.43 111.28 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.502 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 77.5 mt -60.29 -61.68 7.44 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 111.535 0.198 . . . . 1.49 111.535 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.502 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.4 Cg_endo -55.57 -39.39 91.33 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.853 1.702 . . . . 0.96 111.544 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.402 ' O ' HG13 ' B' ' 18' ' ' ILE . 50.3 t -64.21 -51.68 62.56 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.146 -0.479 . . . . 0.88 112.012 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.599 HG13 HD12 ' B' ' 17' ' ' LEU . 10.0 p -62.43 -38.26 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 120.403 -0.519 . . . . 1.21 110.401 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.599 HD12 HG13 ' B' ' 16' ' ' VAL . 7.4 mp -62.32 -53.71 51.07 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.843 -0.162 . . . . 1.34 111.089 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.402 HG13 ' O ' ' B' ' 15' ' ' CYS . 2.6 pp -63.42 -35.36 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 120.782 -0.367 . . . . 1.32 111.189 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.438 ' O ' HG12 ' B' ' 23' ' ' ILE . 37.0 m -66.03 -44.09 85.68 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.563 -0.532 . . . . 1.18 109.563 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 46.6 t -61.16 -51.27 69.75 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.776 -0.647 . . . . 0.97 111.631 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.412 HD13 ' N ' ' B' ' 22' ' ' ALA . 3.2 pp -64.93 -38.86 92.35 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.45 -0.5 . . . . 0.92 111.039 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.412 ' N ' HD13 ' B' ' 21' ' ' LEU . . . -59.93 -57.7 11.75 Favored 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 120.554 -0.458 . . . . 1.15 110.121 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.438 HG12 ' O ' ' B' ' 19' ' ' THR . 51.3 mm -56.32 -39.11 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 122.967 0.167 . . . . 1.14 110.756 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.58 -45.15 85.57 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.865 0.364 . . . . 1.29 110.462 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 69.8 t -79.44 -45.15 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.457 0.646 . . . . 1.24 111.576 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -63.56 -47.56 81.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.908 -1.042 . . . . 0.76 113.012 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 2.7 m-85 -90.96 54.05 2.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.8 0.296 . . . . 0.71 111.8 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.407 HD21 ' H ' ' B' ' 28' ' ' LEU . 2.4 pt? -68.13 130.27 92.61 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 120.89 0.376 . . . . 1.29 111.004 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.49 129.72 29.11 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.71 2.273 . . . . 0.82 113.25 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 96.8 p -143.56 -37.38 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.056 -0.52 . . . . 0.87 111.443 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.48 -86.42 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.496 -0.32 . . . . 0.91 111.837 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 46.8 t -157.17 -14.79 0.09 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.911 0.337 . . . . 1.11 111.911 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.91 -38.55 92.96 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.627 -0.797 . . . . 0.86 112.517 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.957 ' HG2' ' HD3' ' B' ' 35' ' ' LYS . 17.9 pm0 -71.94 -36.46 69.92 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.72 0.408 . . . . 0.56 111.599 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.957 ' HD3' ' HG2' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.514 -0.755 . . . . 0.9 110.548 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 110.703 -0.11 . . . . 4.55 110.703 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 62.09 44.85 7.6 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.643 0.377 . . . . 3.09 110.911 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' B' ' 4' ' ' PRO . 57.1 mtpt 64.82 114.79 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.702 0 CA-C-N 115.842 -0.617 . . . . 1.86 111.492 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' B' ' 3' ' ' LYS . 13.4 Cg_endo -57.22 111.64 0.87 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.779 2.32 . . . . 2.17 113.494 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 53.1 35.06 18.68 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.52 -0.764 . . . . 2.3 112.373 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -156.87 54.75 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.122 0.487 . . . . 1.34 110.579 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.64 51.69 0.14 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.803 -0.635 . . . . 1.77 112.519 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.6 t -156.83 149.15 23.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.531 . . . . 1.24 111.101 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.628 ' HB ' HD12 ' B' ' 13' ' ' ILE . 57.7 mt -60.81 -43.84 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.036 0.446 . . . . 1.27 110.835 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -161.28 -151.01 0.21 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.937 -0.574 . . . . 0.73 111.218 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.23 -20.51 26.81 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.195 0.813 . . . . 1.62 113.195 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 39.9 mm -64.25 -45.71 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 112.408 0.522 . . . . 1.45 112.408 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.697 ' H ' HD13 ' B' ' 13' ' ' ILE . 3.1 mp -54.21 -59.98 8.68 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 111.905 0.335 . . . . 1.31 111.905 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.408 ' O ' HG12 ' B' ' 18' ' ' ILE . 12.1 Cg_endo -56.29 -41.31 77.79 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 121.967 1.778 . . . . 0.94 112.065 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.1 t -58.75 -48.08 82.44 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.733 0.301 . . . . 1.71 110.868 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.03 -47.14 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 116.37 -0.377 . . . . 1.51 110.967 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.407 HD11 ' O ' ' B' ' 13' ' ' ILE . 8.6 mp -58.54 -50.68 72.9 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.661 -0.245 . . . . 1.68 111.417 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.408 HG12 ' O ' ' B' ' 14' ' ' PRO . 46.4 mm -61.36 -44.89 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 120.448 0.166 . . . . 1.72 110.835 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 44.7 m -60.87 -47.19 87.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.715 0.293 . . . . 1.38 110.69 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 44.4 t -60.38 -50.98 71.46 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.272 -0.422 . . . . 1.58 110.929 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 8.8 mp -59.03 -45.82 89.76 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 116.553 -0.294 . . . . 1.93 110.768 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' B' ' 26' ' ' PHE . . . -58.64 -57.57 12.4 Favored 'General case' 0 C--O 1.207 -1.174 0 N-CA-C 110.044 -0.354 . . . . 1.45 110.044 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.491 ' O ' ' HB2' ' B' ' 27' ' ' TYR . 30.7 mm -53.21 -38.35 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.481 0.181 . . . . 1.27 111.458 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.9 tp -60.67 -45.86 92.55 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.836 0.35 . . . . 1.98 110.654 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -80.58 -37.92 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.547 0.689 . . . . 1.86 111.392 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.409 ' HB2' ' O ' ' B' ' 22' ' ' ALA . 2.8 m-85 -78.79 -119.71 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.401 1.08 . . . . 1.73 111.913 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 0.0 OUTLIER 51.2 46.47 26.4 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.858 -1.064 . . . . 1.65 112.458 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 16.5 tp 59.33 70.1 1.18 Allowed Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.074 -0.512 . . . . 1.96 111.935 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.17 50.62 1.9 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.831 2.354 . . . . 1.09 112.967 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 95.5 p 53.98 46.26 25.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.261 0.624 . . . . 0.88 111.702 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -56.24 116.88 3.3 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.234 -0.439 . . . . 1.57 111.381 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 71.7 m 60.42 29.19 18.82 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.748 -0.66 . . . . 2.41 111.96 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.3 53.02 2.68 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.332 -0.461 . . . . 1.73 113.139 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -80.91 75.48 7.86 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.067 0.46 . . . . 2.67 111.546 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.445 ' N ' ' HD2' ' B' ' 35' ' ' LYS . 11.1 mptt . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.397 -0.811 . . . . 3.46 112.198 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.219 0.057 . . . . 2.03 111.053 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 59.42 45.76 13.28 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.129 0.49 . . . . 1.51 110.737 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.415 ' HE3' ' HB3' ' B' ' 3' ' ' LYS . 10.1 ttpp 60.2 92.0 0.07 OUTLIER Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 115.487 -0.779 . . . . 0.9 112.22 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.72 -142.17 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.143 2.562 . . . . 0.6 112.987 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' B' ' 5' ' ' LEU . 3.6 mm? -73.11 45.75 0.16 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.305 0.483 . . . . 1.47 112.305 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -86.48 53.58 2.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.894 0.378 . . . . 1.25 111.251 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.404 ' HD1' ' N ' ' B' ' 8' ' ' THR . 0.8 OUTLIER -68.65 -46.9 67.94 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.105 0.409 . . . . 1.03 112.105 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.404 ' N ' ' HD1' ' B' ' 7' ' ' TYR . 67.4 p 50.14 39.86 20.44 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.544 0.572 . . . . 1.38 112.544 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 17.7 pt -75.18 50.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.888 0.699 . . . . 1.51 112.888 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 58.93 57.72 3.48 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.298 0.481 . . . . 1.48 112.298 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.482 ' N ' HD21 ' B' ' 11' ' ' LEU . 3.4 mm? -74.4 49.26 0.37 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.883 0.373 . . . . 1.45 111.749 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.413 HG22 ' N ' ' B' ' 13' ' ' ILE . 7.4 tp -69.93 -38.98 76.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 111.875 0.324 . . . . 1.37 111.875 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.708 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 74.4 mt -58.38 -62.48 5.53 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 111.854 0.316 . . . . 1.35 111.854 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.505 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.4 Cg_endo -54.42 -40.13 84.5 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 121.882 1.722 . . . . 0.64 111.834 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 t -61.93 -50.29 72.75 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.014 -0.539 . . . . 1.3 111.558 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.533 HG11 ' N ' ' B' ' 17' ' ' LEU . 7.2 p -64.14 -39.0 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.6 -0.44 . . . . 1.06 110.947 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.708 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 60.3 mt -62.78 -53.39 54.99 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 122.451 -0.156 . . . . 1.2 111.275 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.83 -36.69 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 120.762 -0.375 . . . . 1.19 111.15 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 88.1 m -64.78 -46.38 82.32 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.826 0.346 . . . . 0.96 110.126 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.5 m -60.14 -50.96 71.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.051 -0.522 . . . . 0.46 110.626 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -59.62 -44.46 93.45 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 116.592 -0.276 . . . . 1.12 110.629 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.549 ' O ' ' HB2' ' B' ' 26' ' ' PHE . . . -59.16 -60.57 3.66 Favored 'General case' 0 C--O 1.205 -1.287 0 CA-C-O 119.259 -0.401 . . . . 1.13 110.131 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.649 ' O ' ' HB2' ' B' ' 27' ' ' TYR . 36.6 mm -51.04 -38.67 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 117.817 0.281 . . . . 1.22 111.289 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 53.7 tp -59.54 -47.54 85.14 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.755 0.312 . . . . 1.34 110.927 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 60.8 t -83.37 -39.94 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.771 0.796 . . . . 1.35 111.373 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.549 ' HB2' ' O ' ' B' ' 22' ' ' ALA . 3.9 m-85 -80.15 -114.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.895 1.278 . . . . 0.86 111.947 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.649 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 0.6 OUTLIER 57.69 79.55 0.2 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.497 -1.228 . . . . 0.93 113.187 179.477 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.488 ' N ' HD23 ' B' ' 28' ' ' LEU . 3.4 mm? -65.94 133.07 94.79 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.096 -0.502 . . . . 1.54 110.586 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 28' ' ' LEU . 23.5 Cg_exo -65.36 67.0 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.431 2.754 . . . . 1.36 113.792 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -145.94 44.31 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.153 0.502 . . . . 1.63 111.071 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -66.03 131.03 45.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.965 -0.562 . . . . 0.91 111.3 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 54.0 t -72.02 115.31 11.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.284 -0.416 . . . . 1.59 111.216 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.39 129.4 19.9 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.803 -0.713 . . . . 1.52 112.714 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -74.88 121.36 21.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.828 0.347 . . . . 2.84 111.045 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.861 ' H ' ' HD3' ' B' ' 35' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.459 0 CA-C-O 118.444 -0.788 . . . . 4.06 111.298 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 111.57 0.211 . . . . 2.31 111.57 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -74.4 129.42 37.75 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 121.219 -0.192 . . . . 4.78 110.83 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.432 ' HD2' ' HD2' ' B' ' 4' ' ' PRO . 26.7 tptp 67.54 109.33 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.538 0 O-C-N 123.717 0.636 . . . . 2.44 110.947 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.432 ' HD2' ' HD2' ' B' ' 3' ' ' LYS . 33.6 Cg_exo -59.52 115.94 2.94 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.446 2.097 . . . . 2.36 112.741 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' B' ' 5' ' ' LEU . 54.1 mt -82.04 56.94 3.31 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.118 -0.492 . . . . 2.17 111.433 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.28 34.78 0.06 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.272 0.842 . . . . 2.34 113.272 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.403 ' H ' ' C ' ' B' ' 5' ' ' LEU . 27.5 t80 -81.54 -30.36 33.15 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.327 0.584 . . . . 2.28 110.177 178.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -166.28 -160.84 0.44 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.523 -0.762 . . . . 1.84 110.157 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 pt -78.46 46.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.108 0.48 . . . . 2.4 112.225 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -76.95 67.33 2.94 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.427 -0.352 . . . . 1.35 111.175 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.473 ' HB3' ' HG2' ' B' ' 14' ' ' PRO . 93.2 mt 53.32 41.15 32.14 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.222 -0.445 . . . . 1.51 111.753 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.482 HG22 ' N ' ' B' ' 13' ' ' ILE . 7.7 tp -63.73 -42.53 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 112.089 0.403 . . . . 1.38 112.089 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.661 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 73.9 mt -59.49 -62.71 5.32 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 111.709 0.263 . . . . 1.5 111.709 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.509 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.2 Cg_endo -54.51 -37.2 90.11 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.735 1.623 . . . . 0.72 111.604 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 41.3 t -61.24 -51.3 69.51 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.198 -0.455 . . . . 0.9 111.56 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 35.5 m -65.77 -39.08 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 120.684 -0.406 . . . . 1.26 111.225 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 57.3 mt -61.84 -53.97 48.5 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 121.165 -0.214 . . . . 1.34 110.73 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 45.0 mm -60.15 -43.36 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.642 -0.254 . . . . 1.29 111.085 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.4 HG22 HD13 ' B' ' 23' ' ' ILE . 58.4 m -60.44 -44.37 95.88 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.653 0.263 . . . . 1.26 110.423 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -61.53 -50.61 72.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.241 -0.436 . . . . 0.71 110.818 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 60.6 mt -58.28 -44.89 88.67 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.781 0.324 . . . . 1.49 110.534 179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.01 -57.65 11.87 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 116.222 -0.445 . . . . 1.35 110.59 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.4 HD13 HG22 ' B' ' 19' ' ' THR . 71.6 mt -56.23 -37.96 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 122.821 0.076 . . . . 1.38 110.915 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 54.8 tp -58.9 -45.34 90.54 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.042 0.449 . . . . 1.54 110.281 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 70.7 t -78.62 -46.3 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.447 0.641 . . . . 1.63 111.34 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -62.74 -49.0 76.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.009 -0.996 . . . . 1.54 112.69 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -93.12 47.12 1.25 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.859 0.361 . . . . 1.57 110.873 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -62.85 134.69 95.67 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 120.93 0.395 . . . . 1.56 111.546 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.24 126.0 14.97 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.56 2.173 . . . . 1.36 112.888 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 40.5 t -71.38 141.62 50.36 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.194 -0.457 . . . . 1.03 111.8 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.78 -39.81 68.79 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.103 -0.499 . . . . 1.87 111.653 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 25.6 p -89.48 19.13 4.71 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.989 0.366 . . . . 1.62 111.989 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.51 -59.53 2.88 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.327 -0.464 . . . . 1.9 113.587 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.492 ' HB3' ' H ' ' B' ' 35' ' ' LYS . 19.1 mm-40 59.37 -142.2 0.62 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.453 0.538 . . . . 2.27 112.453 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.492 ' H ' ' HB3' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.57 0 CA-C-O 117.868 -1.063 . . . . 3.19 109.915 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . 0.415 ' HB3' ' H ' ' B' ' 2' ' ' ARG . 25.0 mmt85 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 111.043 0.016 . . . . 1.4 111.043 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.415 ' H ' ' HB3' ' B' ' 1' ' ' ARG . 60.2 mtm180 -78.64 131.55 36.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.792 0.33 . . . . 0.89 111.204 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.432 ' HB2' ' HD2' ' B' ' 4' ' ' PRO . 13.9 pttp -73.72 157.94 86.81 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.134 -0.485 . . . . 1.29 111.06 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.521 ' HD3' HD21 ' B' ' 11' ' ' LEU . 29.0 Cg_endo -62.76 135.05 50.12 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.382 2.055 . . . . 0.63 112.457 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.79 54.11 2.94 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.264 -0.425 . . . . 1.47 111.898 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 58.96 52.12 6.68 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.213 0.53 . . . . 1.63 111.584 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -150.87 145.86 25.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.948 -0.569 . . . . 1.1 110.306 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -72.92 45.91 0.16 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.515 0.674 . . . . 1.31 112.498 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.452 HG23 ' H ' ' B' ' 11' ' ' LEU . 9.1 tp -75.46 -28.5 20.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.119 -0.491 . . . . 1.22 110.413 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 60.18 36.32 20.99 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.763 -0.653 . . . . 0.63 111.984 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.521 HD21 ' HD3' ' B' ' 4' ' ' PRO . 95.7 mt 53.36 46.84 25.51 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.104 0.779 . . . . 1.24 113.104 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.405 HG12 ' O ' ' B' ' 9' ' ' ILE . 3.8 mm -66.83 -43.95 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 120.562 0.22 . . . . 1.28 111.564 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.698 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 73.8 mt -54.61 -62.63 3.79 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.857 0.318 . . . . 1.21 111.857 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.506 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.3 Cg_endo -55.53 -39.9 88.46 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 121.73 1.62 . . . . 0.44 111.723 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 40.8 t -60.96 -50.75 72.12 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.103 -0.499 . . . . 1.13 111.448 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.445 HG12 ' O ' ' B' ' 13' ' ' ILE . 8.4 p -64.73 -41.79 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.9 -0.32 . . . . 1.16 111.177 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.698 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 60.0 mt -60.19 -51.14 70.84 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 122.276 -0.265 . . . . 1.18 110.605 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.8 mt -60.02 -44.04 93.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.536 -0.302 . . . . 1.32 110.718 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.477 ' O ' HG12 ' B' ' 23' ' ' ILE . 67.6 m -60.54 -45.01 95.47 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.405 -0.361 . . . . 1.2 110.625 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.3 t -60.7 -49.64 76.71 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.245 -0.434 . . . . 0.83 110.647 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 60.4 mt -59.71 -44.6 93.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.721 0.296 . . . . 1.21 110.556 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.77 11.42 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 116.418 -0.356 . . . . 1.19 110.641 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.477 HG12 ' O ' ' B' ' 19' ' ' THR . 45.4 mm -56.8 -36.91 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.282 0.087 . . . . 1.28 110.956 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.6 -44.44 96.27 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.952 0.406 . . . . 1.82 110.162 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 79.6 t -78.51 -47.54 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 121.444 0.64 . . . . 1.32 111.138 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -61.27 -48.6 80.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.898 -1.046 . . . . 1.04 112.405 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 2.1 m-85 -95.7 48.47 1.14 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.402 -0.363 . . . . 1.27 110.558 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.532 HD23 ' H ' ' B' ' 28' ' ' LEU . 2.6 pt? -61.01 131.23 91.79 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 121.218 0.532 . . . . 1.4 112.116 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.85 75.22 3.2 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.869 2.379 . . . . 1.19 113.068 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 68.0 m -156.25 128.92 7.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.78 0.324 . . . . 0.81 111.257 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.51 123.87 20.36 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.136 -0.484 . . . . 1.24 111.511 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 17.6 t 56.63 45.31 22.33 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.286 0.565 . . . . 1.34 111.128 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.5 -23.51 77.53 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.62 -0.718 . . . . 1.1 114.003 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -38.86 85.59 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 117.042 0.421 . . . . 1.62 111.918 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.569 ' NZ ' ' HB3' ' B' ' 35' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.497 -0.763 . . . . 2.06 111.152 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.457 0.17 . . . . 1.2 110.91 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -142.69 140.68 31.62 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.736 0.303 . . . . 1.07 111.144 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.48 ' C ' ' H ' ' B' ' 5' ' ' LEU . 13.3 mmmm -68.59 134.73 90.53 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.253 -0.43 . . . . 0.54 111.309 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.31 28.98 0.26 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.741 2.294 . . . . 0.62 113.364 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.48 ' H ' ' C ' ' B' ' 3' ' ' LYS . 17.3 mt -158.81 27.64 0.22 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.428 -0.805 . . . . 1.17 110.099 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . 0.45 ' HB2' ' HB2' ' B' ' 3' ' ' LYS . 12.8 t80 -106.35 54.0 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.61 -0.723 . . . . 0.91 110.476 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.576 ' HB2' ' HG ' ' B' ' 11' ' ' LEU . 6.0 m-85 -79.65 -44.52 20.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 1.23 111.677 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.431 ' O ' HG12 ' B' ' 12' ' ' ILE . 9.0 t -168.94 -161.34 0.32 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.34 -0.391 . . . . 1.23 111.067 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.481 ' O ' ' HB ' ' B' ' 12' ' ' ILE . 49.4 mm -62.59 -46.9 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 111.992 0.368 . . . . 1.42 111.992 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -58.9 -39.23 80.86 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.952 0.406 . . . . 0.89 111.768 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . 0.576 ' HG ' ' HB2' ' B' ' 7' ' ' TYR . 4.3 mm? -74.44 -14.35 60.83 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.795 0.665 . . . . 1.24 112.795 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . 0.481 ' HB ' ' O ' ' B' ' 9' ' ' ILE . 8.6 mm -60.11 -39.33 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 111.763 0.283 . . . . 1.29 111.763 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.417 HD11 ' H ' ' B' ' 13' ' ' ILE . 3.6 mp -57.99 -62.44 5.48 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 116.646 -0.252 . . . . 1.17 111.591 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.404 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.5 Cg_endo -56.03 -38.07 95.3 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.642 1.561 . . . . 0.36 111.821 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.427 ' O ' HG13 ' B' ' 18' ' ' ILE . 42.0 t -60.86 -53.78 53.19 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.316 -0.402 . . . . 0.67 111.551 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.568 HG12 HD11 ' B' ' 17' ' ' LEU . 12.1 p -63.96 -37.85 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 120.684 -0.406 . . . . 1.2 110.623 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.568 HD11 HG12 ' B' ' 16' ' ' VAL . 6.9 mp -61.5 -53.04 61.63 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.942 -0.117 . . . . 1.18 111.19 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.427 HG13 ' O ' ' B' ' 15' ' ' CYS . 2.6 pp -63.57 -34.27 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 120.707 -0.397 . . . . 1.13 110.831 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.464 ' O ' HG12 ' B' ' 23' ' ' ILE . 34.8 m -66.11 -48.07 72.1 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.811 0.338 . . . . 1.18 110.27 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -59.09 -48.53 81.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.012 -0.54 . . . . 0.87 110.504 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 9.1 mp -60.78 -45.55 93.93 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.26 -0.427 . . . . 1.18 110.937 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.36 -56.33 23.54 Favored 'General case' 0 C--O 1.215 -0.731 0 C-N-CA 120.822 -0.351 . . . . 1.13 110.608 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.464 HG12 ' O ' ' B' ' 19' ' ' THR . 46.4 mm -56.73 -37.64 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 122.835 0.085 . . . . 1.31 110.779 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.91 -45.31 92.97 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.971 0.415 . . . . 1.31 110.407 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -77.33 -45.93 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.444 0.64 . . . . 1.32 111.312 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -63.52 -50.88 67.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.306 1.042 . . . . 1.02 112.573 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . 0.4 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 2.1 m-85 -92.89 46.63 1.23 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.193 -0.458 . . . . 1.17 110.764 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -63.68 133.12 95.42 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 121.09 0.472 . . . . 1.49 111.945 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -72.86 59.04 3.45 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.95 2.434 . . . . 1.14 112.889 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 56.2 p -87.19 -13.47 43.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 1.49 112.101 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.93 128.9 38.34 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.273 0.559 . . . . 1.95 111.67 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 51.8 t -139.85 141.15 36.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.32 0.581 . . . . 2.41 111.507 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.41 -46.42 0.2 Allowed Glycine 0 C--N 1.322 -0.241 0 N-CA-C 110.282 -1.127 . . . . 1.87 110.282 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.453 ' OE1' ' HG2' ' B' ' 35' ' ' LYS . 0.0 OUTLIER -93.49 -37.49 11.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.632 -0.784 . . . . 3.09 109.229 177.294 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.453 ' HG2' ' OE1' ' B' ' 34' ' ' GLU . 20.5 pttm . . . . . 0 C--O 1.25 1.107 0 CA-C-N 115.24 -0.891 . . . . 3.7 111.051 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 111.563 0.209 . . . . 4.14 111.563 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 58.14 38.56 26.42 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.677 0.61 . . . . 3.65 111.649 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' B' ' 3' ' ' LYS . 43.8 mtmt 67.41 118.78 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 122.878 0.471 . . . . 1.87 111.567 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.12 107.73 0.31 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.429 2.086 . . . . 1.69 112.099 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 54.42 29.48 11.11 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.857 -0.61 . . . . 3.02 111.41 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 55.03 32.49 18.3 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.892 -0.594 . . . . 2.48 111.742 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -87.6 -44.34 11.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.018 0.437 . . . . 2.44 111.552 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 60.2 p -73.94 63.08 0.9 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.322 0.49 . . . . 1.35 112.322 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 49.8 mm -75.43 126.27 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.358 -0.383 . . . . 1.57 111.459 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -70.79 110.45 5.57 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.906 0.384 . . . . 2.22 110.4 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 93.8 mt -87.07 -20.12 27.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 2.24 111.299 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 51.3 mm -61.8 -50.3 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 112.479 0.548 . . . . 2.27 112.479 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.439 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 84.1 mt -54.01 -61.37 5.43 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 111.878 0.325 . . . . 2.29 111.878 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.439 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.3 Cg_endo -54.87 -41.25 80.2 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 122.088 1.858 . . . . 1.63 111.605 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 41.2 t -60.2 -48.48 81.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.364 -0.38 . . . . 2.11 110.817 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 t -62.06 -46.61 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 120.696 0.284 . . . . 1.85 110.762 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.56 ' O ' HD23 ' B' ' 21' ' ' LEU . 4.1 mm? -60.24 -51.49 69.35 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.456 -0.338 . . . . 1.89 111.816 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.37 -36.77 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 120.49 -0.484 . . . . 1.57 110.978 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.487 ' O ' HG12 ' B' ' 23' ' ' ILE . 80.4 m -65.9 -47.09 75.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.878 0.371 . . . . 1.38 110.039 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.508 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 41.0 t -58.81 -51.81 68.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.015 -0.539 . . . . 1.09 110.782 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.56 HD23 ' O ' ' B' ' 17' ' ' LEU . 4.1 mm? -59.01 -44.65 91.73 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.654 -0.248 . . . . 1.79 110.786 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.72 -56.29 23.88 Favored 'General case' 0 C--O 1.211 -0.928 0 C-N-CA 120.852 -0.339 . . . . 1.31 110.585 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.487 HG12 ' O ' ' B' ' 19' ' ' THR . 50.0 mm -55.61 -40.13 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.288 0.09 . . . . 1.22 111.144 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' B' ' 20' ' ' SER . 87.9 mt -59.23 -43.78 92.35 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.779 0.323 . . . . 1.49 110.6 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 73.5 t -78.83 -45.6 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.528 0.68 . . . . 1.46 111.652 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -64.18 -56.5 14.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.277 1.031 . . . . 1.05 112.975 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -79.71 -35.46 38.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.27 -0.423 . . . . 1.23 111.42 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' B' ' 28' ' ' LEU . 17.5 tp 56.7 64.08 4.95 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.852 -0.613 . . . . 1.68 111.974 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.14 52.82 1.93 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.856 2.371 . . . . 1.17 113.338 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 28.7 t -72.01 -45.23 61.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.038 -0.528 . . . . 1.79 111.565 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -140.17 137.62 34.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 2.13 111.102 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 52.5 t -151.91 -36.69 0.12 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.383 0.512 . . . . 2.36 112.383 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.42 39.98 0.04 OUTLIER Glycine 0 CA--C 1.517 0.176 0 C-N-CA 121.017 -0.611 . . . . 2.7 111.671 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.423 ' OE1' ' HG3' ' B' ' 35' ' ' LYS . 0.0 OUTLIER -141.89 -168.75 2.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.35 -0.425 . . . . 2.66 111.927 -178.592 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . 0.423 ' HG3' ' OE1' ' B' ' 34' ' ' GLU . 34.1 mtmm . . . . . 0 C--O 1.252 1.217 0 CA-C-O 118.373 -0.823 . . . . 3.16 112.148 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 111.82 0.304 . . . . 1.85 111.82 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 61.13 -151.04 0.4 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.193 -0.458 . . . . 2.11 111.215 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.435 ' N ' ' HD3' ' B' ' 4' ' ' PRO . 21.7 pttp -170.77 60.18 0.33 Allowed Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 112.309 0.485 . . . . 1.75 112.309 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' B' ' 7' ' ' TYR . 18.5 Cg_exo -64.75 110.35 1.44 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.236 1.957 . . . . 1.29 111.824 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' LEU . . . . . 0.454 ' HA ' HD21 ' B' ' 5' ' ' LEU . 66.3 mt 56.12 40.43 30.17 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.529 -0.305 . . . . 1.83 111.731 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 63.68 38.28 9.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.081 -0.508 . . . . 1.24 112.105 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.448 ' HB3' ' HD2' ' B' ' 4' ' ' PRO . 24.5 t80 -76.98 127.21 32.29 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.439 -0.346 . . . . 1.32 111.372 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 61.2 p 53.11 38.06 26.49 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.95 0.722 . . . . 1.2 112.95 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 16.5 tt -91.22 145.65 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.695 0.283 . . . . 1.26 111.212 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -72.38 50.08 0.22 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.114 0.483 . . . . 0.76 111.755 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -144.08 -48.21 0.28 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.112 -0.495 . . . . 1.39 109.752 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.37 -36.68 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.109 -0.496 . . . . 1.32 110.981 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.568 ' O ' HD21 ' B' ' 17' ' ' LEU . 79.9 mt -58.18 -62.21 5.98 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 111.832 0.308 . . . . 1.29 111.832 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . 0.498 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.9 Cg_endo -55.91 -40.4 85.29 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 121.873 1.716 . . . . 0.59 111.671 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.3 t -59.76 -52.66 64.52 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.153 -0.476 . . . . 0.97 111.715 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.487 HG11 ' N ' ' B' ' 17' ' ' LEU . 11.8 p -64.84 -41.23 91.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 120.805 -0.358 . . . . 1.35 111.332 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' LEU . . . . . 0.568 HD21 ' O ' ' B' ' 13' ' ' ILE . 3.8 mm? -61.09 -52.16 66.07 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 121.144 -0.222 . . . . 1.39 111.023 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.403 HG12 ' O ' ' B' ' 14' ' ' PRO . 43.9 mm -60.16 -43.89 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.599 0.238 . . . . 1.28 110.675 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 75.5 m -60.6 -47.37 86.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.679 0.276 . . . . 0.88 110.669 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' SER . . . . . 0.498 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 48.1 t -59.44 -52.78 64.12 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.323 -0.399 . . . . 0.98 110.771 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -57.83 -45.58 85.98 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.576 -0.284 . . . . 1.59 110.918 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.99 -54.78 42.85 Favored 'General case' 0 C--O 1.212 -0.872 0 C-N-CA 120.922 -0.311 . . . . 1.28 110.164 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 34.2 mm -54.53 -45.88 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 122.932 0.145 . . . . 1.44 110.973 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' B' ' 20' ' ' SER . 93.3 mt -54.45 -41.55 69.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.821 0.343 . . . . 1.56 110.872 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 91.7 t -81.32 -36.02 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.374 0.607 . . . . 1.42 111.49 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 -75.87 -120.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.094 0.958 . . . . 1.03 113.389 -177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 21.83 47.87 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.078 1.751 . . . . 1.15 115.281 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.415 ' H ' ' CD2' ' B' ' 28' ' ' LEU . 1.9 pt? -67.89 130.86 92.65 Favored Pre-proline 0 N--CA 1.455 -0.213 0 CA-C-N 116.197 -0.456 . . . . 1.32 110.961 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.59 48.64 1.34 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.709 2.273 . . . . 1.42 113.153 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 81.7 p -79.88 53.62 1.7 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.005 0.431 . . . . 0.97 111.15 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -83.39 136.38 34.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.259 0.552 . . . . 1.88 111.177 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 25.6 p -83.87 -13.77 52.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.684 -0.689 . . . . 1.81 111.143 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.02 53.2 2.58 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 114.332 0.493 . . . . 2.21 114.332 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.29 -151.41 0.41 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.415 0.524 . . . . 3.17 112.415 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.624 -0.703 . . . . 3.09 110.886 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.0 tp . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 111.988 0.366 . . . . 0.69999999999999996 111.988 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.485 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 78.3 mt -55.99 -61.98 5.49 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 111.767 0.284 . . . . 0.90000000000000002 111.767 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.485 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.9 Cg_endo -55.23 -40.5 85.36 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 122.153 1.902 . . . . 0.54000000000000004 111.852 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 t -59.76 -47.47 85.56 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.455 -0.339 . . . . 0.47999999999999998 110.911 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.5 t -63.93 -46.88 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 116.555 -0.293 . . . . 0.70999999999999996 110.895 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.663 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 9.4 mp -59.22 -50.56 73.56 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.455 -0.338 . . . . 0.81000000000000005 111.125 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.6 mt -59.97 -44.68 95.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.567 0.222 . . . . 0.48999999999999999 110.699 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.441 ' O ' HG12 ' B' ' 23' ' ' ILE . 51.3 m -60.63 -45.72 92.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.845 0.355 . . . . 0.53000000000000003 110.339 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 43.3 t -58.82 -50.71 72.94 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.09 -0.505 . . . . 0.63 110.954 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 58.7 mt -60.0 -45.55 92.39 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.69 0.281 . . . . 0.69999999999999996 110.793 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.24 -58.18 9.6 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 116.39 -0.368 . . . . 0.40000000000000002 110.784 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.441 HG12 ' O ' ' B' ' 19' ' ' THR . 52.0 mm -55.13 -39.56 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.39 0.138 . . . . 0.56000000000000005 110.907 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 54.7 tp -57.78 -45.95 85.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.932 0.396 . . . . 0.70999999999999996 110.504 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 78.6 t -78.76 -46.68 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.467 0.651 . . . . 0.67000000000000004 111.639 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 . . . . . 0 C--N 1.325 -0.484 0 C-N-CA 124.28 1.032 . . . . 0.81000000000000005 113.171 -178.9 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 tp . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 113.044 0.757 . . . . 0.48999999999999999 113.044 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.418 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 68.8 mt -59.34 -61.17 8.38 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.315 0.487 . . . . 0.44 112.315 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.418 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.1 Cg_endo -54.48 -40.03 85.29 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.864 1.709 . . . . 0.39000000000000001 111.485 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.8 t -60.1 -51.93 67.51 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.22 -0.446 . . . . 0.35999999999999999 111.671 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 34.7 m -65.22 -38.89 83.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 112.296 0.48 . . . . 0.35999999999999999 112.296 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.481 HD12 ' N ' ' B' ' 18' ' ' ILE . 3.5 pp -69.97 -43.35 71.67 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 119.624 -0.83 . . . . 0.46000000000000002 111.651 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.481 ' N ' HD12 ' B' ' 17' ' ' LEU . 2.6 pp -66.5 -38.04 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.276 -0.57 . . . . 0.41999999999999998 110.312 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.486 ' O ' HG12 ' B' ' 23' ' ' ILE . 87.5 m -64.59 -47.22 79.49 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.126 -0.324 . . . . 0.39000000000000001 110.126 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.48 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 48.7 m -59.17 -51.48 69.83 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.19 -0.459 . . . . 0.37 110.618 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.406 HD13 ' O ' ' B' ' 17' ' ' LEU . 8.6 mp -57.97 -45.22 87.05 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.63 -0.259 . . . . 0.53000000000000003 110.847 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.95 -57.26 13.31 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 116.489 -0.323 . . . . 0.33000000000000002 110.855 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.486 HG12 ' O ' ' B' ' 19' ' ' THR . 45.9 mm -55.3 -40.75 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 117.521 0.146 . . . . 0.47999999999999998 111.208 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' B' ' 20' ' ' SER . 84.4 mt -58.31 -42.57 87.01 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.868 0.366 . . . . 0.41999999999999998 110.485 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 76.9 t -80.61 -46.3 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.472 0.653 . . . . 0.39000000000000001 111.667 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 . . . . . 0 N--CA 1.469 0.479 0 C-N-CA 124.412 1.085 . . . . 0.60999999999999999 113.134 -178.873 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.1 tp . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 111.974 0.361 . . . . 0.88 111.974 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.518 ' O ' HG12 ' B' ' 16' ' ' VAL . 71.6 mt -61.72 -63.07 4.7 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 111.889 0.329 . . . . 0.69999999999999996 111.889 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.491 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.4 Cg_endo -54.76 -40.48 84.58 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.863 1.709 . . . . 0.80000000000000004 111.461 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 52.0 t -62.43 -48.66 78.71 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.093 -0.503 . . . . 0.77000000000000002 111.564 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.518 HG12 ' O ' ' B' ' 13' ' ' ILE . 7.5 p -64.76 -39.45 85.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.029 0.381 . . . . 0.55000000000000004 112.029 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.424 HD12 ' N ' ' B' ' 18' ' ' ILE . 3.0 pp -70.65 -42.8 70.33 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 119.842 -0.743 . . . . 0.57999999999999996 111.561 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.424 ' N ' HD12 ' B' ' 17' ' ' LEU . 2.6 pp -65.9 -37.11 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 120.067 -0.653 . . . . 0.64000000000000001 110.188 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 89.0 m -65.83 -46.26 79.24 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.805 0.336 . . . . 0.58999999999999997 110.145 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -60.56 -51.51 69.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.124 -0.489 . . . . 0.34999999999999998 110.904 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -59.89 -45.74 91.56 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.588 -0.278 . . . . 0.46999999999999997 111.075 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 -57.98 10.15 Favored 'General case' 0 C--O 1.213 -0.862 0 C-N-CA 120.965 -0.294 . . . . 0.37 110.613 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 74.8 mt -54.55 -39.95 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.351 0.12 . . . . 0.55000000000000004 110.979 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 49.8 tp -56.81 -47.17 80.86 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.987 0.423 . . . . 0.58999999999999997 110.607 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 77.9 t -79.93 -44.31 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.51 0.671 . . . . 0.5 111.962 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 . . . . . 0 C--N 1.322 -0.625 0 N-CA-C 114.053 1.131 . . . . 0.62 114.053 -177.962 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.8 tp . . . . . 0 CA--C 1.543 0.692 0 N-CA-C 112.542 0.571 . . . . 0.81000000000000005 112.542 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.484 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 72.3 mt -59.78 -63.91 3.65 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 112.279 0.474 . . . . 0.52000000000000002 112.279 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.484 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.4 Cg_endo -55.95 -37.71 95.65 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.689 1.593 . . . . 0.66000000000000003 111.453 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 40.8 t -60.85 -53.4 57.79 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.092 -0.503 . . . . 0.78000000000000003 111.742 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.531 HG13 HD22 ' B' ' 17' ' ' LEU . 11.9 p -64.9 -40.68 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 120.824 -0.35 . . . . 0.59999999999999998 111.509 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.531 HD22 HG13 ' B' ' 16' ' ' VAL . 3.8 mm? -62.82 -51.83 65.53 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.42 -0.175 . . . . 0.63 111.152 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 63.7 mt -60.79 -44.8 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.552 0.215 . . . . 0.79000000000000004 110.904 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 64.0 m -60.07 -46.98 87.77 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.663 0.268 . . . . 0.65000000000000002 110.775 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.1 m -60.23 -50.55 73.22 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.288 -0.414 . . . . 0.57999999999999996 110.725 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.412 HD13 ' O ' ' B' ' 17' ' ' LEU . 8.8 mp -58.86 -45.18 90.71 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.44 -0.346 . . . . 0.76000000000000001 110.68 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.58 -55.67 31.62 Favored 'General case' 0 C--O 1.208 -1.117 0 C-N-CA 120.894 -0.322 . . . . 0.57999999999999996 110.329 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 74.1 mt -52.89 -41.68 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 122.967 0.167 . . . . 0.59999999999999998 111.187 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.29 -46.96 87.14 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.927 0.394 . . . . 0.78000000000000003 110.577 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.63 -36.32 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.474 0.654 . . . . 0.68999999999999995 111.209 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 . . . . . 0 N--CA 1.447 -0.596 0 C-N-CA 124.107 0.963 . . . . 0.71999999999999997 111.466 -179.249 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.2 tp . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 112.332 0.493 . . . . 0.63 112.332 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.478 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 78.3 mt -56.62 -61.5 6.7 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 111.982 0.364 . . . . 0.69999999999999996 111.982 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.478 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 14.1 Cg_endo -56.56 -39.74 89.26 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.788 1.659 . . . . 0.60999999999999999 111.742 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 41.2 t -60.26 -53.05 62.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.343 -0.39 . . . . 0.59999999999999998 111.792 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.0 p -65.49 -40.67 88.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 120.893 -0.323 . . . . 0.60999999999999999 111.118 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 7.7 mp -60.89 -51.93 67.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.486 0.184 . . . . 0.81999999999999995 110.776 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.5 mt -60.31 -44.0 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 120.699 0.285 . . . . 0.81000000000000005 110.689 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 75.0 m -59.96 -45.23 93.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.423 -0.353 . . . . 0.60999999999999999 110.48 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 40.9 t -60.3 -50.62 72.9 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.169 -0.469 . . . . 0.70999999999999996 110.826 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 53.6 mt -59.23 -44.98 92.32 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.731 0.301 . . . . 0.88 110.844 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.27 -57.77 11.42 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 116.326 -0.397 . . . . 0.67000000000000004 110.712 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.06 -36.56 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 121.415 -0.114 . . . . 0.65000000000000002 110.978 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' B' ' 24' ' ' LEU . 1.5 tm? -59.83 -45.77 91.35 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.771 -0.455 . . . . 0.90000000000000002 109.771 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.6 t -78.08 -46.28 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.424 0.631 . . . . 0.83999999999999997 111.442 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 . . . . . 0 C--N 1.326 -0.447 0 C-N-CA 124.183 0.993 . . . . 0.93000000000000005 112.478 -179.12 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 112.07 0.396 . . . . 0.72999999999999998 112.07 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.509 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 72.3 mt -55.98 -62.89 3.9 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.123 0.416 . . . . 1.2 112.123 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.509 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.1 Cg_endo -54.48 -40.16 84.67 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.97 1.78 . . . . 1.0900000000000001 111.603 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 46.7 t -60.13 -51.43 69.66 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.932 -0.576 . . . . 0.81000000000000005 111.664 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.12 -38.96 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.482 0.549 . . . . 0.78000000000000003 112.482 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.446 HD12 ' N ' ' B' ' 18' ' ' ILE . 3.3 pp -69.1 -42.53 76.01 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 119.651 -0.82 . . . . 1.1599999999999999 111.399 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.446 ' N ' HD12 ' B' ' 17' ' ' LEU . 2.6 pp -66.76 -36.88 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 120.057 -0.657 . . . . 1.04 110.034 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.482 ' O ' HG12 ' B' ' 23' ' ' ILE . 86.5 m -65.51 -47.25 76.62 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.972 -0.381 . . . . 0.63 109.972 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 48.3 t -58.68 -49.72 76.52 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.073 -0.512 . . . . 0.83999999999999997 110.757 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.428 HD13 ' O ' ' B' ' 17' ' ' LEU . 8.4 mp -60.51 -45.4 93.93 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.326 -0.397 . . . . 1.1899999999999999 111.044 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.18 -56.51 21.1 Favored 'General case' 0 C--O 1.214 -0.802 0 C-N-CA 120.871 -0.332 . . . . 0.65000000000000002 110.752 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.482 HG12 ' O ' ' B' ' 19' ' ' THR . 47.7 mm -56.63 -37.93 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 110.774 -0.084 . . . . 0.53000000000000003 110.774 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -59.36 -46.63 88.11 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.886 -0.413 . . . . 0.94999999999999996 109.886 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.1 t -76.51 -45.76 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.446 0.641 . . . . 0.83999999999999997 111.591 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 . . . . . 0 C--N 1.325 -0.5 0 C-N-CA 124.121 0.968 . . . . 0.88 112.493 -179.115 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 50.7 mm . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 112.503 0.557 . . . . 0.56999999999999995 112.503 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.497 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 72.8 mt -55.74 -63.12 3.5 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.233 0.457 . . . . 0.65000000000000002 112.233 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.497 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.8 Cg_endo -55.47 -39.99 88.0 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.041 1.827 . . . . 0.56000000000000005 111.899 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 50.2 t -59.65 -47.08 87.01 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.387 -0.369 . . . . 0.44 110.95 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 22.2 t -63.98 -47.57 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 116.617 -0.265 . . . . 0.5 111.133 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' B' ' 17' ' ' LEU . 4.2 mm? -59.46 -48.71 80.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.749 -0.205 . . . . 0.64000000000000001 111.221 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.2 mt -61.24 -45.32 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.557 0.218 . . . . 0.62 110.757 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 38.4 m -61.43 -46.6 89.43 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.754 0.311 . . . . 0.34000000000000002 110.796 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 48.0 t -59.83 -50.88 72.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.176 -0.465 . . . . 0.45000000000000001 110.942 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 9.1 mp -60.56 -44.35 96.26 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.63 0.252 . . . . 0.55000000000000004 111.024 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.22 -59.6 5.05 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 116.566 -0.288 . . . . 0.33000000000000002 110.604 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 77.3 mt -54.46 -39.3 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.353 0.121 . . . . 0.34999999999999998 110.907 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.8 tp -57.47 -45.75 84.46 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.758 0.313 . . . . 0.46999999999999997 110.631 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 72.4 t -80.87 -43.66 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.642 0.734 . . . . 0.34999999999999998 111.88 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 . . . . . 0 C--N 1.321 -0.635 0 C-N-CA 124.281 1.032 . . . . 0.58999999999999997 113.543 -178.321 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 45.7 mm . . . . . 0 N--CA 1.442 -0.83 0 CA-C-O 120.705 0.288 . . . . 0.57999999999999996 111.524 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.469 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 80.6 mt -53.84 -60.74 6.54 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 116.151 -0.477 . . . . 0.87 112.177 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.469 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.0 Cg_endo -55.32 -40.69 84.3 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.928 1.752 . . . . 0.55000000000000004 112.003 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 48.3 t -61.04 -53.33 58.54 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.299 -0.409 . . . . 0.38 111.911 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.35 -38.03 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 120.701 -0.399 . . . . 0.51000000000000001 111.191 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.418 HD13 ' O ' ' B' ' 13' ' ' ILE . 7.1 mp -61.92 -53.2 58.96 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.313 0.101 . . . . 0.79000000000000004 111.204 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.97 -35.62 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 120.736 -0.386 . . . . 0.59999999999999998 110.849 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 80.0 m -65.35 -47.0 77.97 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.97 -0.382 . . . . 0.40999999999999998 109.97 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 39.9 t -59.83 -50.9 72.0 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.991 -0.55 . . . . 0.52000000000000002 110.898 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -60.22 -44.87 94.81 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.651 -0.25 . . . . 0.71999999999999997 111.099 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.54 -57.16 14.17 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 120.866 -0.333 . . . . 0.51000000000000001 110.566 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.62 -37.1 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 121.49 -0.084 . . . . 0.52000000000000002 110.957 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.5 tp -59.86 -45.65 91.78 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.011 0.434 . . . . 0.66000000000000003 110.269 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 73.8 t -77.5 -47.24 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.461 0.648 . . . . 0.79000000000000004 111.316 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 114.98 -1.009 . . . . 0.90000000000000002 112.207 -179.427 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.7 tp . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 111.591 0.219 . . . . 0.78000000000000003 111.591 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.468 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 82.1 mt -57.15 -61.11 7.7 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 111.933 0.346 . . . . 0.85999999999999999 111.933 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.468 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.1 Cg_endo -55.37 -38.91 93.47 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.727 1.618 . . . . 0.78000000000000003 111.641 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 40.9 t -59.69 -54.5 45.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.042 -0.526 . . . . 0.71999999999999997 111.796 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.421 HG23 HD22 ' B' ' 17' ' ' LEU . 27.5 m -65.1 -40.91 90.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 121.021 -0.272 . . . . 0.71999999999999997 111.665 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.663 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 3.9 mm? -60.75 -53.03 62.39 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 121.173 -0.211 . . . . 0.76000000000000001 111.019 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 43.5 mm -60.09 -43.74 93.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.508 0.194 . . . . 0.72999999999999998 110.64 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 91.5 m -60.0 -45.5 92.53 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.625 0.25 . . . . 0.62 110.374 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 47.7 t -60.09 -51.04 71.31 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.236 -0.438 . . . . 0.68000000000000005 110.497 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 60.4 mt -58.11 -44.62 87.78 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 120.765 0.317 . . . . 0.68000000000000005 110.48 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' B' ' 26' ' ' PHE . . . -59.0 -60.54 3.7 Favored 'General case' 0 C--O 1.204 -1.306 0 CA-C-N 116.296 -0.411 . . . . 0.46000000000000002 110.237 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 71.8 mt -50.95 -39.79 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 120.572 0.225 . . . . 0.56999999999999995 111.147 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 52.6 tp -58.31 -47.78 82.6 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.684 0.278 . . . . 0.73999999999999999 110.929 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.11 -39.6 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.671 0.748 . . . . 0.55000000000000004 111.295 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' B' ' 22' ' ' ALA . 3.3 m-85 . . . . . 0 C--N 1.324 -0.537 0 C-N-CA 124.693 1.197 . . . . 0.52000000000000002 111.812 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.4 HG23 ' N ' ' B' ' 13' ' ' ILE . 5.7 tp . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 110.641 -0.133 . . . . 0.62 110.641 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.564 ' N ' ' HD2' ' B' ' 14' ' ' PRO . 87.5 mt -56.25 -55.09 45.78 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 110.63 -0.137 . . . . 0.76000000000000001 110.63 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' B' ' 13' ' ' ILE . 19.7 Cg_endo -54.1 -44.82 45.85 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.882 2.388 . . . . 0.45000000000000001 111.401 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.1 t -60.14 -43.73 95.47 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.965 -0.561 . . . . 0.46999999999999997 110.856 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.28 -48.82 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 112.071 0.397 . . . . 0.55000000000000004 112.071 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 pp -66.55 -43.56 84.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.401 -0.52 . . . . 0.55000000000000004 111.397 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 31.6 mm -60.52 -45.15 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.666 0.269 . . . . 0.52000000000000002 110.517 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.473 ' O ' HG12 ' B' ' 23' ' ' ILE . 47.6 m -62.57 -45.73 91.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.501 -0.318 . . . . 0.46000000000000002 110.387 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.512 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 49.9 m -58.89 -52.47 65.58 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.19 -0.459 . . . . 0.47999999999999998 110.894 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -58.72 -44.11 90.34 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.716 -0.22 . . . . 0.55000000000000004 110.682 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.17 -56.13 26.05 Favored 'General case' 0 C--O 1.212 -0.893 0 C-N-CA 120.891 -0.324 . . . . 0.41999999999999998 110.467 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.473 HG12 ' O ' ' B' ' 19' ' ' THR . 50.1 mm -55.06 -40.02 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 122.82 0.075 . . . . 0.54000000000000004 111.15 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' B' ' 20' ' ' SER . 92.6 mt -60.11 -44.83 94.58 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.89 0.376 . . . . 0.52000000000000002 110.795 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 92.3 t -77.69 -40.47 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.68 0.752 . . . . 0.53000000000000003 111.649 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 115.022 -0.99 . . . . 0.76000000000000001 113.345 -178.294 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.493 ' O ' HD13 ' B' ' 12' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.605 0 CA-C-O 120.312 0.101 . . . . 0.37 111.147 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.69 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 4.8 mp -57.93 -62.21 5.91 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 111.454 0.168 . . . . 0.44 111.454 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.481 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.7 Cg_endo -55.01 -39.63 89.97 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.89 1.726 . . . . 0.31 111.855 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 53.7 t -60.28 -49.85 75.99 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.201 -0.454 . . . . 0.34999999999999998 111.511 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.466 HG12 ' O ' ' B' ' 13' ' ' ILE . 7.3 p -66.0 -41.2 89.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 120.761 -0.376 . . . . 0.32000000000000001 111.074 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 58.7 mt -59.65 -52.85 63.74 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 121.23 -0.188 . . . . 0.37 110.576 178.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.424 HG12 ' O ' ' B' ' 14' ' ' PRO . 45.4 mm -59.65 -42.81 89.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.622 -0.263 . . . . 0.40999999999999998 110.572 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.553 ' O ' HG12 ' B' ' 23' ' ' ILE . 76.4 m -60.6 -46.46 90.16 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.151 -0.314 . . . . 0.32000000000000001 110.151 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 48.4 t -59.22 -51.56 69.44 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.322 -0.399 . . . . 0.34000000000000002 110.883 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 58.8 mt -58.63 -44.82 90.12 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.715 0.293 . . . . 0.46999999999999997 110.889 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.87 -55.74 31.21 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 116.441 -0.345 . . . . 0.34999999999999998 110.756 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.553 HG12 ' O ' ' B' ' 19' ' ' THR . 43.9 mm -57.4 -37.39 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 121.266 -0.173 . . . . 0.44 110.724 179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 52.7 tp -59.78 -46.01 90.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.965 0.412 . . . . 0.48999999999999999 110.311 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t -76.97 -46.36 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.401 0.619 . . . . 0.44 111.36 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 . . . . . 0 C--N 1.326 -0.451 0 C-N-CA 124.175 0.99 . . . . 0.66000000000000003 112.303 -179.2 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 6.9 tp . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 111.636 0.236 . . . . 1.1799999999999999 111.636 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.473 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 79.6 mt -57.14 -61.22 7.51 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 111.756 0.28 . . . . 1.4399999999999999 111.756 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.9 Cg_endo -55.36 -40.31 86.27 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.841 1.694 . . . . 1.05 111.869 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 42.9 t -61.68 -53.24 58.78 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.285 -0.416 . . . . 0.81000000000000005 111.901 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 12.5 p -63.82 -38.4 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 120.601 -0.439 . . . . 1.0700000000000001 110.83 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.641 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 7.0 mp -61.66 -54.18 46.27 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.998 -0.092 . . . . 1.1499999999999999 111.201 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.58 -35.83 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.838 -0.345 . . . . 0.70999999999999996 110.882 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.442 ' O ' HG12 ' B' ' 23' ' ' ILE . 86.5 m -64.46 -45.77 85.99 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.841 -0.429 . . . . 0.80000000000000004 109.841 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.487 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 48.4 t -60.23 -52.28 65.99 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.882 -0.599 . . . . 0.92000000000000004 110.528 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 59.8 mt -57.16 -44.61 83.66 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.74 0.305 . . . . 0.85999999999999999 110.812 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.28 -58.15 9.77 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 116.326 -0.397 . . . . 0.55000000000000004 110.705 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.442 HG12 ' O ' ' B' ' 19' ' ' THR . 51.9 mm -54.61 -40.49 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 117.58 0.173 . . . . 0.92000000000000004 111.113 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' B' ' 20' ' ' SER . 85.7 mt -58.99 -44.57 91.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 121.093 -0.243 . . . . 0.80000000000000004 111.029 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -80.06 -43.26 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.67 0.748 . . . . 0.72999999999999998 111.738 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 114.951 -1.022 . . . . 0.96999999999999997 113.399 -178.488 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 9.0 tp . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 120.331 0.11 . . . . 0.94999999999999996 111.28 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.496 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 77.5 mt -60.29 -61.68 7.44 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 111.535 0.198 . . . . 1.03 111.535 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.496 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.4 Cg_endo -55.57 -39.39 91.33 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.853 1.702 . . . . 0.90000000000000002 111.544 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' CYS . . . . . 0.403 ' O ' HG13 ' B' ' 18' ' ' ILE . 50.3 t -64.21 -51.68 62.56 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.146 -0.479 . . . . 0.83999999999999997 112.012 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 10.0 p -62.43 -38.26 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 120.403 -0.519 . . . . 0.65000000000000002 110.401 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.419 HD13 ' O ' ' B' ' 13' ' ' ILE . 7.4 mp -62.32 -53.71 51.07 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.843 -0.162 . . . . 0.83999999999999997 111.089 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.403 HG13 ' O ' ' B' ' 15' ' ' CYS . 2.6 pp -63.42 -35.36 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 120.782 -0.367 . . . . 0.80000000000000004 111.189 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.455 ' O ' HG12 ' B' ' 23' ' ' ILE . 37.0 m -66.03 -44.09 85.68 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.563 -0.532 . . . . 0.63 109.563 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 46.6 t -61.16 -51.27 69.75 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.776 -0.647 . . . . 0.5 111.631 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.436 HD12 ' N ' ' B' ' 22' ' ' ALA . 3.2 pp -64.93 -38.86 92.35 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.45 -0.5 . . . . 0.69999999999999996 111.039 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.436 ' N ' HD12 ' B' ' 21' ' ' LEU . . . -59.93 -57.7 11.75 Favored 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 120.554 -0.458 . . . . 0.5 110.121 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.455 HG12 ' O ' ' B' ' 19' ' ' THR . 51.3 mm -56.32 -39.11 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 122.967 0.167 . . . . 0.45000000000000001 110.756 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.58 -45.15 85.57 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.865 0.364 . . . . 0.68999999999999995 110.462 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 69.8 t -79.44 -45.15 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.457 0.646 . . . . 0.66000000000000003 111.576 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 114.908 -1.042 . . . . 0.67000000000000004 113.012 -178.877 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 39.9 mm . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 112.408 0.522 . . . . 0.97999999999999998 112.408 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.473 HD12 ' H ' ' B' ' 13' ' ' ILE . 3.1 mp -54.21 -59.98 8.68 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 111.905 0.335 . . . . 0.78000000000000003 111.905 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.431 ' O ' HG12 ' B' ' 18' ' ' ILE . 12.1 Cg_endo -56.29 -41.31 77.79 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 121.967 1.778 . . . . 0.87 112.065 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.1 t -58.75 -48.08 82.44 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.733 0.301 . . . . 0.93000000000000005 110.868 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.03 -47.14 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 116.37 -0.377 . . . . 0.97999999999999998 110.967 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 8.6 mp -58.54 -50.68 72.9 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.661 -0.245 . . . . 1.28 111.417 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.431 HG12 ' O ' ' B' ' 14' ' ' PRO . 46.4 mm -61.36 -44.89 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 120.448 0.166 . . . . 1.3100000000000001 110.835 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 44.7 m -60.87 -47.19 87.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.715 0.293 . . . . 0.88 110.69 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 44.4 t -60.38 -50.98 71.46 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.272 -0.422 . . . . 1.22 110.929 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 8.8 mp -59.03 -45.82 89.76 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 116.553 -0.294 . . . . 1.6499999999999999 110.768 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.64 -57.57 12.4 Favored 'General case' 0 C--O 1.207 -1.174 0 N-CA-C 110.044 -0.354 . . . . 0.98999999999999999 110.044 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 30.7 mm -53.21 -38.35 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.481 0.181 . . . . 0.89000000000000001 111.458 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.9 tp -60.67 -45.86 92.55 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.836 0.35 . . . . 1.6299999999999999 110.654 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -80.58 -37.92 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.547 0.689 . . . . 1.49 111.392 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 C--N 1.324 -0.522 0 C-N-CA 124.401 1.08 . . . . 1.55 111.913 -179.154 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 7.4 tp . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 111.875 0.324 . . . . 0.93999999999999995 111.875 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.718 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 74.4 mt -58.38 -62.48 5.53 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 111.854 0.316 . . . . 0.71999999999999997 111.854 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.502 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.4 Cg_endo -54.42 -40.13 84.5 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 121.882 1.722 . . . . 0.58999999999999997 111.834 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 t -61.93 -50.29 72.75 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.014 -0.539 . . . . 0.70999999999999996 111.558 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.471 HG12 ' O ' ' B' ' 13' ' ' ILE . 7.2 p -64.14 -39.0 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.6 -0.44 . . . . 0.53000000000000003 110.947 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 60.3 mt -62.78 -53.39 54.99 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 122.451 -0.156 . . . . 0.53000000000000003 111.275 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.83 -36.69 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 120.762 -0.375 . . . . 0.56999999999999995 111.15 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 88.1 m -64.78 -46.38 82.32 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.826 0.346 . . . . 0.56999999999999995 110.126 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.5 m -60.14 -50.96 71.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.051 -0.522 . . . . 0.45000000000000001 110.626 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.451 ' HA ' HD13 ' B' ' 21' ' ' LEU . 4.1 mm? -59.62 -44.46 93.45 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 116.592 -0.276 . . . . 0.69999999999999996 110.629 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' B' ' 26' ' ' PHE . . . -59.16 -60.57 3.66 Favored 'General case' 0 C--O 1.205 -1.287 0 CA-C-O 119.259 -0.401 . . . . 0.46999999999999997 110.131 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.6 mm -51.04 -38.67 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 117.817 0.281 . . . . 0.59999999999999998 111.289 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 53.7 tp -59.54 -47.54 85.14 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.755 0.312 . . . . 0.81000000000000005 110.927 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 60.8 t -83.37 -39.94 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.771 0.796 . . . . 0.78000000000000003 111.373 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' B' ' 22' ' ' ALA . 3.9 m-85 . . . . . 0 C--N 1.324 -0.523 0 C-N-CA 124.895 1.278 . . . . 0.77000000000000002 111.947 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 7.7 tp . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 112.089 0.403 . . . . 0.89000000000000001 112.089 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.67 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 73.9 mt -59.49 -62.71 5.32 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 111.709 0.263 . . . . 1.0 111.709 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.504 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.2 Cg_endo -54.51 -37.2 90.11 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.735 1.623 . . . . 0.64000000000000001 111.604 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 41.3 t -61.24 -51.3 69.51 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.198 -0.455 . . . . 0.56000000000000005 111.56 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 35.5 m -65.77 -39.08 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 120.684 -0.406 . . . . 0.68999999999999995 111.225 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 57.3 mt -61.84 -53.97 48.5 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 121.165 -0.214 . . . . 0.81999999999999995 110.73 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 45.0 mm -60.15 -43.36 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.642 -0.254 . . . . 0.76000000000000001 111.085 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 58.4 m -60.44 -44.37 95.88 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.653 0.263 . . . . 0.68999999999999995 110.423 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -61.53 -50.61 72.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.241 -0.436 . . . . 0.68999999999999995 110.818 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 60.6 mt -58.28 -44.89 88.67 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.781 0.324 . . . . 0.94999999999999996 110.534 179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.01 -57.65 11.87 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 116.222 -0.445 . . . . 0.81999999999999995 110.59 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 71.6 mt -56.23 -37.96 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 122.821 0.076 . . . . 0.87 110.915 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 54.8 tp -58.9 -45.34 90.54 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.042 0.449 . . . . 1.0900000000000001 110.281 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 70.7 t -78.62 -46.3 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.447 0.641 . . . . 1.21 111.34 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.009 -0.996 . . . . 1.4099999999999999 112.69 -179.146 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' B' ' 12' ' ' ILE . 3.8 mm . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.562 0.22 . . . . 0.70999999999999996 111.564 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.707 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 73.8 mt -54.61 -62.63 3.79 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.857 0.318 . . . . 0.62 111.857 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.501 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.3 Cg_endo -55.53 -39.9 88.46 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 121.73 1.62 . . . . 0.40999999999999998 111.723 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 40.8 t -60.96 -50.75 72.12 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.103 -0.499 . . . . 0.57999999999999996 111.448 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.437 HG12 ' O ' ' B' ' 13' ' ' ILE . 8.4 p -64.73 -41.79 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.9 -0.32 . . . . 0.5 111.177 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 60.0 mt -60.19 -51.14 70.84 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 122.276 -0.265 . . . . 0.53000000000000003 110.605 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.8 mt -60.02 -44.04 93.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.536 -0.302 . . . . 0.59999999999999998 110.718 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.496 ' O ' HG12 ' B' ' 23' ' ' ILE . 67.6 m -60.54 -45.01 95.47 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.405 -0.361 . . . . 0.57999999999999996 110.625 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.3 t -60.7 -49.64 76.71 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.245 -0.434 . . . . 0.45000000000000001 110.647 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 60.4 mt -59.71 -44.6 93.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.721 0.296 . . . . 0.63 110.556 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.77 11.42 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 116.418 -0.356 . . . . 0.59999999999999998 110.641 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.496 HG12 ' O ' ' B' ' 19' ' ' THR . 45.4 mm -56.8 -36.91 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.282 0.087 . . . . 0.68999999999999995 110.956 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.6 -44.44 96.27 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.952 0.406 . . . . 1.3 110.162 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 79.6 t -78.51 -47.54 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 121.444 0.64 . . . . 0.80000000000000004 111.138 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 114.898 -1.046 . . . . 0.92000000000000004 112.405 -179.285 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.6 mm . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 111.763 0.283 . . . . 0.69999999999999996 111.763 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.514 HD12 ' H ' ' B' ' 13' ' ' ILE . 3.6 mp -57.99 -62.44 5.48 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 116.646 -0.252 . . . . 0.54000000000000004 111.591 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.406 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.5 Cg_endo -56.03 -38.07 95.3 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.642 1.561 . . . . 0.33000000000000002 111.821 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' CYS . . . . . 0.421 ' O ' HG13 ' B' ' 18' ' ' ILE . 42.0 t -60.86 -53.78 53.19 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.316 -0.402 . . . . 0.35999999999999999 111.551 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.96 -37.85 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 120.684 -0.406 . . . . 0.52000000000000002 110.623 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.422 HD13 ' O ' ' B' ' 13' ' ' ILE . 6.9 mp -61.5 -53.04 61.63 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.942 -0.117 . . . . 0.42999999999999999 111.19 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.421 HG13 ' O ' ' B' ' 15' ' ' CYS . 2.6 pp -63.57 -34.27 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 120.707 -0.397 . . . . 0.40999999999999998 110.831 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.481 ' O ' HG12 ' B' ' 23' ' ' ILE . 34.8 m -66.11 -48.07 72.1 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.811 0.338 . . . . 0.55000000000000004 110.27 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -59.09 -48.53 81.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.012 -0.54 . . . . 0.59999999999999998 110.504 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.41 HD13 ' O ' ' B' ' 17' ' ' LEU . 9.1 mp -60.78 -45.55 93.93 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.26 -0.427 . . . . 0.56000000000000005 110.937 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.36 -56.33 23.54 Favored 'General case' 0 C--O 1.215 -0.731 0 C-N-CA 120.822 -0.351 . . . . 0.62 110.608 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.481 HG12 ' O ' ' B' ' 19' ' ' THR . 46.4 mm -56.73 -37.64 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 122.835 0.085 . . . . 0.72999999999999998 110.779 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.91 -45.31 92.97 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.971 0.415 . . . . 0.78000000000000003 110.407 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -77.33 -45.93 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.444 0.64 . . . . 0.78000000000000003 111.312 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 . . . . . 0 C--N 1.326 -0.424 0 C-N-CA 124.306 1.042 . . . . 0.87 112.573 -179.051 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 51.3 mm . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 112.479 0.548 . . . . 1.98 112.479 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.439 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 84.1 mt -54.01 -61.37 5.43 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 111.878 0.325 . . . . 2.0 111.878 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.439 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.3 Cg_endo -54.87 -41.25 80.2 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 122.088 1.858 . . . . 1.5600000000000001 111.605 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 41.2 t -60.2 -48.48 81.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.364 -0.38 . . . . 1.3400000000000001 110.817 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 t -62.06 -46.61 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 120.696 0.284 . . . . 1.5 110.762 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' B' ' 17' ' ' LEU . 4.1 mm? -60.24 -51.49 69.35 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.456 -0.338 . . . . 1.55 111.816 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.37 -36.77 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 120.49 -0.484 . . . . 1.1599999999999999 110.978 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.501 ' O ' HG12 ' B' ' 23' ' ' ILE . 80.4 m -65.9 -47.09 75.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.878 0.371 . . . . 1.03 110.039 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.519 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 41.0 t -58.81 -51.81 68.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.015 -0.539 . . . . 1.0600000000000001 110.782 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.445 ' HA ' HD13 ' B' ' 21' ' ' LEU . 4.1 mm? -59.01 -44.65 91.73 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.654 -0.248 . . . . 1.24 110.786 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.72 -56.29 23.88 Favored 'General case' 0 C--O 1.211 -0.928 0 C-N-CA 120.852 -0.339 . . . . 0.72999999999999998 110.585 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.501 HG12 ' O ' ' B' ' 19' ' ' THR . 50.0 mm -55.61 -40.13 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.288 0.09 . . . . 0.68000000000000005 111.144 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' B' ' 20' ' ' SER . 87.9 mt -59.23 -43.78 92.35 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.779 0.323 . . . . 1.01 110.6 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 73.5 t -78.83 -45.6 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.528 0.68 . . . . 0.97999999999999998 111.652 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 . . . . . 0 C--N 1.325 -0.46 0 C-N-CA 124.277 1.031 . . . . 0.93000000000000005 112.975 -178.83 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.6 tp . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 120.581 0.229 . . . . 0.80000000000000004 110.981 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.494 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 79.9 mt -58.18 -62.21 5.98 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 111.832 0.308 . . . . 0.66000000000000003 111.832 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' PRO . . . . . 0.494 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.9 Cg_endo -55.91 -40.4 85.29 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 121.873 1.716 . . . . 0.54000000000000004 111.671 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.3 t -59.76 -52.66 64.52 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.153 -0.476 . . . . 0.71999999999999997 111.715 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.47 HG13 HD22 ' B' ' 17' ' ' LEU . 11.8 p -64.84 -41.23 91.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 120.805 -0.358 . . . . 0.80000000000000004 111.332 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' LEU . . . . . 0.47 HD22 HG13 ' B' ' 16' ' ' VAL . 3.8 mm? -61.09 -52.16 66.07 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 121.144 -0.222 . . . . 0.85999999999999999 111.023 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.426 HG12 ' O ' ' B' ' 14' ' ' PRO . 43.9 mm -60.16 -43.89 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.599 0.238 . . . . 0.69999999999999996 110.675 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 75.5 m -60.6 -47.37 86.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.679 0.276 . . . . 0.81999999999999995 110.669 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 48.1 t -59.44 -52.78 64.12 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.323 -0.399 . . . . 0.97999999999999998 110.771 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -57.83 -45.58 85.98 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.576 -0.284 . . . . 1.01 110.918 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.99 -54.78 42.85 Favored 'General case' 0 C--O 1.212 -0.872 0 C-N-CA 120.922 -0.311 . . . . 0.77000000000000002 110.164 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 34.2 mm -54.53 -45.88 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 122.932 0.145 . . . . 0.94999999999999996 110.973 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' B' ' 20' ' ' SER . 93.3 mt -54.45 -41.55 69.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.821 0.343 . . . . 1.0900000000000001 110.872 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 91.7 t -81.32 -36.02 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.374 0.607 . . . . 0.94999999999999996 111.49 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 . . . . . 0 C--N 1.326 -0.44 0 C-N-CA 124.094 0.958 . . . . 0.95999999999999996 113.389 -177.884 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.291 0.091 . . . . 1.1699999999999999 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -88.31 -151.56 0.2 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.01 0.434 . . . . 1.22 110.697 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.615 ' H ' ' HD3' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -72.27 154.76 91.98 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.16 -0.473 . . . . 0.87 110.694 179.214 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.69 153.45 11.1 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.3 2.666 . . . . 0.94999999999999996 113.857 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' B' ' 6' ' ' PHE . 3.9 mm? 68.1 97.31 0.06 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.608 -0.724 . . . . 0.93999999999999995 111.541 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.425 ' HB2' ' O ' ' B' ' 5' ' ' LEU . 5.2 m-85 72.18 108.49 0.07 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.572 -0.74 . . . . 1.1100000000000001 111.718 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.98 -134.78 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.539 -0.755 . . . . 0.90000000000000002 111.599 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 5.5 t -68.02 132.88 48.08 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.82 -0.55 . . . . 0.60999999999999999 111.075 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 17.7 mm -77.3 59.12 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 112.681 0.623 . . . . 0.64000000000000001 112.681 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -77.51 60.05 2.03 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.157 -0.339 . . . . 0.70999999999999996 111.075 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 99.0 mt 59.8 35.71 22.04 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.962 -0.563 . . . . 0.68999999999999995 111.004 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.0 tp -68.15 -41.0 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.748 -0.66 . . . . 0.69999999999999996 111.988 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.485 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 78.3 mt -55.99 -61.98 5.49 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 111.767 0.284 . . . . 0.90000000000000002 111.767 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.485 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.9 Cg_endo -55.23 -40.5 85.36 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 122.153 1.902 . . . . 0.54000000000000004 111.852 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 t -59.76 -47.47 85.56 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.455 -0.339 . . . . 0.47999999999999998 110.911 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.5 t -63.93 -46.88 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 116.555 -0.293 . . . . 0.70999999999999996 110.895 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.663 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 9.4 mp -59.22 -50.56 73.56 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.455 -0.338 . . . . 0.81000000000000005 111.125 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.6 mt -59.97 -44.68 95.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.567 0.222 . . . . 0.48999999999999999 110.699 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.441 ' O ' HG12 ' B' ' 23' ' ' ILE . 51.3 m -60.63 -45.72 92.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.845 0.355 . . . . 0.53000000000000003 110.339 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 43.3 t -58.82 -50.71 72.94 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.09 -0.505 . . . . 0.63 110.954 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 58.7 mt -60.0 -45.55 92.39 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.69 0.281 . . . . 0.69999999999999996 110.793 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.24 -58.18 9.6 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 116.39 -0.368 . . . . 0.40000000000000002 110.784 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.441 HG12 ' O ' ' B' ' 19' ' ' THR . 52.0 mm -55.13 -39.56 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.39 0.138 . . . . 0.56000000000000005 110.907 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 54.7 tp -57.78 -45.95 85.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.932 0.396 . . . . 0.70999999999999996 110.504 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 78.6 t -78.76 -46.68 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.467 0.651 . . . . 0.67000000000000004 111.639 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -61.63 -53.11 60.63 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.28 1.032 . . . . 0.81000000000000005 113.171 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.415 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 2.7 m-85 -82.48 -36.81 26.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.477 -0.329 . . . . 0.90000000000000002 111.493 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.528 ' O ' ' HE2' ' B' ' 35' ' ' LYS . 17.1 tp 57.82 68.0 2.09 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.086 -0.506 . . . . 0.66000000000000003 112.15 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.05 55.51 1.82 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.761 2.307 . . . . 0.73999999999999999 113.614 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 87.5 p -79.14 146.29 33.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.761 0.315 . . . . 0.52000000000000002 111.524 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -72.29 59.79 0.42 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.13 0.491 . . . . 1.3700000000000001 111.843 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 40.9 t -158.34 135.83 10.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.101 -0.5 . . . . 0.93000000000000005 110.472 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.54 46.88 1.76 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 115.335 0.894 . . . . 1.4199999999999999 115.335 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.4 -33.36 19.14 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.046 0.923 . . . . 1.96 109.783 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.528 ' HE2' ' O ' ' B' ' 28' ' ' LEU . 9.2 ptpp? . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.36 -0.829 . . . . 1.54 111.737 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 111.504 0.187 . . . . 1.1200000000000001 111.504 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -71.29 136.23 47.8 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.555 -0.293 . . . . 1.1399999999999999 110.739 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -67.16 138.9 94.86 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.81 0.338 . . . . 0.95999999999999996 110.604 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.02 125.3 16.75 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.235 1.957 . . . . 0.44 112.525 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.51 59.55 1.12 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.089 -0.505 . . . . 0.73999999999999999 110.721 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 66.1 45.81 2.28 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.35 -0.841 . . . . 0.75 110.959 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -63.15 -35.41 80.18 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.921 -0.582 . . . . 0.96999999999999997 112.343 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.459 HG23 HD21 ' B' ' 10' ' ' ASN . 3.3 t -148.97 134.76 18.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.192 0.52 . . . . 0.63 111.822 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.47 HD12 HD12 ' B' ' 13' ' ' ILE . 5.4 tp -79.4 125.16 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.767 -0.651 . . . . 0.52000000000000002 111.697 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.482 ' OD1' HG22 ' B' ' 12' ' ' ILE . 11.0 p30 -173.64 -143.12 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.613 -0.722 . . . . 0.37 110.542 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.95 -23.96 44.23 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.488 0.921 . . . . 0.66000000000000003 113.488 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.482 HG22 ' OD1' ' B' ' 10' ' ' ASN . 10.9 tp -63.25 -42.36 96.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 113.044 0.757 . . . . 0.48999999999999999 113.044 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.47 HD12 HD12 ' B' ' 9' ' ' ILE . 68.8 mt -59.34 -61.17 8.38 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.315 0.487 . . . . 0.44 112.315 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.418 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.1 Cg_endo -54.48 -40.03 85.29 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.864 1.709 . . . . 0.39000000000000001 111.485 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.8 t -60.1 -51.93 67.51 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.22 -0.446 . . . . 0.35999999999999999 111.671 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 34.7 m -65.22 -38.89 83.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 112.296 0.48 . . . . 0.35999999999999999 112.296 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.481 HD12 ' N ' ' B' ' 18' ' ' ILE . 3.5 pp -69.97 -43.35 71.67 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 119.624 -0.83 . . . . 0.46000000000000002 111.651 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.481 ' N ' HD12 ' B' ' 17' ' ' LEU . 2.6 pp -66.5 -38.04 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.276 -0.57 . . . . 0.41999999999999998 110.312 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.486 ' O ' HG12 ' B' ' 23' ' ' ILE . 87.5 m -64.59 -47.22 79.49 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.126 -0.324 . . . . 0.39000000000000001 110.126 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.48 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 48.7 m -59.17 -51.48 69.83 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.19 -0.459 . . . . 0.37 110.618 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.406 HD13 ' O ' ' B' ' 17' ' ' LEU . 8.6 mp -57.97 -45.22 87.05 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.63 -0.259 . . . . 0.53000000000000003 110.847 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.95 -57.26 13.31 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 116.489 -0.323 . . . . 0.33000000000000002 110.855 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.486 HG12 ' O ' ' B' ' 19' ' ' THR . 45.9 mm -55.3 -40.75 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 117.521 0.146 . . . . 0.47999999999999998 111.208 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' B' ' 20' ' ' SER . 84.4 mt -58.31 -42.57 87.01 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.868 0.366 . . . . 0.41999999999999998 110.485 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 76.9 t -80.61 -46.3 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.472 0.653 . . . . 0.39000000000000001 111.667 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -62.39 -61.36 2.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.412 1.085 . . . . 0.60999999999999999 113.134 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -73.59 -32.4 64.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.273 -0.421 . . . . 0.69999999999999996 110.931 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.511 HD11 ' HZ1' ' B' ' 35' ' ' LYS . 13.6 tp 59.98 61.53 3.83 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.464 -0.789 . . . . 0.48999999999999999 111.877 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' B' ' 28' ' ' LEU . 31.3 Cg_endo -85.63 41.67 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.517 2.145 . . . . 0.59999999999999998 112.011 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.426 ' HB2' ' HA ' ' B' ' 34' ' ' GLU . 12.8 p -91.22 44.47 1.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.817 -0.628 . . . . 0.62 111.359 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -69.31 -49.09 59.06 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.223 -0.444 . . . . 1.26 111.674 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 41.2 t -64.19 -26.44 68.52 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.938 0.399 . . . . 1.48 111.33 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.27 126.89 1.39 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.034 -0.603 . . . . 0.81999999999999995 112.463 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' B' ' 30' ' ' SER . 41.8 mm-40 -74.24 64.04 1.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.114 0.783 . . . . 1.1899999999999999 113.114 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.511 ' HZ1' HD11 ' B' ' 28' ' ' LEU . 3.9 mppt? . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.322 -0.847 . . . . 1.6100000000000001 111.987 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 111.209 0.077 . . . . 3.0699999999999998 111.209 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.473 ' HB3' ' H ' ' B' ' 3' ' ' LYS . 22.3 mmm180 56.48 -147.14 0.53 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.97 0.414 . . . . 2.0800000000000001 111.703 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.519 ' HD2' ' HB2' ' B' ' 6' ' ' PHE . 59.2 pttt -169.82 146.9 2.81 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.001 -0.545 . . . . 0.93000000000000005 110.617 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.449 ' HG2' ' CD1' ' B' ' 6' ' ' PHE . 56.2 Cg_endo -72.04 -140.66 0.02 OUTLIER 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.761 2.307 . . . . 1.0900000000000001 112.724 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.422 ' H ' ' HB2' ' B' ' 4' ' ' PRO . 3.5 mm? -72.89 43.17 0.11 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.433 0.531 . . . . 1.8 112.433 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.519 ' HB2' ' HD2' ' B' ' 3' ' ' LYS . 3.5 m-30 -86.82 53.64 2.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.966 0.412 . . . . 1.5900000000000001 111.166 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -81.92 32.7 0.37 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.021 0.439 . . . . 1.71 111.966 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 63.3 p -79.0 56.87 2.06 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.296 -0.411 . . . . 1.1899999999999999 111.908 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 8.4 tp -83.07 -32.55 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.33 0.492 . . . . 0.95999999999999996 112.33 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -70.86 56.25 0.18 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.945 0.721 . . . . 0.90000000000000002 112.945 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.53 -21.92 66.82 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.935 0.398 . . . . 1.1899999999999999 111.843 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.1 tp -61.95 -34.76 64.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.282 -0.417 . . . . 0.88 111.974 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.518 ' O ' HG12 ' B' ' 16' ' ' VAL . 71.6 mt -61.72 -63.07 4.7 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 111.889 0.329 . . . . 0.69999999999999996 111.889 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.491 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.4 Cg_endo -54.76 -40.48 84.58 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.863 1.709 . . . . 0.80000000000000004 111.461 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 52.0 t -62.43 -48.66 78.71 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.093 -0.503 . . . . 0.77000000000000002 111.564 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.518 HG12 ' O ' ' B' ' 13' ' ' ILE . 7.5 p -64.76 -39.45 85.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.029 0.381 . . . . 0.55000000000000004 112.029 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.424 HD12 ' N ' ' B' ' 18' ' ' ILE . 3.0 pp -70.65 -42.8 70.33 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 119.842 -0.743 . . . . 0.57999999999999996 111.561 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.424 ' N ' HD12 ' B' ' 17' ' ' LEU . 2.6 pp -65.9 -37.11 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 120.067 -0.653 . . . . 0.64000000000000001 110.188 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 89.0 m -65.83 -46.26 79.24 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.805 0.336 . . . . 0.58999999999999997 110.145 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -60.56 -51.51 69.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.124 -0.489 . . . . 0.34999999999999998 110.904 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -59.89 -45.74 91.56 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.588 -0.278 . . . . 0.46999999999999997 111.075 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 -57.98 10.15 Favored 'General case' 0 C--O 1.213 -0.862 0 C-N-CA 120.965 -0.294 . . . . 0.37 110.613 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' B' ' 27' ' ' TYR . 74.8 mt -54.55 -39.95 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.351 0.12 . . . . 0.55000000000000004 110.979 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 49.8 tp -56.81 -47.17 80.86 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.987 0.423 . . . . 0.58999999999999997 110.607 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' B' ' 34' ' ' GLU . 77.9 t -79.93 -44.31 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.51 0.671 . . . . 0.5 111.962 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -64.62 -46.46 82.52 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.053 1.131 . . . . 0.62 114.053 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 3.8 m-85 -79.06 -41.94 27.6 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.211 0.819 . . . . 0.84999999999999998 113.211 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.61 116.03 61.57 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-O 121.144 0.497 . . . . 0.88 112.09 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.39 50.65 3.32 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.939 2.426 . . . . 1.04 113.184 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 79.9 p -80.13 -45.29 18.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.978 0.418 . . . . 1.01 111.804 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -159.24 -122.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.924 -0.58 . . . . 0.82999999999999996 111.175 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 38.8 t -161.62 25.31 0.12 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 111.806 0.299 . . . . 0.80000000000000004 111.806 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.11 60.53 3.09 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.958 -0.639 . . . . 0.64000000000000001 112.865 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.411 ' HA ' HG11 ' B' ' 25' ' ' VAL . 13.2 pt-20 -71.76 143.01 49.73 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.793 0.664 . . . . 0.73999999999999999 112.793 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 mptt . . . . . 0 C--O 1.251 1.164 0 CA-C-N 115.362 -0.835 . . . . 0.93999999999999995 112.14 179.468 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 42.6 ptt85 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.534 0.207 . . . . 1.4299999999999999 111.243 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -80.36 133.03 35.87 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.058 0.456 . . . . 2.0800000000000001 111.828 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.556 ' HG2' ' HB3' ' B' ' 7' ' ' TYR . 25.4 tptp -169.66 128.17 0.86 Allowed Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 115.929 -0.578 . . . . 1.1200000000000001 109.875 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' B' ' 3' ' ' LYS . 18.2 Cg_exo -67.45 52.89 0.49 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.461 2.774 . . . . 1.1100000000000001 114.188 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 62.5 mt 53.67 46.12 26.61 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.449 0.537 . . . . 1.8300000000000001 112.449 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -145.2 49.18 1.27 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.167 0.508 . . . . 1.3300000000000001 111.077 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.556 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 9.3 t80 -173.6 114.99 0.23 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.954 -0.566 . . . . 0.56999999999999995 110.647 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.6 t -86.76 -175.17 5.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.641 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 6.2 tp -92.52 122.4 43.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.331 0.586 . . . . 0.65000000000000002 111.153 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.518 ' O ' ' HD2' ' B' ' 14' ' ' PRO . 63.1 m-20 -73.25 129.52 38.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.54000000000000004 110.521 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -55.34 -31.69 61.91 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.566 0.58 . . . . 0.94999999999999996 112.566 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.8 tp -63.0 -33.4 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.542 0.571 . . . . 0.81000000000000005 112.542 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.484 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 72.3 mt -59.78 -63.91 3.65 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 112.279 0.474 . . . . 0.52000000000000002 112.279 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' B' ' 10' ' ' ASN . 12.4 Cg_endo -55.95 -37.71 95.65 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.689 1.593 . . . . 0.66000000000000003 111.453 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 40.8 t -60.85 -53.4 57.79 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.092 -0.503 . . . . 0.78000000000000003 111.742 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.531 HG13 HD22 ' B' ' 17' ' ' LEU . 11.9 p -64.9 -40.68 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 120.824 -0.35 . . . . 0.59999999999999998 111.509 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.531 HD22 HG13 ' B' ' 16' ' ' VAL . 3.8 mm? -62.82 -51.83 65.53 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.42 -0.175 . . . . 0.63 111.152 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 63.7 mt -60.79 -44.8 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.552 0.215 . . . . 0.79000000000000004 110.904 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 64.0 m -60.07 -46.98 87.77 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.663 0.268 . . . . 0.65000000000000002 110.775 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.1 m -60.23 -50.55 73.22 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.288 -0.414 . . . . 0.57999999999999996 110.725 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.412 HD13 ' O ' ' B' ' 17' ' ' LEU . 8.8 mp -58.86 -45.18 90.71 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.44 -0.346 . . . . 0.76000000000000001 110.68 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.58 -55.67 31.62 Favored 'General case' 0 C--O 1.208 -1.117 0 C-N-CA 120.894 -0.322 . . . . 0.57999999999999996 110.329 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.416 HG23 ' CG ' ' B' ' 27' ' ' TYR . 74.1 mt -52.89 -41.68 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 122.967 0.167 . . . . 0.59999999999999998 111.187 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.29 -46.96 87.14 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.927 0.394 . . . . 0.78000000000000003 110.577 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.63 -36.32 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.474 0.654 . . . . 0.68999999999999995 111.209 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.491 ' HB3' ' H ' ' B' ' 27' ' ' TYR . 3.2 m-30 -80.6 -132.14 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.107 0.963 . . . . 0.71999999999999997 111.466 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.491 ' H ' ' HB3' ' B' ' 26' ' ' PHE . 3.3 m-85 34.03 47.8 0.21 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.42 -1.263 . . . . 0.95999999999999996 113.585 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.94 127.93 93.47 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.342 -0.39 . . . . 0.84999999999999998 111.314 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.25 45.05 0.75 Allowed 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.882 2.388 . . . . 0.73999999999999999 113.29 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 90.8 p -79.65 54.59 1.82 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.992 0.425 . . . . 0.66000000000000003 111.117 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -75.87 54.82 0.84 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.631 0.729 . . . . 1.03 111.299 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 28.3 p -129.86 127.92 41.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.049 -0.523 . . . . 0.77000000000000002 110.912 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.16 -132.89 2.63 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.932 -0.652 . . . . 1.0800000000000001 111.883 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mp0 -76.11 47.01 0.42 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.743 0.272 . . . . 1.9299999999999999 111.347 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.455 -0.783 . . . . 1.54 111.35 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.235 0.064 . . . . 1.8300000000000001 110.847 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 55.77 58.23 4.62 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.646 0.736 . . . . 1.1299999999999999 111.141 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' B' ' 3' ' ' LYS . 31.3 mmtm -149.02 131.44 7.8 Favored Pre-proline 0 C--O 1.236 0.351 0 CA-C-N 115.582 -0.736 . . . . 0.68000000000000005 111.022 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.89 119.31 6.31 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.498 2.132 . . . . 0.56000000000000005 111.586 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 53.14 34.27 17.02 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.103 -0.499 . . . . 1.0600000000000001 111.368 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 21.5 p90 43.67 39.65 2.54 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.834 0.854 . . . . 1.3899999999999999 112.769 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -145.15 151.07 37.89 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.156 -0.474 . . . . 0.92000000000000004 111.064 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 70.0 p -73.74 50.15 0.33 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.203 0.445 . . . . 0.83999999999999997 112.203 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 8.4 tt -97.05 124.46 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.049 0.452 . . . . 0.35999999999999999 111.45 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -82.66 44.34 0.89 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 111.956 0.354 . . . . 0.65000000000000002 111.956 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 50.91 45.4 27.59 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.631 0.604 . . . . 0.51000000000000001 112.631 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.2 tp -68.45 -40.7 82.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 112.332 0.493 . . . . 0.63 112.332 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.478 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 78.3 mt -56.62 -61.5 6.7 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 111.982 0.364 . . . . 0.69999999999999996 111.982 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.478 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 14.1 Cg_endo -56.56 -39.74 89.26 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.788 1.659 . . . . 0.60999999999999999 111.742 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 41.2 t -60.26 -53.05 62.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.343 -0.39 . . . . 0.59999999999999998 111.792 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.0 p -65.49 -40.67 88.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 120.893 -0.323 . . . . 0.60999999999999999 111.118 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 7.7 mp -60.89 -51.93 67.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.486 0.184 . . . . 0.81999999999999995 110.776 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.5 mt -60.31 -44.0 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 120.699 0.285 . . . . 0.81000000000000005 110.689 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 75.0 m -59.96 -45.23 93.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.423 -0.353 . . . . 0.60999999999999999 110.48 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 40.9 t -60.3 -50.62 72.9 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.169 -0.469 . . . . 0.70999999999999996 110.826 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 53.6 mt -59.23 -44.98 92.32 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.731 0.301 . . . . 0.88 110.844 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.27 -57.77 11.42 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 116.326 -0.397 . . . . 0.67000000000000004 110.712 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.06 -36.56 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 121.415 -0.114 . . . . 0.65000000000000002 110.978 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' B' ' 24' ' ' LEU . 1.5 tm? -59.83 -45.77 91.35 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.771 -0.455 . . . . 0.90000000000000002 109.771 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.6 t -78.08 -46.28 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.424 0.631 . . . . 0.83999999999999997 111.442 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -62.54 -50.4 71.49 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.183 0.993 . . . . 0.93000000000000005 112.478 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -93.99 38.83 1.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.301 -0.409 . . . . 0.92000000000000004 110.798 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 0.0 OUTLIER -65.04 140.95 98.23 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-O 121.223 0.535 . . . . 0.62 111.838 -179.398 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' B' ' 28' ' ' LEU . 16.3 Cg_exo -68.3 68.39 1.02 Allowed 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.289 2.66 . . . . 0.92000000000000004 113.151 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 37.6 t -66.36 117.59 8.82 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.782 0.325 . . . . 0.46000000000000002 111.371 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.529 ' HA ' ' NZ ' ' B' ' 35' ' ' LYS . 13.4 t0 -165.17 111.31 0.94 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.779 0.323 . . . . 1.0800000000000001 111.576 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 51.2 t -172.81 -40.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.2 -0.454 . . . . 1.97 111.384 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.64 36.26 0.02 OUTLIER Glycine 0 CA--C 1.519 0.333 0 C-N-CA 121.189 -0.529 . . . . 2.0699999999999998 112.072 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -107.72 -41.84 4.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.839 0.352 . . . . 2.02 111.612 -179.155 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.529 ' NZ ' ' HA ' ' B' ' 31' ' ' ASP . 33.4 mtmm . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.268 -0.872 . . . . 2.4100000000000001 111.798 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.607 0.241 . . . . 1.9099999999999999 111.393 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -77.13 139.3 39.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.762 0.315 . . . . 3.0699999999999998 110.875 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.607 ' HD2' ' HD2' ' B' ' 4' ' ' PRO . 23.4 tptm -67.37 126.53 92.68 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.091 -0.504 . . . . 2.2799999999999998 111.224 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.607 ' HD2' ' HD2' ' B' ' 3' ' ' LYS . 68.3 Cg_endo -73.27 53.6 2.59 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.139 2.559 . . . . 1.1399999999999999 113.88 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 55.0 mt -79.18 47.35 0.78 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.412 0.523 . . . . 1.26 112.412 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.07 41.75 0.45 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.095 0.474 . . . . 0.95999999999999996 111.979 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -164.15 143.25 7.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.178 -0.464 . . . . 0.91000000000000003 110.393 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.411 ' HB ' HD12 ' B' ' 11' ' ' LEU . 80.4 p -73.85 41.8 0.13 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.586 0.587 . . . . 0.88 112.586 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 7.9 tp -71.6 -35.59 56.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.115 0.483 . . . . 0.83999999999999997 110.747 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.417 ' O ' ' HD2' ' B' ' 14' ' ' PRO . 6.8 p30 -64.33 -36.19 83.32 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.106 -0.497 . . . . 0.90000000000000002 111.671 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.411 HD12 ' HB ' ' B' ' 8' ' ' THR . 92.4 mt -65.8 -22.59 66.57 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.308 0.484 . . . . 1.0700000000000001 112.308 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 43.5 mm -61.88 -41.92 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 112.07 0.396 . . . . 0.72999999999999998 112.07 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.509 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 72.3 mt -55.98 -62.89 3.9 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.123 0.416 . . . . 1.2 112.123 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.509 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.1 Cg_endo -54.48 -40.16 84.67 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.97 1.78 . . . . 1.0900000000000001 111.603 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 46.7 t -60.13 -51.43 69.66 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.932 -0.576 . . . . 0.81000000000000005 111.664 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.12 -38.96 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.482 0.549 . . . . 0.78000000000000003 112.482 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.446 HD12 ' N ' ' B' ' 18' ' ' ILE . 3.3 pp -69.1 -42.53 76.01 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 119.651 -0.82 . . . . 1.1599999999999999 111.399 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.446 ' N ' HD12 ' B' ' 17' ' ' LEU . 2.6 pp -66.76 -36.88 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 120.057 -0.657 . . . . 1.04 110.034 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.482 ' O ' HG12 ' B' ' 23' ' ' ILE . 86.5 m -65.51 -47.25 76.62 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.972 -0.381 . . . . 0.63 109.972 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 48.3 t -58.68 -49.72 76.52 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.073 -0.512 . . . . 0.83999999999999997 110.757 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.428 HD13 ' O ' ' B' ' 17' ' ' LEU . 8.4 mp -60.51 -45.4 93.93 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.326 -0.397 . . . . 1.1899999999999999 111.044 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.18 -56.51 21.1 Favored 'General case' 0 C--O 1.214 -0.802 0 C-N-CA 120.871 -0.332 . . . . 0.65000000000000002 110.752 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.482 HG12 ' O ' ' B' ' 19' ' ' THR . 47.7 mm -56.63 -37.93 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 110.774 -0.084 . . . . 0.53000000000000003 110.774 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -59.36 -46.63 88.11 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.886 -0.413 . . . . 0.94999999999999996 109.886 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.1 t -76.51 -45.76 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.446 0.641 . . . . 0.83999999999999997 111.591 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -63.57 -50.92 67.56 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.121 0.968 . . . . 0.88 112.493 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -92.44 40.97 1.06 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.184 -0.462 . . . . 0.90000000000000002 110.801 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.416 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 0.0 OUTLIER -70.45 148.17 95.28 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.271 -0.422 . . . . 0.55000000000000004 111.58 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 28' ' ' LEU . 21.8 Cg_exo -66.08 67.11 0.44 Allowed 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.35 2.7 . . . . 1.02 113.2 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 42.3 t -70.33 -50.97 33.69 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.358 -0.383 . . . . 0.70999999999999996 111.186 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 55.62 -125.65 2.1 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.71 -0.677 . . . . 1.3300000000000001 112.315 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 50.7 t -70.05 134.56 48.38 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.058 0.456 . . . . 1.76 111.88 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.13 128.07 1.28 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.118 -0.563 . . . . 1.3100000000000001 113.362 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -69.2 71.32 0.26 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.995 0.518 . . . . 2.2000000000000002 111.968 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.613 -0.708 . . . . 0.94999999999999996 110.928 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 110.831 -0.062 . . . . 1.0 110.831 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 12.4 ptt85 -159.5 42.96 0.22 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.65 0.262 . . . . 0.72999999999999998 111.221 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.682 ' HG3' ' HB2' ' B' ' 6' ' ' PHE . 23.7 ttmm 63.8 77.87 0.3 Allowed Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 121.318 0.58 . . . . 0.69999999999999996 111.035 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.11 69.94 1.8 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.419 2.746 . . . . 0.53000000000000003 112.402 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' B' ' 9' ' ' ILE . 3.9 mm? 69.84 24.56 5.25 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.68 -0.691 . . . . 0.55000000000000004 111.053 -178.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.682 ' HB2' ' HG3' ' B' ' 3' ' ' LYS . 3.1 m-85 -82.01 50.81 1.63 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.822 -0.626 . . . . 0.92000000000000004 110.507 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.516 ' HB2' ' HD3' ' B' ' 3' ' ' LYS . 4.6 t80 -178.41 -130.49 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.338 -0.846 . . . . 0.78000000000000003 108.811 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 80.6 p -82.4 139.02 34.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 0.40999999999999998 110.823 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' B' ' 5' ' ' LEU . 42.1 mt -68.98 -37.5 77.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 120.915 0.388 . . . . 0.54000000000000004 110.888 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.401 ' O ' ' HD2' ' B' ' 14' ' ' PRO . 69.0 m-20 62.57 49.48 3.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.727 -0.669 . . . . 0.46999999999999997 112.369 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 93.9 mt -62.38 -23.33 66.75 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.883 0.373 . . . . 0.65000000000000002 111.793 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 50.7 mm -60.75 -42.57 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 112.503 0.557 . . . . 0.56999999999999995 112.503 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.497 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 72.8 mt -55.74 -63.12 3.5 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.233 0.457 . . . . 0.65000000000000002 112.233 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.497 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.8 Cg_endo -55.47 -39.99 88.0 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.041 1.827 . . . . 0.56000000000000005 111.899 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 50.2 t -59.65 -47.08 87.01 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.387 -0.369 . . . . 0.44 110.95 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 22.2 t -63.98 -47.57 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 116.617 -0.265 . . . . 0.5 111.133 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' B' ' 17' ' ' LEU . 4.2 mm? -59.46 -48.71 80.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.749 -0.205 . . . . 0.64000000000000001 111.221 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.2 mt -61.24 -45.32 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.557 0.218 . . . . 0.62 110.757 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 38.4 m -61.43 -46.6 89.43 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.754 0.311 . . . . 0.34000000000000002 110.796 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 48.0 t -59.83 -50.88 72.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.176 -0.465 . . . . 0.45000000000000001 110.942 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 9.1 mp -60.56 -44.35 96.26 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.63 0.252 . . . . 0.55000000000000004 111.024 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.22 -59.6 5.05 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 116.566 -0.288 . . . . 0.33000000000000002 110.604 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' B' ' 27' ' ' TYR . 77.3 mt -54.46 -39.3 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.353 0.121 . . . . 0.34999999999999998 110.907 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.521 ' O ' ' HB2' ' B' ' 28' ' ' LEU . 55.8 tp -57.47 -45.75 84.46 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.758 0.313 . . . . 0.46999999999999997 110.631 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 72.4 t -80.87 -43.66 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.642 0.734 . . . . 0.34999999999999998 111.88 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -64.89 -46.57 81.17 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.281 1.032 . . . . 0.58999999999999997 113.543 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 3.5 m-85 -86.67 -51.21 6.27 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.428 0.529 . . . . 0.56999999999999995 112.428 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.521 ' HB2' ' O ' ' B' ' 24' ' ' LEU . 6.7 mp -83.03 135.95 44.43 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-O 120.788 0.327 . . . . 0.48999999999999999 111.383 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.65 53.07 1.36 Allowed 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.056 2.504 . . . . 0.48999999999999999 113.403 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 86.8 p 56.62 -124.62 1.87 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.232 0.613 . . . . 0.45000000000000001 112.188 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -141.9 -49.32 0.38 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.04 0.447 . . . . 0.64000000000000001 111.473 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 29.3 m -63.74 -39.51 94.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.759 -0.655 . . . . 0.59999999999999998 111.93 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.5 -55.02 0.09 OUTLIER Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.648 -0.787 . . . . 0.5 112.673 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.07 157.97 18.87 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.214 0.531 . . . . 0.58999999999999997 111.449 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-N 115.288 -0.869 . . . . 0.63 111.765 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 120.547 0.213 . . . . 1.3 111.303 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -165.83 128.25 2.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.452 -0.34 . . . . 1.46 110.687 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp 66.23 111.53 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.606 0 O-C-N 123.748 0.655 . . . . 0.83999999999999997 112.06 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.32 139.6 50.38 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.761 2.308 . . . . 0.51000000000000001 113.033 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.45 36.88 0.32 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.954 0.407 . . . . 0.62 111.787 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -87.17 55.03 3.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.98 0.419 . . . . 1.21 111.323 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -70.84 -50.54 34.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.69999999999999996 111.658 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -176.35 -153.77 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.087 -0.506 . . . . 0.48999999999999999 110.656 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.403 HG12 ' H ' ' B' ' 9' ' ' ILE . 21.0 pt -73.91 50.31 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.366 0.603 . . . . 0.84999999999999998 112.316 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -117.61 45.65 1.89 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.357 -0.383 . . . . 0.93999999999999995 110.908 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.3 45.27 0.28 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.937 0.399 . . . . 0.58999999999999997 112.046 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 45.7 mm -72.58 -42.23 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 122.72 0.408 . . . . 0.57999999999999996 111.524 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.469 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 80.6 mt -53.84 -60.74 6.54 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 116.151 -0.477 . . . . 0.87 112.177 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.469 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.0 Cg_endo -55.32 -40.69 84.3 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.928 1.752 . . . . 0.55000000000000004 112.003 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 48.3 t -61.04 -53.33 58.54 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.299 -0.409 . . . . 0.38 111.911 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.35 -38.03 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 120.701 -0.399 . . . . 0.51000000000000001 111.191 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.418 HD13 ' O ' ' B' ' 13' ' ' ILE . 7.1 mp -61.92 -53.2 58.96 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.313 0.101 . . . . 0.79000000000000004 111.204 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.97 -35.62 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 120.736 -0.386 . . . . 0.59999999999999998 110.849 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 80.0 m -65.35 -47.0 77.97 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.97 -0.382 . . . . 0.40999999999999998 109.97 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 39.9 t -59.83 -50.9 72.0 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.991 -0.55 . . . . 0.52000000000000002 110.898 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -60.22 -44.87 94.81 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.651 -0.25 . . . . 0.71999999999999997 111.099 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.54 -57.16 14.17 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 120.866 -0.333 . . . . 0.51000000000000001 110.566 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' B' ' 27' ' ' TYR . 65.4 mt -56.62 -37.1 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 121.49 -0.084 . . . . 0.52000000000000002 110.957 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.5 tp -59.86 -45.65 91.78 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.011 0.434 . . . . 0.66000000000000003 110.269 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 73.8 t -77.5 -47.24 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.461 0.648 . . . . 0.79000000000000004 111.316 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -61.71 -51.84 66.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.98 -1.009 . . . . 0.90000000000000002 112.207 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 2.0 m-85 -92.01 55.08 2.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.059 -0.519 . . . . 0.98999999999999999 110.562 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.559 ' H ' HD23 ' B' ' 28' ' ' LEU . 2.2 pt? -53.72 131.97 56.24 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 121.342 0.591 . . . . 0.90000000000000002 111.916 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.37 127.44 18.2 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.589 2.193 . . . . 0.46000000000000002 112.829 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 48.3 t -78.9 -46.8 17.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.204 -0.453 . . . . 0.83999999999999997 110.854 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -104.69 -173.61 2.34 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.15 0.5 . . . . 1.1499999999999999 111.48 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 39.8 m -80.6 131.21 35.48 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.072 -0.513 . . . . 1.23 111.86 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.67 38.37 93.7 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 121.305 -0.474 . . . . 1.1499999999999999 112.548 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -78.64 -49.06 13.85 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.175 0.435 . . . . 1.04 112.175 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 40.8 mttp . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.423 -0.799 . . . . 1.52 110.85 -179.929 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 120.427 0.156 . . . . 1.55 111.324 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.36 145.03 44.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.58 -0.282 . . . . 2.5 110.778 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -54.0 131.84 58.71 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 116.191 -0.458 . . . . 1.4399999999999999 112.208 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.39 46.85 0.78 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.058 2.505 . . . . 1.1899999999999999 113.492 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 69.9 mt -81.19 50.87 1.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.816 0.341 . . . . 0.84999999999999998 111.72 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.02 31.31 0.55 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.064 0.459 . . . . 1.3600000000000001 111.931 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -87.45 -38.16 16.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 1.72 111.076 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -167.48 -147.43 0.08 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.178 -0.465 . . . . 1.02 110.849 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 35.6 pt -65.07 144.03 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 121.213 0.53 . . . . 1.0700000000000001 112.353 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -66.91 -40.69 87.75 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.03 -0.532 . . . . 0.80000000000000004 111.439 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.87 44.46 0.75 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.006 0.432 . . . . 1.0 111.814 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.7 tp -71.17 -37.37 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.402 -0.363 . . . . 0.78000000000000003 111.591 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.468 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 82.1 mt -57.15 -61.11 7.7 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 111.933 0.346 . . . . 0.85999999999999999 111.933 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.468 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.1 Cg_endo -55.37 -38.91 93.47 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.727 1.618 . . . . 0.78000000000000003 111.641 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 40.9 t -59.69 -54.5 45.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.042 -0.526 . . . . 0.71999999999999997 111.796 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.421 HG23 HD22 ' B' ' 17' ' ' LEU . 27.5 m -65.1 -40.91 90.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 121.021 -0.272 . . . . 0.71999999999999997 111.665 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.663 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 3.9 mm? -60.75 -53.03 62.39 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 121.173 -0.211 . . . . 0.76000000000000001 111.019 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 43.5 mm -60.09 -43.74 93.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.508 0.194 . . . . 0.72999999999999998 110.64 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 91.5 m -60.0 -45.5 92.53 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.625 0.25 . . . . 0.62 110.374 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 47.7 t -60.09 -51.04 71.31 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.236 -0.438 . . . . 0.68000000000000005 110.497 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 60.4 mt -58.11 -44.62 87.78 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 120.765 0.317 . . . . 0.68000000000000005 110.48 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' B' ' 26' ' ' PHE . . . -59.0 -60.54 3.7 Favored 'General case' 0 C--O 1.204 -1.306 0 CA-C-N 116.296 -0.411 . . . . 0.46000000000000002 110.237 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.619 ' O ' ' HB2' ' B' ' 27' ' ' TYR . 71.8 mt -50.95 -39.79 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 120.572 0.225 . . . . 0.56999999999999995 111.147 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 52.6 tp -58.31 -47.78 82.6 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.684 0.278 . . . . 0.73999999999999999 110.929 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.11 -39.6 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.671 0.748 . . . . 0.55000000000000004 111.295 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' B' ' 22' ' ' ALA . 3.3 m-85 -79.73 -117.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.693 1.197 . . . . 0.52000000000000002 111.812 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.619 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 0.4 OUTLIER 51.98 43.7 30.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 114.511 -1.222 . . . . 0.78000000000000003 112.696 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.94 113.15 45.88 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.439 -0.346 . . . . 0.98999999999999999 111.128 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.14 50.46 2.86 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.637 2.225 . . . . 1.25 112.607 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 54.6 p -75.16 -61.11 2.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.983 0.421 . . . . 1.8100000000000001 111.975 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.28 -143.94 0.08 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.904 -0.589 . . . . 2.5 111.761 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 25.8 p -77.13 118.6 19.83 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.921 0.391 . . . . 2.3100000000000001 111.514 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 167.11 128.81 1.01 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.866 -0.683 . . . . 1.46 112.654 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 39.72 58.61 2.02 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.718 0.807 . . . . 1.21 113.079 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.558 -0.734 . . . . 1.6499999999999999 110.658 179.793 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 87.1 mtm-85 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.612 0.244 . . . . 1.5800000000000001 111.408 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -75.96 60.04 1.34 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.265 0.469 . . . . 1.52 112.265 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.423 ' N ' ' HD3' ' B' ' 4' ' ' PRO . 19.0 ptpt 41.08 62.83 6.36 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.668 0.988 . . . . 1.6599999999999999 113.668 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.423 ' HD3' ' N ' ' B' ' 3' ' ' LYS . 4.5 Cg_exo -73.08 136.87 25.45 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.974 2.449 . . . . 0.90000000000000002 112.197 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' B' ' 5' ' ' LEU . 3.7 mm? -73.63 51.92 0.38 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.205 0.446 . . . . 1.46 112.205 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.99 42.51 0.32 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.094 0.473 . . . . 0.76000000000000001 112.091 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -76.59 -35.71 57.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.123 -0.49 . . . . 1.5800000000000001 111.402 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 42.3 p -76.41 -30.8 57.6 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.546 0.573 . . . . 0.83999999999999997 112.546 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 15.2 tt -156.28 138.34 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.111 0.411 . . . . 0.87 112.111 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 t30 62.88 52.18 2.74 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.441 -0.8 . . . . 0.54000000000000004 111.783 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.77 -65.4 0.7 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.814 -0.63 . . . . 1.49 112.109 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.4 HG23 ' N ' ' B' ' 13' ' ' ILE . 5.7 tp -159.78 -53.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.261 -0.427 . . . . 0.62 110.641 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.564 ' N ' ' HD2' ' B' ' 14' ' ' PRO . 87.5 mt -56.25 -55.09 45.78 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 110.63 -0.137 . . . . 0.76000000000000001 110.63 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' B' ' 13' ' ' ILE . 19.7 Cg_endo -54.1 -44.82 45.85 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.882 2.388 . . . . 0.45000000000000001 111.401 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.1 t -60.14 -43.73 95.47 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.965 -0.561 . . . . 0.46999999999999997 110.856 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.28 -48.82 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 112.071 0.397 . . . . 0.55000000000000004 112.071 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 pp -66.55 -43.56 84.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.401 -0.52 . . . . 0.55000000000000004 111.397 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 31.6 mm -60.52 -45.15 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.666 0.269 . . . . 0.52000000000000002 110.517 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.473 ' O ' HG12 ' B' ' 23' ' ' ILE . 47.6 m -62.57 -45.73 91.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.501 -0.318 . . . . 0.46000000000000002 110.387 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.512 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 49.9 m -58.89 -52.47 65.58 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.19 -0.459 . . . . 0.47999999999999998 110.894 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -58.72 -44.11 90.34 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.716 -0.22 . . . . 0.55000000000000004 110.682 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.17 -56.13 26.05 Favored 'General case' 0 C--O 1.212 -0.893 0 C-N-CA 120.891 -0.324 . . . . 0.41999999999999998 110.467 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.473 HG12 ' O ' ' B' ' 19' ' ' THR . 50.1 mm -55.06 -40.02 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 122.82 0.075 . . . . 0.54000000000000004 111.15 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' B' ' 20' ' ' SER . 92.6 mt -60.11 -44.83 94.58 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.89 0.376 . . . . 0.52000000000000002 110.795 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 92.3 t -77.69 -40.47 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.68 0.752 . . . . 0.53000000000000003 111.649 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -70.34 -51.71 28.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.022 -0.99 . . . . 0.76000000000000001 113.345 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 3.1 m-85 -80.65 49.01 1.12 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.571 0.952 . . . . 0.82999999999999996 113.571 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 76.6 mt -82.58 127.49 70.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 O-C-N 122.184 -0.322 . . . . 0.62 110.836 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.78 36.88 0.44 Allowed 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.798 2.332 . . . . 0.68999999999999995 113.286 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 39.5 t -178.87 134.77 0.13 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.021 -0.536 . . . . 0.73999999999999999 110.64 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 58.56 33.64 23.26 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.61 0.596 . . . . 0.80000000000000004 112.61 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 46.2 t -174.46 -54.89 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.777 0.322 . . . . 0.51000000000000001 111.367 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.87 61.39 2.1 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.242 -0.504 . . . . 0.69999999999999996 114.166 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 1.051 ' HB2' ' HE2' ' B' ' 35' ' ' LYS . 27.1 mt-10 -63.04 -35.96 81.97 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.259 0.552 . . . . 0.93999999999999995 111.145 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 1.051 ' HE2' ' HB2' ' B' ' 34' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.278 0 CA-C-O 118.079 -0.962 . . . . 1.0900000000000001 110.863 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ARG . . . . . 0.509 ' HG3' ' SG ' ' B' ' 15' ' ' CYS . 73.8 mtp180 . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 111.504 0.187 . . . . 0.40999999999999998 111.504 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -81.99 47.85 1.16 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.687 0.28 . . . . 0.57999999999999996 111.663 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' B' ' 3' ' ' LYS . 31.5 mmtm -155.1 133.99 7.4 Favored Pre-proline 0 N--CA 1.468 0.457 0 CA-C-N 116.329 -0.396 . . . . 0.62 110.808 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.22 48.88 1.26 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.916 2.411 . . . . 0.66000000000000003 112.873 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 43.4 mt -145.15 62.38 1.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.505 . . . . 0.68000000000000005 111.191 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -76.45 50.27 0.65 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.392 0.516 . . . . 0.55000000000000004 112.392 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.467 ' CE1' HG23 ' B' ' 8' ' ' THR . 4.7 p90 -67.4 -25.25 65.86 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.995 0.368 . . . . 0.5 111.995 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.467 HG23 ' CE1' ' B' ' 7' ' ' TYR . 18.1 p -75.98 105.83 7.24 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.805 0.336 . . . . 0.46999999999999997 111.709 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 14.5 tt -74.22 -30.0 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.107 -0.497 . . . . 0.67000000000000004 111.36 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -57.62 113.19 1.7 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.356 -0.383 . . . . 0.66000000000000003 111.428 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 97.1 mt 57.47 35.1 25.5 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.782 -0.645 . . . . 0.59999999999999998 112.146 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.493 ' O ' HD13 ' B' ' 12' ' ' ILE . 0.0 OUTLIER -68.73 -38.39 78.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.612 -0.267 . . . . 0.37 111.147 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.69 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 4.8 mp -57.93 -62.21 5.91 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 111.454 0.168 . . . . 0.44 111.454 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.481 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.7 Cg_endo -55.01 -39.63 89.97 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.89 1.726 . . . . 0.31 111.855 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.509 ' SG ' ' HG3' ' B' ' 1' ' ' ARG . 53.7 t -60.28 -49.85 75.99 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.201 -0.454 . . . . 0.34999999999999998 111.511 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.466 HG12 ' O ' ' B' ' 13' ' ' ILE . 7.3 p -66.0 -41.2 89.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 120.761 -0.376 . . . . 0.32000000000000001 111.074 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 58.7 mt -59.65 -52.85 63.74 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 121.23 -0.188 . . . . 0.37 110.576 178.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.424 HG12 ' O ' ' B' ' 14' ' ' PRO . 45.4 mm -59.65 -42.81 89.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.622 -0.263 . . . . 0.40999999999999998 110.572 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.553 ' O ' HG12 ' B' ' 23' ' ' ILE . 76.4 m -60.6 -46.46 90.16 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.151 -0.314 . . . . 0.32000000000000001 110.151 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 48.4 t -59.22 -51.56 69.44 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.322 -0.399 . . . . 0.34000000000000002 110.883 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 58.8 mt -58.63 -44.82 90.12 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.715 0.293 . . . . 0.46999999999999997 110.889 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.87 -55.74 31.21 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 116.441 -0.345 . . . . 0.34999999999999998 110.756 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.553 HG12 ' O ' ' B' ' 19' ' ' THR . 43.9 mm -57.4 -37.39 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 121.266 -0.173 . . . . 0.44 110.724 179.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 52.7 tp -59.78 -46.01 90.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.965 0.412 . . . . 0.48999999999999999 110.311 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.406 ' O ' HD22 ' B' ' 28' ' ' LEU . 68.9 t -76.97 -46.36 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.401 0.619 . . . . 0.44 111.36 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -63.17 -52.3 62.96 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.175 0.99 . . . . 0.66000000000000003 112.303 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -93.44 39.53 1.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.016 -0.538 . . . . 0.56999999999999995 110.357 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.406 HD22 ' O ' ' B' ' 25' ' ' VAL . 2.4 pt? -65.25 143.28 98.75 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.46000000000000002 111.742 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.86 -136.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.487 2.125 . . . . 0.56999999999999995 112.367 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 96.7 p 54.97 34.43 22.35 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.511 0.725 . . . . 0.54000000000000004 112.742 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 51.22 59.68 4.42 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.58 0.585 . . . . 0.73999999999999999 112.58 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 12.8 p -71.99 51.78 0.23 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.643 0.609 . . . . 0.47999999999999998 112.643 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.39 130.13 10.52 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.98 -0.628 . . . . 0.66000000000000003 112.917 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.78 -160.42 0.68 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.862 0.363 . . . . 1.8600000000000001 111.054 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.348 -0.834 . . . . 2.1299999999999999 111.477 179.741 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 111.981 0.363 . . . . 1.6699999999999999 111.981 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -76.6 121.93 23.9 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.52 0.2 . . . . 2.3300000000000001 110.888 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 55.89 66.88 3.26 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-N 116.106 -0.497 . . . . 1.78 111.664 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -79.42 47.4 2.5 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.456 2.104 . . . . 0.98999999999999999 113.363 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' B' ' 5' ' ' LEU . 3.9 mm? -84.0 51.71 2.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.058 0.456 . . . . 1.1399999999999999 111.351 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -148.55 36.15 0.8 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.046 0.45 . . . . 1.03 111.896 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.409 ' OH ' ' HA ' ' B' ' 10' ' ' ASN . 33.5 t80 -75.8 143.06 42.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.011 0.434 . . . . 0.77000000000000002 111.17 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -162.47 -52.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 1.0700000000000001 112.081 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 58.8 mt -81.0 115.63 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 1.05 111.149 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.409 ' HA ' ' OH ' ' B' ' 7' ' ' TYR . 77.0 m-20 -73.17 133.93 44.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.363 -0.38 . . . . 1.01 111.656 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 97.6 mt 59.67 37.49 22.33 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.682 -0.69 . . . . 1.1699999999999999 111.649 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 6.9 tp -68.51 -40.6 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.106 -0.497 . . . . 1.1799999999999999 111.636 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.473 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 79.6 mt -57.14 -61.22 7.51 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 111.756 0.28 . . . . 1.4399999999999999 111.756 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.9 Cg_endo -55.36 -40.31 86.27 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.841 1.694 . . . . 1.05 111.869 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 42.9 t -61.68 -53.24 58.78 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.285 -0.416 . . . . 0.81000000000000005 111.901 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 12.5 p -63.82 -38.4 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 120.601 -0.439 . . . . 1.0700000000000001 110.83 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.641 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 7.0 mp -61.66 -54.18 46.27 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.998 -0.092 . . . . 1.1499999999999999 111.201 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.58 -35.83 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.838 -0.345 . . . . 0.70999999999999996 110.882 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.442 ' O ' HG12 ' B' ' 23' ' ' ILE . 86.5 m -64.46 -45.77 85.99 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.841 -0.429 . . . . 0.80000000000000004 109.841 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.487 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 48.4 t -60.23 -52.28 65.99 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.882 -0.599 . . . . 0.92000000000000004 110.528 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 59.8 mt -57.16 -44.61 83.66 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.74 0.305 . . . . 0.85999999999999999 110.812 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.28 -58.15 9.77 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 116.326 -0.397 . . . . 0.55000000000000004 110.705 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.442 HG12 ' O ' ' B' ' 19' ' ' THR . 51.9 mm -54.61 -40.49 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 117.58 0.173 . . . . 0.92000000000000004 111.113 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' B' ' 20' ' ' SER . 85.7 mt -58.99 -44.57 91.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 121.093 -0.243 . . . . 0.80000000000000004 111.029 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -80.06 -43.26 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.67 0.748 . . . . 0.72999999999999998 111.738 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -65.73 -48.64 71.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.951 -1.022 . . . . 0.96999999999999997 113.399 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 3.0 m-85 -85.15 -50.15 7.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.368 0.507 . . . . 1.3899999999999999 112.368 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 83.4 mt -92.66 137.41 24.26 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.743 0.306 . . . . 0.82999999999999996 111.469 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.17 48.45 0.9 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.811 2.341 . . . . 0.62 113.226 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 38.2 t -85.0 157.17 20.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.966 0.412 . . . . 0.60999999999999999 111.867 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.451 ' HA ' ' HE3' ' B' ' 35' ' ' LYS . 3.4 m-20 57.39 50.3 11.6 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.661 -0.699 . . . . 1.0800000000000001 112.515 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 42.7 t -76.81 52.87 0.87 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.509 0.671 . . . . 1.9399999999999999 110.947 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.64 152.19 7.98 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.564 -0.744 . . . . 1.8400000000000001 111.357 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.54 102.87 5.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.126 0.463 . . . . 3.0099999999999998 111.571 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' B' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.614 -0.708 . . . . 1.6000000000000001 110.5 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.584 0.23 . . . . 3.5800000000000001 111.196 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -99.43 56.53 1.01 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.346 0.593 . . . . 0.87 112.067 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -160.34 133.36 4.66 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 0.77000000000000002 111.226 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.51 -154.89 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.578 2.185 . . . . 0.72999999999999998 112.569 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 67.5 mt -90.82 -125.08 0.07 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.69 0.757 . . . . 1.75 111.86 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -80.61 54.19 2.04 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.963 -1.017 . . . . 1.8500000000000001 111.893 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -129.78 -55.7 1.14 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.723 0.296 . . . . 1.97 111.468 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 26.5 p -143.95 157.33 44.41 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.421 -0.354 . . . . 1.3300000000000001 111.308 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 33.3 pt -74.43 -166.5 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.082 0.468 . . . . 1.74 111.551 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -70.97 127.61 33.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.984 0.421 . . . . 0.79000000000000004 110.441 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt -75.15 14.08 0.61 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.669 0.618 . . . . 1.6799999999999999 112.669 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 9.0 tp -70.07 -39.83 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.331 0.11 . . . . 0.94999999999999996 111.28 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.496 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 77.5 mt -60.29 -61.68 7.44 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 111.535 0.198 . . . . 1.03 111.535 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.496 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.4 Cg_endo -55.57 -39.39 91.33 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.853 1.702 . . . . 0.90000000000000002 111.544 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.403 ' O ' HG13 ' B' ' 18' ' ' ILE . 50.3 t -64.21 -51.68 62.56 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.146 -0.479 . . . . 0.83999999999999997 112.012 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 10.0 p -62.43 -38.26 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 120.403 -0.519 . . . . 0.65000000000000002 110.401 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.419 HD13 ' O ' ' B' ' 13' ' ' ILE . 7.4 mp -62.32 -53.71 51.07 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.843 -0.162 . . . . 0.83999999999999997 111.089 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.403 HG13 ' O ' ' B' ' 15' ' ' CYS . 2.6 pp -63.42 -35.36 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 120.782 -0.367 . . . . 0.80000000000000004 111.189 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.455 ' O ' HG12 ' B' ' 23' ' ' ILE . 37.0 m -66.03 -44.09 85.68 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.563 -0.532 . . . . 0.63 109.563 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 46.6 t -61.16 -51.27 69.75 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.776 -0.647 . . . . 0.5 111.631 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.436 HD12 ' N ' ' B' ' 22' ' ' ALA . 3.2 pp -64.93 -38.86 92.35 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.45 -0.5 . . . . 0.69999999999999996 111.039 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.436 ' N ' HD12 ' B' ' 21' ' ' LEU . . . -59.93 -57.7 11.75 Favored 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 120.554 -0.458 . . . . 0.5 110.121 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.455 HG12 ' O ' ' B' ' 19' ' ' THR . 51.3 mm -56.32 -39.11 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 122.967 0.167 . . . . 0.45000000000000001 110.756 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.58 -45.15 85.57 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.865 0.364 . . . . 0.68999999999999995 110.462 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 69.8 t -79.44 -45.15 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.457 0.646 . . . . 0.66000000000000003 111.576 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -63.56 -47.56 81.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.908 -1.042 . . . . 0.67000000000000004 113.012 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 2.7 m-85 -90.96 54.05 2.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.8 0.296 . . . . 0.57999999999999996 111.8 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.65 ' H ' HD23 ' B' ' 28' ' ' LEU . 2.4 pt? -68.13 130.27 92.61 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 120.89 0.376 . . . . 0.73999999999999999 111.004 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.49 129.72 29.11 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.71 2.273 . . . . 0.76000000000000001 113.25 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 96.8 p -143.56 -37.38 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.056 -0.52 . . . . 0.87 111.443 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.48 -86.42 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.496 -0.32 . . . . 0.84999999999999998 111.837 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 46.8 t -157.17 -14.79 0.09 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.911 0.337 . . . . 1.0900000000000001 111.911 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.91 -38.55 92.96 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.627 -0.797 . . . . 0.76000000000000001 112.517 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.98 ' HG2' ' HD3' ' B' ' 35' ' ' LYS . 17.9 pm0 -71.94 -36.46 69.92 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.72 0.408 . . . . 0.56000000000000005 111.599 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.98 ' HD3' ' HG2' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.514 -0.755 . . . . 0.90000000000000002 110.548 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 110.703 -0.11 . . . . 4.3099999999999996 110.703 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 62.09 44.85 7.6 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.643 0.377 . . . . 2.9300000000000002 110.911 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' B' ' 4' ' ' PRO . 57.1 mtpt 64.82 114.79 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.702 0 CA-C-N 115.842 -0.617 . . . . 1.6499999999999999 111.492 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' B' ' 3' ' ' LYS . 13.4 Cg_endo -57.22 111.64 0.87 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.779 2.32 . . . . 1.79 113.494 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' B' ' 5' ' ' LEU . 3.6 mm? 53.1 35.06 18.68 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.52 -0.764 . . . . 1.71 112.373 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -156.87 54.75 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.122 0.487 . . . . 1.1299999999999999 110.579 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.64 51.69 0.14 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.803 -0.635 . . . . 1.4399999999999999 112.519 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.6 t -156.83 149.15 23.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.531 . . . . 0.56999999999999995 111.101 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 57.7 mt -60.81 -43.84 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.036 0.446 . . . . 0.68999999999999995 110.835 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' ASN . . . . . 0.412 ' HB2' ' H ' ' B' ' 11' ' ' LEU . 16.7 p30 -161.28 -151.01 0.21 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.937 -0.574 . . . . 0.67000000000000004 111.218 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.412 ' H ' ' HB2' ' B' ' 10' ' ' ASN . 95.8 mt -87.23 -20.51 26.81 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.195 0.813 . . . . 1.1499999999999999 113.195 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 39.9 mm -64.25 -45.71 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 112.408 0.522 . . . . 0.97999999999999998 112.408 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.473 HD12 ' H ' ' B' ' 13' ' ' ILE . 3.1 mp -54.21 -59.98 8.68 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 111.905 0.335 . . . . 0.78000000000000003 111.905 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.431 ' O ' HG12 ' B' ' 18' ' ' ILE . 12.1 Cg_endo -56.29 -41.31 77.79 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 121.967 1.778 . . . . 0.87 112.065 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.1 t -58.75 -48.08 82.44 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.733 0.301 . . . . 0.93000000000000005 110.868 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.03 -47.14 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 116.37 -0.377 . . . . 0.97999999999999998 110.967 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 8.6 mp -58.54 -50.68 72.9 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.661 -0.245 . . . . 1.28 111.417 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.431 HG12 ' O ' ' B' ' 14' ' ' PRO . 46.4 mm -61.36 -44.89 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 120.448 0.166 . . . . 1.3100000000000001 110.835 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 44.7 m -60.87 -47.19 87.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.715 0.293 . . . . 0.88 110.69 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 44.4 t -60.38 -50.98 71.46 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.272 -0.422 . . . . 1.22 110.929 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 8.8 mp -59.03 -45.82 89.76 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 116.553 -0.294 . . . . 1.6499999999999999 110.768 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.64 -57.57 12.4 Favored 'General case' 0 C--O 1.207 -1.174 0 N-CA-C 110.044 -0.354 . . . . 0.98999999999999999 110.044 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.525 HG23 ' CD1' ' B' ' 27' ' ' TYR . 30.7 mm -53.21 -38.35 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.481 0.181 . . . . 0.89000000000000001 111.458 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.9 tp -60.67 -45.86 92.55 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.836 0.35 . . . . 1.6299999999999999 110.654 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -80.58 -37.92 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.547 0.689 . . . . 1.49 111.392 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.433 ' HB3' ' H ' ' B' ' 27' ' ' TYR . 2.8 m-85 -78.79 -119.71 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.401 1.08 . . . . 1.55 111.913 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.525 ' CD1' HG23 ' B' ' 23' ' ' ILE . 0.0 OUTLIER 51.2 46.47 26.4 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.858 -1.064 . . . . 1.4099999999999999 112.458 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 16.5 tp 59.33 70.1 1.18 Allowed Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.074 -0.512 . . . . 1.52 111.935 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.17 50.62 1.9 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.831 2.354 . . . . 0.92000000000000004 112.967 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 95.5 p 53.98 46.26 25.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.261 0.624 . . . . 0.88 111.702 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -56.24 116.88 3.3 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.234 -0.439 . . . . 1.3899999999999999 111.381 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 71.7 m 60.42 29.19 18.82 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.748 -0.66 . . . . 2.0899999999999999 111.96 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.3 53.02 2.68 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.332 -0.461 . . . . 1.73 113.139 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -80.91 75.48 7.86 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.067 0.46 . . . . 2.6699999999999999 111.546 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' B' ' 35' ' ' LYS . 11.1 mptt . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.397 -0.811 . . . . 3.3300000000000001 112.198 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.219 0.057 . . . . 1.8300000000000001 111.053 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 59.42 45.76 13.28 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.129 0.49 . . . . 1.3500000000000001 110.737 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 ttpp 60.2 92.0 0.07 OUTLIER Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 115.487 -0.779 . . . . 0.78000000000000003 112.22 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.72 -142.17 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.143 2.562 . . . . 0.58999999999999997 112.987 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.11 45.75 0.16 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.305 0.483 . . . . 0.98999999999999999 112.305 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -86.48 53.58 2.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.894 0.378 . . . . 1.0800000000000001 111.251 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.65 -46.9 67.94 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.105 0.409 . . . . 0.97999999999999998 112.105 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 67.4 p 50.14 39.86 20.44 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.544 0.572 . . . . 1.04 112.544 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.403 HG12 ' H ' ' B' ' 9' ' ' ILE . 17.7 pt -75.18 50.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.888 0.699 . . . . 1.1399999999999999 112.888 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 58.93 57.72 3.48 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.298 0.481 . . . . 1.3899999999999999 112.298 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.446 ' HB3' ' HG2' ' B' ' 14' ' ' PRO . 3.4 mm? -74.4 49.26 0.37 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.883 0.373 . . . . 0.81999999999999995 111.749 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 7.4 tp -69.93 -38.98 76.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 111.875 0.324 . . . . 0.93999999999999995 111.875 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.718 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 74.4 mt -58.38 -62.48 5.53 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 111.854 0.316 . . . . 0.71999999999999997 111.854 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.502 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.4 Cg_endo -54.42 -40.13 84.5 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 121.882 1.722 . . . . 0.58999999999999997 111.834 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 t -61.93 -50.29 72.75 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.014 -0.539 . . . . 0.70999999999999996 111.558 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.471 HG12 ' O ' ' B' ' 13' ' ' ILE . 7.2 p -64.14 -39.0 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.6 -0.44 . . . . 0.53000000000000003 110.947 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 60.3 mt -62.78 -53.39 54.99 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 122.451 -0.156 . . . . 0.53000000000000003 111.275 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.83 -36.69 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 120.762 -0.375 . . . . 0.56999999999999995 111.15 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 88.1 m -64.78 -46.38 82.32 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.826 0.346 . . . . 0.56999999999999995 110.126 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.5 m -60.14 -50.96 71.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.051 -0.522 . . . . 0.45000000000000001 110.626 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.451 ' HA ' HD13 ' B' ' 21' ' ' LEU . 4.1 mm? -59.62 -44.46 93.45 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 116.592 -0.276 . . . . 0.69999999999999996 110.629 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' B' ' 26' ' ' PHE . . . -59.16 -60.57 3.66 Favored 'General case' 0 C--O 1.205 -1.287 0 CA-C-O 119.259 -0.401 . . . . 0.46999999999999997 110.131 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.667 ' O ' ' HB2' ' B' ' 27' ' ' TYR . 36.6 mm -51.04 -38.67 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 117.817 0.281 . . . . 0.59999999999999998 111.289 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 53.7 tp -59.54 -47.54 85.14 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.755 0.312 . . . . 0.81000000000000005 110.927 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 60.8 t -83.37 -39.94 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.771 0.796 . . . . 0.78000000000000003 111.373 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' B' ' 22' ' ' ALA . 3.9 m-85 -80.15 -114.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.895 1.278 . . . . 0.77000000000000002 111.947 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.667 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 0.6 OUTLIER 57.69 79.55 0.2 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.497 -1.228 . . . . 0.92000000000000004 113.187 179.477 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.4 mm? -65.94 133.07 94.79 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.096 -0.502 . . . . 1.1799999999999999 110.586 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 28' ' ' LEU . 23.5 Cg_exo -65.36 67.0 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.431 2.754 . . . . 1.3600000000000001 113.792 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -145.94 44.31 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.153 0.502 . . . . 1.6299999999999999 111.071 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -66.03 131.03 45.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.965 -0.562 . . . . 0.91000000000000003 111.3 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 54.0 t -72.02 115.31 11.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.284 -0.416 . . . . 1.5900000000000001 111.216 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.39 129.4 19.9 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.803 -0.713 . . . . 1.52 112.714 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -74.88 121.36 21.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.828 0.347 . . . . 2.8399999999999999 111.045 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.925 ' HD3' ' H ' ' B' ' 35' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.459 0 CA-C-O 118.444 -0.788 . . . . 3.6099999999999999 111.298 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 111.57 0.211 . . . . 1.8400000000000001 111.57 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -74.4 129.42 37.75 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 121.219 -0.192 . . . . 4.4100000000000001 110.83 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.456 ' HD2' ' HD2' ' B' ' 4' ' ' PRO . 26.7 tptp 67.54 109.33 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.538 0 O-C-N 123.717 0.636 . . . . 2.21 110.947 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.456 ' HD2' ' HD2' ' B' ' 3' ' ' LYS . 33.6 Cg_exo -59.52 115.94 2.94 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.446 2.097 . . . . 2.1899999999999999 112.741 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 54.1 mt -82.04 56.94 3.31 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.118 -0.492 . . . . 1.8300000000000001 111.433 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.28 34.78 0.06 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.272 0.842 . . . . 2.0699999999999998 113.272 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -81.54 -30.36 33.15 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.327 0.584 . . . . 2.1699999999999999 110.177 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -166.28 -160.84 0.44 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.523 -0.762 . . . . 1.6599999999999999 110.157 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 pt -78.46 46.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.108 0.48 . . . . 2.0800000000000001 112.225 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -76.95 67.33 2.94 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.427 -0.352 . . . . 1.2 111.175 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.501 ' HB3' ' HG2' ' B' ' 14' ' ' PRO . 93.2 mt 53.32 41.15 32.14 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.222 -0.445 . . . . 0.93999999999999995 111.753 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 7.7 tp -63.73 -42.53 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 112.089 0.403 . . . . 0.89000000000000001 112.089 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.67 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 73.9 mt -59.49 -62.71 5.32 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 111.709 0.263 . . . . 1.0 111.709 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.504 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.2 Cg_endo -54.51 -37.2 90.11 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.735 1.623 . . . . 0.64000000000000001 111.604 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 41.3 t -61.24 -51.3 69.51 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.198 -0.455 . . . . 0.56000000000000005 111.56 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 35.5 m -65.77 -39.08 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 120.684 -0.406 . . . . 0.68999999999999995 111.225 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 57.3 mt -61.84 -53.97 48.5 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 121.165 -0.214 . . . . 0.81999999999999995 110.73 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 45.0 mm -60.15 -43.36 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.642 -0.254 . . . . 0.76000000000000001 111.085 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 58.4 m -60.44 -44.37 95.88 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.653 0.263 . . . . 0.68999999999999995 110.423 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -61.53 -50.61 72.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.241 -0.436 . . . . 0.68999999999999995 110.818 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 60.6 mt -58.28 -44.89 88.67 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.781 0.324 . . . . 0.94999999999999996 110.534 179.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.01 -57.65 11.87 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 116.222 -0.445 . . . . 0.81999999999999995 110.59 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 71.6 mt -56.23 -37.96 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 122.821 0.076 . . . . 0.87 110.915 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 54.8 tp -58.9 -45.34 90.54 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.042 0.449 . . . . 1.0900000000000001 110.281 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 70.7 t -78.62 -46.3 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.447 0.641 . . . . 1.21 111.34 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -62.74 -49.0 76.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.009 -0.996 . . . . 1.4099999999999999 112.69 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -93.12 47.12 1.25 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.859 0.361 . . . . 1.3999999999999999 110.873 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.52 ' H ' HD23 ' B' ' 28' ' ' LEU . 2.6 pt? -62.85 134.69 95.67 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 120.93 0.395 . . . . 1.05 111.546 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.24 126.0 14.97 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.56 2.173 . . . . 1.1599999999999999 112.888 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 40.5 t -71.38 141.62 50.36 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.194 -0.457 . . . . 1.03 111.8 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.78 -39.81 68.79 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.103 -0.499 . . . . 1.8700000000000001 111.653 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 25.6 p -89.48 19.13 4.71 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.989 0.366 . . . . 1.6200000000000001 111.989 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.51 -59.53 2.88 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.327 -0.464 . . . . 1.6399999999999999 113.587 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.433 ' HB3' ' H ' ' B' ' 35' ' ' LYS . 19.1 mm-40 59.37 -142.2 0.62 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.453 0.538 . . . . 2.27 112.453 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.463 ' N ' ' HD3' ' B' ' 35' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.57 0 CA-C-O 117.868 -1.063 . . . . 2.9100000000000001 109.915 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 111.043 0.016 . . . . 0.85999999999999999 111.043 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -78.64 131.55 36.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.792 0.33 . . . . 0.81000000000000005 111.204 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.435 ' HB2' ' HD2' ' B' ' 4' ' ' PRO . 13.9 pttp -73.72 157.94 86.81 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.134 -0.485 . . . . 0.88 111.06 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.603 ' HD3' HD21 ' B' ' 11' ' ' LEU . 29.0 Cg_endo -62.76 135.05 50.12 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.382 2.055 . . . . 0.63 112.457 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.79 54.11 2.94 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.264 -0.425 . . . . 0.98999999999999999 111.898 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 58.96 52.12 6.68 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.213 0.53 . . . . 1.45 111.584 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -150.87 145.86 25.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.948 -0.569 . . . . 0.98999999999999999 110.306 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -72.92 45.91 0.16 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.515 0.674 . . . . 0.75 112.498 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.529 HG23 ' H ' ' B' ' 11' ' ' LEU . 9.1 tp -75.46 -28.5 20.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.119 -0.491 . . . . 0.64000000000000001 110.413 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 60.18 36.32 20.99 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.763 -0.653 . . . . 0.56999999999999995 111.984 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.603 HD21 ' HD3' ' B' ' 4' ' ' PRO . 95.7 mt 53.36 46.84 25.51 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.104 0.779 . . . . 0.57999999999999996 113.104 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.427 HG12 ' O ' ' B' ' 9' ' ' ILE . 3.8 mm -66.83 -43.95 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 120.562 0.22 . . . . 0.70999999999999996 111.564 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.707 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 73.8 mt -54.61 -62.63 3.79 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.857 0.318 . . . . 0.62 111.857 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.544 ' HG2' ' HB3' ' B' ' 11' ' ' LEU . 12.3 Cg_endo -55.53 -39.9 88.46 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 121.73 1.62 . . . . 0.40999999999999998 111.723 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 40.8 t -60.96 -50.75 72.12 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.103 -0.499 . . . . 0.57999999999999996 111.448 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.437 HG12 ' O ' ' B' ' 13' ' ' ILE . 8.4 p -64.73 -41.79 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.9 -0.32 . . . . 0.5 111.177 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 60.0 mt -60.19 -51.14 70.84 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 122.276 -0.265 . . . . 0.53000000000000003 110.605 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.8 mt -60.02 -44.04 93.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.536 -0.302 . . . . 0.59999999999999998 110.718 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.496 ' O ' HG12 ' B' ' 23' ' ' ILE . 67.6 m -60.54 -45.01 95.47 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.405 -0.361 . . . . 0.57999999999999996 110.625 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.3 t -60.7 -49.64 76.71 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.245 -0.434 . . . . 0.45000000000000001 110.647 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 60.4 mt -59.71 -44.6 93.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.721 0.296 . . . . 0.63 110.556 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.77 11.42 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 116.418 -0.356 . . . . 0.59999999999999998 110.641 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.496 HG12 ' O ' ' B' ' 19' ' ' THR . 45.4 mm -56.8 -36.91 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.282 0.087 . . . . 0.68999999999999995 110.956 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.6 -44.44 96.27 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.952 0.406 . . . . 1.3 110.162 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 79.6 t -78.51 -47.54 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 121.444 0.64 . . . . 0.80000000000000004 111.138 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -61.27 -48.6 80.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.898 -1.046 . . . . 0.92000000000000004 112.405 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 2.1 m-85 -95.7 48.47 1.14 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.402 -0.363 . . . . 0.95999999999999996 110.558 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.501 ' H ' HD23 ' B' ' 28' ' ' LEU . 2.6 pt? -61.01 131.23 91.79 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 121.218 0.532 . . . . 0.87 112.116 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.85 75.22 3.2 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.869 2.379 . . . . 0.98999999999999999 113.068 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 68.0 m -156.25 128.92 7.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.78 0.324 . . . . 0.75 111.257 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.51 123.87 20.36 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.136 -0.484 . . . . 1.24 111.511 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 17.6 t 56.63 45.31 22.33 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.286 0.565 . . . . 1.3400000000000001 111.128 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.5 -23.51 77.53 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.62 -0.718 . . . . 1.1000000000000001 114.003 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -38.86 85.59 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 117.042 0.421 . . . . 1.6200000000000001 111.918 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.567 ' NZ ' ' HB3' ' B' ' 35' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.497 -0.763 . . . . 1.9099999999999999 111.152 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.457 0.17 . . . . 1.02 110.91 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -142.69 140.68 31.62 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.736 0.303 . . . . 0.93999999999999995 111.144 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.482 ' HB2' ' HB2' ' B' ' 6' ' ' PHE . 13.3 mmmm -68.59 134.73 90.53 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.253 -0.43 . . . . 0.42999999999999999 111.309 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.31 28.98 0.26 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.741 2.294 . . . . 0.55000000000000004 113.364 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' LEU . . . . . 0.443 ' H ' ' C ' ' B' ' 3' ' ' LYS . 17.3 mt -158.81 27.64 0.22 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.428 -0.805 . . . . 0.42999999999999999 110.099 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' PHE . . . . . 0.482 ' HB2' ' HB2' ' B' ' 3' ' ' LYS . 12.8 t80 -106.35 54.0 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.61 -0.723 . . . . 0.80000000000000004 110.476 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.582 ' HB2' ' HG ' ' B' ' 11' ' ' LEU . 6.0 m-85 -79.65 -44.52 20.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 1.0700000000000001 111.677 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.439 ' O ' HG12 ' B' ' 12' ' ' ILE . 9.0 t -168.94 -161.34 0.32 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.34 -0.391 . . . . 0.76000000000000001 111.067 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.49 ' O ' ' HB ' ' B' ' 12' ' ' ILE . 49.4 mm -62.59 -46.9 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 111.992 0.368 . . . . 0.94999999999999996 111.992 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -58.9 -39.23 80.86 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.952 0.406 . . . . 0.79000000000000004 111.768 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' LEU . . . . . 0.582 ' HG ' ' HB2' ' B' ' 7' ' ' TYR . 4.3 mm? -74.44 -14.35 60.83 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.795 0.665 . . . . 0.62 112.795 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' B' ' 9' ' ' ILE . 8.6 mm -60.11 -39.33 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 111.763 0.283 . . . . 0.69999999999999996 111.763 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.514 HD12 ' H ' ' B' ' 13' ' ' ILE . 3.6 mp -57.99 -62.44 5.48 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 116.646 -0.252 . . . . 0.54000000000000004 111.591 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.406 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.5 Cg_endo -56.03 -38.07 95.3 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.642 1.561 . . . . 0.33000000000000002 111.821 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.421 ' O ' HG13 ' B' ' 18' ' ' ILE . 42.0 t -60.86 -53.78 53.19 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.316 -0.402 . . . . 0.35999999999999999 111.551 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.96 -37.85 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 120.684 -0.406 . . . . 0.52000000000000002 110.623 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.422 HD13 ' O ' ' B' ' 13' ' ' ILE . 6.9 mp -61.5 -53.04 61.63 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.942 -0.117 . . . . 0.42999999999999999 111.19 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.421 HG13 ' O ' ' B' ' 15' ' ' CYS . 2.6 pp -63.57 -34.27 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 120.707 -0.397 . . . . 0.40999999999999998 110.831 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.481 ' O ' HG12 ' B' ' 23' ' ' ILE . 34.8 m -66.11 -48.07 72.1 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.811 0.338 . . . . 0.55000000000000004 110.27 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -59.09 -48.53 81.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.012 -0.54 . . . . 0.59999999999999998 110.504 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.41 HD13 ' O ' ' B' ' 17' ' ' LEU . 9.1 mp -60.78 -45.55 93.93 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.26 -0.427 . . . . 0.56000000000000005 110.937 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.36 -56.33 23.54 Favored 'General case' 0 C--O 1.215 -0.731 0 C-N-CA 120.822 -0.351 . . . . 0.62 110.608 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.481 HG12 ' O ' ' B' ' 19' ' ' THR . 46.4 mm -56.73 -37.64 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 122.835 0.085 . . . . 0.72999999999999998 110.779 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.91 -45.31 92.97 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.971 0.415 . . . . 0.78000000000000003 110.407 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -77.33 -45.93 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.444 0.64 . . . . 0.78000000000000003 111.312 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -63.52 -50.88 67.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.306 1.042 . . . . 0.87 112.573 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -92.89 46.63 1.23 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.193 -0.458 . . . . 1.01 110.764 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.483 ' H ' HD23 ' B' ' 28' ' ' LEU . 2.6 pt? -63.68 133.12 95.42 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 121.09 0.472 . . . . 1.01 111.945 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -72.86 59.04 3.45 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.95 2.434 . . . . 1.1000000000000001 112.889 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 56.2 p -87.19 -13.47 43.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 1.3 112.101 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.93 128.9 38.34 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.273 0.559 . . . . 1.9199999999999999 111.67 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 51.8 t -139.85 141.15 36.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.32 0.581 . . . . 2.4100000000000001 111.507 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.41 -46.42 0.2 Allowed Glycine 0 C--N 1.322 -0.241 0 N-CA-C 110.282 -1.127 . . . . 1.8700000000000001 110.282 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.457 ' OE1' ' HG2' ' B' ' 35' ' ' LYS . 0.0 OUTLIER -93.49 -37.49 11.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.632 -0.784 . . . . 3.0899999999999999 109.229 177.294 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.457 ' HG2' ' OE1' ' B' ' 34' ' ' GLU . 20.5 pttm . . . . . 0 C--O 1.25 1.107 0 CA-C-N 115.24 -0.891 . . . . 3.7000000000000002 111.051 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 111.563 0.209 . . . . 3.8399999999999999 111.563 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 58.14 38.56 26.42 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.677 0.61 . . . . 3.4199999999999999 111.649 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' B' ' 3' ' ' LYS . 43.8 mtmt 67.41 118.78 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 122.878 0.471 . . . . 1.49 111.567 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.12 107.73 0.31 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.429 2.086 . . . . 1.51 112.099 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 54.42 29.48 11.11 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.857 -0.61 . . . . 2.6499999999999999 111.41 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 55.03 32.49 18.3 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.892 -0.594 . . . . 2.2000000000000002 111.742 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -87.6 -44.34 11.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.018 0.437 . . . . 2.4399999999999999 111.552 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 60.2 p -73.94 63.08 0.9 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.322 0.49 . . . . 0.81000000000000005 112.322 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 49.8 mm -75.43 126.27 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.358 -0.383 . . . . 1.25 111.459 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -70.79 110.45 5.57 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.906 0.384 . . . . 2.0600000000000001 110.4 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 93.8 mt -87.07 -20.12 27.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 1.9199999999999999 111.299 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 51.3 mm -61.8 -50.3 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 112.479 0.548 . . . . 1.98 112.479 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.439 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 84.1 mt -54.01 -61.37 5.43 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 111.878 0.325 . . . . 2.0 111.878 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.439 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.3 Cg_endo -54.87 -41.25 80.2 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 122.088 1.858 . . . . 1.5600000000000001 111.605 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 41.2 t -60.2 -48.48 81.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.364 -0.38 . . . . 1.3400000000000001 110.817 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 t -62.06 -46.61 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 120.696 0.284 . . . . 1.5 110.762 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' B' ' 17' ' ' LEU . 4.1 mm? -60.24 -51.49 69.35 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.456 -0.338 . . . . 1.55 111.816 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.37 -36.77 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 120.49 -0.484 . . . . 1.1599999999999999 110.978 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.501 ' O ' HG12 ' B' ' 23' ' ' ILE . 80.4 m -65.9 -47.09 75.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.878 0.371 . . . . 1.03 110.039 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.519 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 41.0 t -58.81 -51.81 68.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.015 -0.539 . . . . 1.0600000000000001 110.782 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.445 ' HA ' HD13 ' B' ' 21' ' ' LEU . 4.1 mm? -59.01 -44.65 91.73 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.654 -0.248 . . . . 1.24 110.786 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.72 -56.29 23.88 Favored 'General case' 0 C--O 1.211 -0.928 0 C-N-CA 120.852 -0.339 . . . . 0.72999999999999998 110.585 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.501 HG12 ' O ' ' B' ' 19' ' ' THR . 50.0 mm -55.61 -40.13 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.288 0.09 . . . . 0.68000000000000005 111.144 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' B' ' 20' ' ' SER . 87.9 mt -59.23 -43.78 92.35 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.779 0.323 . . . . 1.01 110.6 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 73.5 t -78.83 -45.6 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.528 0.68 . . . . 0.97999999999999998 111.652 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -64.18 -56.5 14.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.277 1.031 . . . . 0.93000000000000005 112.975 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -79.71 -35.46 38.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.27 -0.423 . . . . 1.04 111.42 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 tp 56.7 64.08 4.95 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.852 -0.613 . . . . 1.25 111.974 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.14 52.82 1.93 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.856 2.371 . . . . 0.94999999999999996 113.338 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 28.7 t -72.01 -45.23 61.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.038 -0.528 . . . . 1.75 111.565 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -140.17 137.62 34.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 2.1299999999999999 111.102 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 52.5 t -151.91 -36.69 0.12 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.383 0.512 . . . . 2.3599999999999999 112.383 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.42 39.98 0.04 OUTLIER Glycine 0 CA--C 1.517 0.176 0 C-N-CA 121.017 -0.611 . . . . 2.7000000000000002 111.671 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.426 ' OE1' ' HG3' ' B' ' 35' ' ' LYS . 0.0 OUTLIER -141.89 -168.75 2.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.35 -0.425 . . . . 2.5099999999999998 111.927 -178.592 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.426 ' HG3' ' OE1' ' B' ' 34' ' ' GLU . 34.1 mtmm . . . . . 0 C--O 1.252 1.217 0 CA-C-O 118.373 -0.823 . . . . 3.1600000000000001 112.148 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 111.82 0.304 . . . . 1.27 111.82 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 61.13 -151.04 0.4 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.193 -0.458 . . . . 1.9299999999999999 111.215 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.44 ' N ' ' HD3' ' B' ' 4' ' ' PRO . 21.7 pttp -170.77 60.18 0.33 Allowed Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 112.309 0.485 . . . . 1.28 112.309 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' B' ' 7' ' ' TYR . 18.5 Cg_exo -64.75 110.35 1.44 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.236 1.957 . . . . 1.1699999999999999 111.824 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 66.3 mt 56.12 40.43 30.17 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.529 -0.305 . . . . 1.4199999999999999 111.731 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 63.68 38.28 9.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.081 -0.508 . . . . 1.0700000000000001 112.105 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.454 ' HB3' ' HD2' ' B' ' 4' ' ' PRO . 24.5 t80 -76.98 127.21 32.29 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.439 -0.346 . . . . 1.0900000000000001 111.372 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 61.2 p 53.11 38.06 26.49 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.95 0.722 . . . . 0.63 112.95 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 16.5 tt -91.22 145.65 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.695 0.283 . . . . 0.65000000000000002 111.212 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -72.38 50.08 0.22 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.114 0.483 . . . . 0.70999999999999996 111.755 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -144.08 -48.21 0.28 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.112 -0.495 . . . . 0.76000000000000001 109.752 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.37 -36.68 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.109 -0.496 . . . . 0.80000000000000004 110.981 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.494 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 79.9 mt -58.18 -62.21 5.98 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 111.832 0.308 . . . . 0.66000000000000003 111.832 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' PRO . . . . . 0.494 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.9 Cg_endo -55.91 -40.4 85.29 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 121.873 1.716 . . . . 0.54000000000000004 111.671 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.3 t -59.76 -52.66 64.52 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.153 -0.476 . . . . 0.71999999999999997 111.715 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.47 HG13 HD22 ' B' ' 17' ' ' LEU . 11.8 p -64.84 -41.23 91.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 120.805 -0.358 . . . . 0.80000000000000004 111.332 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' LEU . . . . . 0.47 HD22 HG13 ' B' ' 16' ' ' VAL . 3.8 mm? -61.09 -52.16 66.07 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 121.144 -0.222 . . . . 0.85999999999999999 111.023 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.426 HG12 ' O ' ' B' ' 14' ' ' PRO . 43.9 mm -60.16 -43.89 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.599 0.238 . . . . 0.69999999999999996 110.675 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 75.5 m -60.6 -47.37 86.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.679 0.276 . . . . 0.81999999999999995 110.669 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 48.1 t -59.44 -52.78 64.12 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.323 -0.399 . . . . 0.97999999999999998 110.771 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -57.83 -45.58 85.98 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.576 -0.284 . . . . 1.01 110.918 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.99 -54.78 42.85 Favored 'General case' 0 C--O 1.212 -0.872 0 C-N-CA 120.922 -0.311 . . . . 0.77000000000000002 110.164 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 34.2 mm -54.53 -45.88 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 122.932 0.145 . . . . 0.94999999999999996 110.973 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' B' ' 20' ' ' SER . 93.3 mt -54.45 -41.55 69.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.821 0.343 . . . . 1.0900000000000001 110.872 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 91.7 t -81.32 -36.02 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.374 0.607 . . . . 0.94999999999999996 111.49 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.417 ' HB3' ' H ' ' B' ' 27' ' ' TYR . 4.9 m-30 -75.87 -120.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.094 0.958 . . . . 0.95999999999999996 113.389 -177.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' TYR . . . . . 0.417 ' H ' ' HB3' ' B' ' 26' ' ' PHE . 0.0 OUTLIER 21.83 47.87 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.078 1.751 . . . . 1.1200000000000001 115.281 -178.439 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.781 ' H ' HD23 ' B' ' 28' ' ' LEU . 1.9 pt? -67.89 130.86 92.65 Favored Pre-proline 0 N--CA 1.455 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.88 110.961 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.59 48.64 1.34 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.709 2.273 . . . . 1.23 113.153 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 81.7 p -79.88 53.62 1.7 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.005 0.431 . . . . 0.88 111.15 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -83.39 136.38 34.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.259 0.552 . . . . 1.8799999999999999 111.177 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 25.6 p -83.87 -13.77 52.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.684 -0.689 . . . . 1.6799999999999999 111.143 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.02 53.2 2.58 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 114.332 0.493 . . . . 2.21 114.332 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.435 ' HB3' ' H ' ' B' ' 35' ' ' LYS . 0.0 OUTLIER 60.29 -151.41 0.41 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.415 0.524 . . . . 3.1699999999999999 112.415 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 35' ' ' LYS . . . . . 0.435 ' H ' ' HB3' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.624 -0.703 . . . . 2.77 110.886 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.0 tp . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 111.988 0.366 . . . . 0.7 111.988 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.485 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 78.3 mt -55.99 -61.98 5.49 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 111.767 0.284 . . . . 0.9 111.767 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.485 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.9 Cg_endo -55.23 -40.5 85.36 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 122.153 1.902 . . . . 0.54 111.852 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 t -59.76 -47.47 85.56 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.455 -0.339 . . . . 0.48 110.911 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.5 t -63.93 -46.88 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 116.555 -0.293 . . . . 0.71 110.895 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.663 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 9.4 mp -59.22 -50.56 73.56 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.455 -0.338 . . . . 0.81 111.125 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.6 mt -59.97 -44.68 95.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.567 0.222 . . . . 0.49 110.699 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.441 ' O ' HG12 ' B' ' 23' ' ' ILE . 51.3 m -60.63 -45.72 92.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.845 0.355 . . . . 0.53 110.339 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 43.3 t -58.82 -50.71 72.94 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.09 -0.505 . . . . 0.63 110.954 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 58.7 mt -60.0 -45.55 92.39 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.69 0.281 . . . . 0.7 110.793 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.24 -58.18 9.6 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 116.39 -0.368 . . . . 0.4 110.784 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.441 HG12 ' O ' ' B' ' 19' ' ' THR . 52.0 mm -55.13 -39.56 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.39 0.138 . . . . 0.56 110.907 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 54.7 tp -57.78 -45.95 85.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.932 0.396 . . . . 0.71 110.504 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 78.6 t -78.76 -46.68 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.467 0.651 . . . . 0.67 111.639 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 . . . . . 0 C--N 1.325 -0.484 0 C-N-CA 124.28 1.032 . . . . 0.81 113.171 -178.9 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 10.9 tp . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 113.044 0.757 . . . . 0.49 113.044 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.418 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 68.8 mt -59.34 -61.17 8.38 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.315 0.487 . . . . 0.44 112.315 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.418 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.1 Cg_endo -54.48 -40.03 85.29 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.864 1.709 . . . . 0.39 111.485 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.8 t -60.1 -51.93 67.51 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.22 -0.446 . . . . 0.36 111.671 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 34.7 m -65.22 -38.89 83.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 112.296 0.48 . . . . 0.36 112.296 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.481 HD12 ' N ' ' B' ' 18' ' ' ILE . 3.5 pp -69.97 -43.35 71.67 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 119.624 -0.83 . . . . 0.46 111.651 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.481 ' N ' HD12 ' B' ' 17' ' ' LEU . 2.6 pp -66.5 -38.04 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.276 -0.57 . . . . 0.42 110.312 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.486 ' O ' HG12 ' B' ' 23' ' ' ILE . 87.5 m -64.59 -47.22 79.49 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.126 -0.324 . . . . 0.39 110.126 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.48 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 48.7 m -59.17 -51.48 69.83 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.19 -0.459 . . . . 0.37 110.618 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.406 HD13 ' O ' ' B' ' 17' ' ' LEU . 8.6 mp -57.97 -45.22 87.05 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.63 -0.259 . . . . 0.53 110.847 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.95 -57.26 13.31 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 116.489 -0.323 . . . . 0.33 110.855 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.486 HG12 ' O ' ' B' ' 19' ' ' THR . 45.9 mm -55.3 -40.75 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 117.521 0.146 . . . . 0.48 111.208 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' B' ' 20' ' ' SER . 84.4 mt -58.31 -42.57 87.01 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.868 0.366 . . . . 0.42 110.485 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 76.9 t -80.61 -46.3 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.472 0.653 . . . . 0.39 111.667 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 . . . . . 0 N--CA 1.469 0.479 0 C-N-CA 124.412 1.085 . . . . 0.61 113.134 -178.873 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.1 tp . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 111.974 0.361 . . . . 0.88 111.974 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.518 ' O ' HG12 ' B' ' 16' ' ' VAL . 71.6 mt -61.72 -63.07 4.7 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 111.889 0.329 . . . . 0.7 111.889 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.491 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.4 Cg_endo -54.76 -40.48 84.58 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.863 1.709 . . . . 0.8 111.461 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 52.0 t -62.43 -48.66 78.71 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.093 -0.503 . . . . 0.77 111.564 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.518 HG12 ' O ' ' B' ' 13' ' ' ILE . 7.5 p -64.76 -39.45 85.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.029 0.381 . . . . 0.55 112.029 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.424 HD12 ' N ' ' B' ' 18' ' ' ILE . 3.0 pp -70.65 -42.8 70.33 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 119.842 -0.743 . . . . 0.58 111.561 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.424 ' N ' HD12 ' B' ' 17' ' ' LEU . 2.6 pp -65.9 -37.11 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 120.067 -0.653 . . . . 0.64 110.188 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 89.0 m -65.83 -46.26 79.24 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.805 0.336 . . . . 0.59 110.145 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -60.56 -51.51 69.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.124 -0.489 . . . . 0.35 110.904 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -59.89 -45.74 91.56 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.588 -0.278 . . . . 0.47 111.075 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 -57.98 10.15 Favored 'General case' 0 C--O 1.213 -0.862 0 C-N-CA 120.965 -0.294 . . . . 0.37 110.613 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 74.8 mt -54.55 -39.95 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.351 0.12 . . . . 0.55 110.979 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 49.8 tp -56.81 -47.17 80.86 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.987 0.423 . . . . 0.59 110.607 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 77.9 t -79.93 -44.31 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.51 0.671 . . . . 0.5 111.962 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 . . . . . 0 C--N 1.322 -0.625 0 N-CA-C 114.053 1.131 . . . . 0.62 114.053 -177.962 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.8 tp . . . . . 0 CA--C 1.543 0.692 0 N-CA-C 112.542 0.571 . . . . 0.81 112.542 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.484 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 72.3 mt -59.78 -63.91 3.65 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 112.279 0.474 . . . . 0.52 112.279 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.484 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.4 Cg_endo -55.95 -37.71 95.65 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.689 1.593 . . . . 0.66 111.453 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 40.8 t -60.85 -53.4 57.79 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.092 -0.503 . . . . 0.78 111.742 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.531 HG13 HD22 ' B' ' 17' ' ' LEU . 11.9 p -64.9 -40.68 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 120.824 -0.35 . . . . 0.6 111.509 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.531 HD22 HG13 ' B' ' 16' ' ' VAL . 3.8 mm? -62.82 -51.83 65.53 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.42 -0.175 . . . . 0.63 111.152 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 63.7 mt -60.79 -44.8 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.552 0.215 . . . . 0.79 110.904 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 64.0 m -60.07 -46.98 87.77 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.663 0.268 . . . . 0.65 110.775 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.1 m -60.23 -50.55 73.22 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.288 -0.414 . . . . 0.58 110.725 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.412 HD13 ' O ' ' B' ' 17' ' ' LEU . 8.8 mp -58.86 -45.18 90.71 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.44 -0.346 . . . . 0.76 110.68 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.58 -55.67 31.62 Favored 'General case' 0 C--O 1.208 -1.117 0 C-N-CA 120.894 -0.322 . . . . 0.58 110.329 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 74.1 mt -52.89 -41.68 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 122.967 0.167 . . . . 0.6 111.187 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.29 -46.96 87.14 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.927 0.394 . . . . 0.78 110.577 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.63 -36.32 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.474 0.654 . . . . 0.69 111.209 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 . . . . . 0 N--CA 1.447 -0.596 0 C-N-CA 124.107 0.963 . . . . 0.72 111.466 -179.249 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.2 tp . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 112.332 0.493 . . . . 0.63 112.332 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.478 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 78.3 mt -56.62 -61.5 6.7 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 111.982 0.364 . . . . 0.7 111.982 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.478 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 14.1 Cg_endo -56.56 -39.74 89.26 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.788 1.659 . . . . 0.61 111.742 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 41.2 t -60.26 -53.05 62.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.343 -0.39 . . . . 0.6 111.792 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.0 p -65.49 -40.67 88.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 120.893 -0.323 . . . . 0.61 111.118 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 7.7 mp -60.89 -51.93 67.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.486 0.184 . . . . 0.82 110.776 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.5 mt -60.31 -44.0 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 120.699 0.285 . . . . 0.81 110.689 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 75.0 m -59.96 -45.23 93.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.423 -0.353 . . . . 0.61 110.48 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 40.9 t -60.3 -50.62 72.9 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.169 -0.469 . . . . 0.71 110.826 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 53.6 mt -59.23 -44.98 92.32 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.731 0.301 . . . . 0.88 110.844 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.27 -57.77 11.42 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 116.326 -0.397 . . . . 0.67 110.712 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.06 -36.56 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 121.415 -0.114 . . . . 0.65 110.978 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' B' ' 24' ' ' LEU . 1.5 tm? -59.83 -45.77 91.35 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.771 -0.455 . . . . 0.9 109.771 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.6 t -78.08 -46.28 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.424 0.631 . . . . 0.84 111.442 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 . . . . . 0 C--N 1.326 -0.447 0 C-N-CA 124.183 0.993 . . . . 0.93 112.478 -179.12 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 43.5 mm . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 112.07 0.396 . . . . 0.73 112.07 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.509 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 72.3 mt -55.98 -62.89 3.9 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.123 0.416 . . . . 1.2 112.123 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.509 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.1 Cg_endo -54.48 -40.16 84.67 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.97 1.78 . . . . 1.09 111.603 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 46.7 t -60.13 -51.43 69.66 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.932 -0.576 . . . . 0.81 111.664 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.12 -38.96 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.482 0.549 . . . . 0.78 112.482 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.446 HD12 ' N ' ' B' ' 18' ' ' ILE . 3.3 pp -69.1 -42.53 76.01 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 119.651 -0.82 . . . . 1.16 111.399 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.446 ' N ' HD12 ' B' ' 17' ' ' LEU . 2.6 pp -66.76 -36.88 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 120.057 -0.657 . . . . 1.04 110.034 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.482 ' O ' HG12 ' B' ' 23' ' ' ILE . 86.5 m -65.51 -47.25 76.62 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.972 -0.381 . . . . 0.63 109.972 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 48.3 t -58.68 -49.72 76.52 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.073 -0.512 . . . . 0.84 110.757 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.428 HD13 ' O ' ' B' ' 17' ' ' LEU . 8.4 mp -60.51 -45.4 93.93 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.326 -0.397 . . . . 1.19 111.044 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.18 -56.51 21.1 Favored 'General case' 0 C--O 1.214 -0.802 0 C-N-CA 120.871 -0.332 . . . . 0.65 110.752 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.482 HG12 ' O ' ' B' ' 19' ' ' THR . 47.7 mm -56.63 -37.93 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 110.774 -0.084 . . . . 0.53 110.774 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -59.36 -46.63 88.11 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.886 -0.413 . . . . 0.95 109.886 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.1 t -76.51 -45.76 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.446 0.641 . . . . 0.84 111.591 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 . . . . . 0 C--N 1.325 -0.5 0 C-N-CA 124.121 0.968 . . . . 0.88 112.493 -179.115 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 50.7 mm . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 112.503 0.557 . . . . 0.57 112.503 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.497 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 72.8 mt -55.74 -63.12 3.5 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.233 0.457 . . . . 0.65 112.233 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.497 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.8 Cg_endo -55.47 -39.99 88.0 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.041 1.827 . . . . 0.56 111.899 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 50.2 t -59.65 -47.08 87.01 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.387 -0.369 . . . . 0.44 110.95 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 22.2 t -63.98 -47.57 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 116.617 -0.265 . . . . 0.5 111.133 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' B' ' 17' ' ' LEU . 4.2 mm? -59.46 -48.71 80.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.749 -0.205 . . . . 0.64 111.221 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.2 mt -61.24 -45.32 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.557 0.218 . . . . 0.62 110.757 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 38.4 m -61.43 -46.6 89.43 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.754 0.311 . . . . 0.34 110.796 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 48.0 t -59.83 -50.88 72.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.176 -0.465 . . . . 0.45 110.942 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 9.1 mp -60.56 -44.35 96.26 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.63 0.252 . . . . 0.55 111.024 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.22 -59.6 5.05 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 116.566 -0.288 . . . . 0.33 110.604 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 77.3 mt -54.46 -39.3 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.353 0.121 . . . . 0.35 110.907 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.8 tp -57.47 -45.75 84.46 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.758 0.313 . . . . 0.47 110.631 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 72.4 t -80.87 -43.66 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.642 0.734 . . . . 0.35 111.88 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 . . . . . 0 C--N 1.321 -0.635 0 C-N-CA 124.281 1.032 . . . . 0.59 113.543 -178.321 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 45.7 mm . . . . . 0 N--CA 1.442 -0.83 0 CA-C-O 120.705 0.288 . . . . 0.58 111.524 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.469 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 80.6 mt -53.84 -60.74 6.54 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 116.151 -0.477 . . . . 0.87 112.177 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.469 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.0 Cg_endo -55.32 -40.69 84.3 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.928 1.752 . . . . 0.55 112.003 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 48.3 t -61.04 -53.33 58.54 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.299 -0.409 . . . . 0.38 111.911 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.35 -38.03 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 120.701 -0.399 . . . . 0.51 111.191 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.418 HD13 ' O ' ' B' ' 13' ' ' ILE . 7.1 mp -61.92 -53.2 58.96 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.313 0.101 . . . . 0.79 111.204 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.97 -35.62 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 120.736 -0.386 . . . . 0.6 110.849 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 80.0 m -65.35 -47.0 77.97 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.97 -0.382 . . . . 0.41 109.97 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 39.9 t -59.83 -50.9 72.0 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.991 -0.55 . . . . 0.52 110.898 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -60.22 -44.87 94.81 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.651 -0.25 . . . . 0.72 111.099 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.54 -57.16 14.17 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 120.866 -0.333 . . . . 0.51 110.566 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.62 -37.1 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 121.49 -0.084 . . . . 0.52 110.957 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.5 tp -59.86 -45.65 91.78 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.011 0.434 . . . . 0.66 110.269 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 73.8 t -77.5 -47.24 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.461 0.648 . . . . 0.79 111.316 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 114.98 -1.009 . . . . 0.9 112.207 -179.427 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.7 tp . . . . . 0 CA--C 1.538 0.511 0 N-CA-C 111.591 0.219 . . . . 0.78 111.591 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.468 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 82.1 mt -57.15 -61.11 7.7 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 111.933 0.346 . . . . 0.86 111.933 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.468 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.1 Cg_endo -55.37 -38.91 93.47 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.727 1.618 . . . . 0.78 111.641 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 40.9 t -59.69 -54.5 45.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.042 -0.526 . . . . 0.72 111.796 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.421 HG23 HD22 ' B' ' 17' ' ' LEU . 27.5 m -65.1 -40.91 90.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 121.021 -0.272 . . . . 0.72 111.665 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.663 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 3.9 mm? -60.75 -53.03 62.39 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 121.173 -0.211 . . . . 0.76 111.019 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 43.5 mm -60.09 -43.74 93.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.508 0.194 . . . . 0.73 110.64 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 91.5 m -60.0 -45.5 92.53 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.625 0.25 . . . . 0.62 110.374 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 47.7 t -60.09 -51.04 71.31 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.236 -0.438 . . . . 0.68 110.497 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 60.4 mt -58.11 -44.62 87.78 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 120.765 0.317 . . . . 0.68 110.48 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' B' ' 26' ' ' PHE . . . -59.0 -60.54 3.7 Favored 'General case' 0 C--O 1.204 -1.306 0 CA-C-N 116.296 -0.411 . . . . 0.46 110.237 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 71.8 mt -50.95 -39.79 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 120.572 0.225 . . . . 0.57 111.147 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 52.6 tp -58.31 -47.78 82.6 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.684 0.278 . . . . 0.74 110.929 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.11 -39.6 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.671 0.748 . . . . 0.55 111.295 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' B' ' 22' ' ' ALA . 3.3 m-85 . . . . . 0 C--N 1.324 -0.537 0 C-N-CA 124.693 1.197 . . . . 0.52 111.812 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.4 HG23 ' N ' ' B' ' 13' ' ' ILE . 5.7 tp . . . . . 0 CA--C 1.532 0.288 0 N-CA-C 110.641 -0.133 . . . . 0.62 110.641 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.564 ' N ' ' HD2' ' B' ' 14' ' ' PRO . 87.5 mt -56.25 -55.09 45.78 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 110.63 -0.137 . . . . 0.76 110.63 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' B' ' 13' ' ' ILE . 19.7 Cg_endo -54.1 -44.82 45.85 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.882 2.388 . . . . 0.45 111.401 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.1 t -60.14 -43.73 95.47 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.965 -0.561 . . . . 0.47 110.856 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.28 -48.82 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 112.071 0.397 . . . . 0.55 112.071 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 pp -66.55 -43.56 84.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.401 -0.52 . . . . 0.55 111.397 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 31.6 mm -60.52 -45.15 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.666 0.269 . . . . 0.52 110.517 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.473 ' O ' HG12 ' B' ' 23' ' ' ILE . 47.6 m -62.57 -45.73 91.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.501 -0.318 . . . . 0.46 110.387 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.512 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 49.9 m -58.89 -52.47 65.58 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.19 -0.459 . . . . 0.48 110.894 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -58.72 -44.11 90.34 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.716 -0.22 . . . . 0.55 110.682 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.17 -56.13 26.05 Favored 'General case' 0 C--O 1.212 -0.893 0 C-N-CA 120.891 -0.324 . . . . 0.42 110.467 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.473 HG12 ' O ' ' B' ' 19' ' ' THR . 50.1 mm -55.06 -40.02 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 122.82 0.075 . . . . 0.54 111.15 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' B' ' 20' ' ' SER . 92.6 mt -60.11 -44.83 94.58 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.89 0.376 . . . . 0.52 110.795 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 92.3 t -77.69 -40.47 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.68 0.752 . . . . 0.53 111.649 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 115.022 -0.99 . . . . 0.76 113.345 -178.294 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.493 ' O ' HD13 ' B' ' 12' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.605 0 CA-C-O 120.312 0.101 . . . . 0.37 111.147 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.69 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 4.8 mp -57.93 -62.21 5.91 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 111.454 0.168 . . . . 0.44 111.454 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.481 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.7 Cg_endo -55.01 -39.63 89.97 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.89 1.726 . . . . 0.31 111.855 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 53.7 t -60.28 -49.85 75.99 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.201 -0.454 . . . . 0.35 111.511 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.466 HG12 ' O ' ' B' ' 13' ' ' ILE . 7.3 p -66.0 -41.2 89.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 120.761 -0.376 . . . . 0.32 111.074 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 58.7 mt -59.65 -52.85 63.74 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 121.23 -0.188 . . . . 0.37 110.576 178.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.424 HG12 ' O ' ' B' ' 14' ' ' PRO . 45.4 mm -59.65 -42.81 89.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.622 -0.263 . . . . 0.41 110.572 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.553 ' O ' HG12 ' B' ' 23' ' ' ILE . 76.4 m -60.6 -46.46 90.16 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.151 -0.314 . . . . 0.32 110.151 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 48.4 t -59.22 -51.56 69.44 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.322 -0.399 . . . . 0.34 110.883 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 58.8 mt -58.63 -44.82 90.12 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.715 0.293 . . . . 0.47 110.889 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.87 -55.74 31.21 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 116.441 -0.345 . . . . 0.35 110.756 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.553 HG12 ' O ' ' B' ' 19' ' ' THR . 43.9 mm -57.4 -37.39 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 121.266 -0.173 . . . . 0.44 110.724 179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 52.7 tp -59.78 -46.01 90.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.965 0.412 . . . . 0.49 110.311 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 68.9 t -76.97 -46.36 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.401 0.619 . . . . 0.44 111.36 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 . . . . . 0 C--N 1.326 -0.451 0 C-N-CA 124.175 0.99 . . . . 0.66 112.303 -179.2 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 6.9 tp . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 111.636 0.236 . . . . 1.18 111.636 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.473 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 79.6 mt -57.14 -61.22 7.51 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 111.756 0.28 . . . . 1.44 111.756 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.9 Cg_endo -55.36 -40.31 86.27 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.841 1.694 . . . . 1.05 111.869 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 42.9 t -61.68 -53.24 58.78 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.285 -0.416 . . . . 0.81 111.901 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 12.5 p -63.82 -38.4 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 120.601 -0.439 . . . . 1.07 110.83 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.641 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 7.0 mp -61.66 -54.18 46.27 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.998 -0.092 . . . . 1.15 111.201 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.58 -35.83 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.838 -0.345 . . . . 0.71 110.882 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.442 ' O ' HG12 ' B' ' 23' ' ' ILE . 86.5 m -64.46 -45.77 85.99 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.841 -0.429 . . . . 0.8 109.841 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.487 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 48.4 t -60.23 -52.28 65.99 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.882 -0.599 . . . . 0.92 110.528 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 59.8 mt -57.16 -44.61 83.66 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.74 0.305 . . . . 0.86 110.812 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.28 -58.15 9.77 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 116.326 -0.397 . . . . 0.55 110.705 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.442 HG12 ' O ' ' B' ' 19' ' ' THR . 51.9 mm -54.61 -40.49 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 117.58 0.173 . . . . 0.92 111.113 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' B' ' 20' ' ' SER . 85.7 mt -58.99 -44.57 91.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 121.093 -0.243 . . . . 0.8 111.029 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -80.06 -43.26 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.67 0.748 . . . . 0.73 111.738 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 . . . . . 0 C--N 1.32 -0.679 0 CA-C-N 114.951 -1.022 . . . . 0.97 113.399 -178.488 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 9.0 tp . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 120.331 0.11 . . . . 0.95 111.28 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.496 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 77.5 mt -60.29 -61.68 7.44 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 111.535 0.198 . . . . 1.03 111.535 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.496 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.4 Cg_endo -55.57 -39.39 91.33 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.853 1.702 . . . . 0.9 111.544 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . 0.403 ' O ' HG13 ' B' ' 18' ' ' ILE . 50.3 t -64.21 -51.68 62.56 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.146 -0.479 . . . . 0.84 112.012 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 10.0 p -62.43 -38.26 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 120.403 -0.519 . . . . 0.65 110.401 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.419 HD13 ' O ' ' B' ' 13' ' ' ILE . 7.4 mp -62.32 -53.71 51.07 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.843 -0.162 . . . . 0.84 111.089 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.403 HG13 ' O ' ' B' ' 15' ' ' CYS . 2.6 pp -63.42 -35.36 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 120.782 -0.367 . . . . 0.8 111.189 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.455 ' O ' HG12 ' B' ' 23' ' ' ILE . 37.0 m -66.03 -44.09 85.68 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.563 -0.532 . . . . 0.63 109.563 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 46.6 t -61.16 -51.27 69.75 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.776 -0.647 . . . . 0.5 111.631 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.436 HD12 ' N ' ' B' ' 22' ' ' ALA . 3.2 pp -64.93 -38.86 92.35 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.45 -0.5 . . . . 0.7 111.039 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.436 ' N ' HD12 ' B' ' 21' ' ' LEU . . . -59.93 -57.7 11.75 Favored 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 120.554 -0.458 . . . . 0.5 110.121 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.455 HG12 ' O ' ' B' ' 19' ' ' THR . 51.3 mm -56.32 -39.11 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 122.967 0.167 . . . . 0.45 110.756 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.58 -45.15 85.57 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.865 0.364 . . . . 0.69 110.462 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 69.8 t -79.44 -45.15 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.457 0.646 . . . . 0.66 111.576 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 114.908 -1.042 . . . . 0.67 113.012 -178.877 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 39.9 mm . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 112.408 0.522 . . . . 0.98 112.408 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.473 HD12 ' H ' ' B' ' 13' ' ' ILE . 3.1 mp -54.21 -59.98 8.68 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 111.905 0.335 . . . . 0.78 111.905 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.431 ' O ' HG12 ' B' ' 18' ' ' ILE . 12.1 Cg_endo -56.29 -41.31 77.79 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 121.967 1.778 . . . . 0.87 112.065 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.1 t -58.75 -48.08 82.44 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.733 0.301 . . . . 0.93 110.868 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.03 -47.14 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 116.37 -0.377 . . . . 0.98 110.967 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 8.6 mp -58.54 -50.68 72.9 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.661 -0.245 . . . . 1.28 111.417 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.431 HG12 ' O ' ' B' ' 14' ' ' PRO . 46.4 mm -61.36 -44.89 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 120.448 0.166 . . . . 1.31 110.835 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 44.7 m -60.87 -47.19 87.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.715 0.293 . . . . 0.88 110.69 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 44.4 t -60.38 -50.98 71.46 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.272 -0.422 . . . . 1.22 110.929 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 8.8 mp -59.03 -45.82 89.76 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 116.553 -0.294 . . . . 1.65 110.768 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.64 -57.57 12.4 Favored 'General case' 0 C--O 1.207 -1.174 0 N-CA-C 110.044 -0.354 . . . . 0.99 110.044 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 30.7 mm -53.21 -38.35 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.481 0.181 . . . . 0.89 111.458 178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.9 tp -60.67 -45.86 92.55 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.836 0.35 . . . . 1.63 110.654 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -80.58 -37.92 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.547 0.689 . . . . 1.49 111.392 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 C--N 1.324 -0.522 0 C-N-CA 124.401 1.08 . . . . 1.55 111.913 -179.154 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 7.4 tp . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 111.875 0.324 . . . . 0.94 111.875 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.718 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 74.4 mt -58.38 -62.48 5.53 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 111.854 0.316 . . . . 0.72 111.854 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.502 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.4 Cg_endo -54.42 -40.13 84.5 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 121.882 1.722 . . . . 0.59 111.834 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 t -61.93 -50.29 72.75 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.014 -0.539 . . . . 0.71 111.558 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.471 HG12 ' O ' ' B' ' 13' ' ' ILE . 7.2 p -64.14 -39.0 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.6 -0.44 . . . . 0.53 110.947 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 60.3 mt -62.78 -53.39 54.99 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 122.451 -0.156 . . . . 0.53 111.275 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.83 -36.69 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 120.762 -0.375 . . . . 0.57 111.15 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 88.1 m -64.78 -46.38 82.32 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.826 0.346 . . . . 0.57 110.126 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.5 m -60.14 -50.96 71.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.051 -0.522 . . . . 0.45 110.626 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -59.62 -44.46 93.45 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 116.592 -0.276 . . . . 0.7 110.629 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' B' ' 26' ' ' PHE . . . -59.16 -60.57 3.66 Favored 'General case' 0 C--O 1.205 -1.287 0 CA-C-O 119.259 -0.401 . . . . 0.47 110.131 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 36.6 mm -51.04 -38.67 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 117.817 0.281 . . . . 0.6 111.289 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 53.7 tp -59.54 -47.54 85.14 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.755 0.312 . . . . 0.81 110.927 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 60.8 t -83.37 -39.94 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.771 0.796 . . . . 0.78 111.373 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' B' ' 22' ' ' ALA . 3.9 m-85 . . . . . 0 C--N 1.324 -0.523 0 C-N-CA 124.895 1.278 . . . . 0.77 111.947 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 7.7 tp . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 112.089 0.403 . . . . 0.89 112.089 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.67 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 73.9 mt -59.49 -62.71 5.32 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 111.709 0.263 . . . . 1.0 111.709 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.504 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.2 Cg_endo -54.51 -37.2 90.11 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.735 1.623 . . . . 0.64 111.604 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 41.3 t -61.24 -51.3 69.51 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.198 -0.455 . . . . 0.56 111.56 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 35.5 m -65.77 -39.08 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 120.684 -0.406 . . . . 0.69 111.225 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 57.3 mt -61.84 -53.97 48.5 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 121.165 -0.214 . . . . 0.82 110.73 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 45.0 mm -60.15 -43.36 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.642 -0.254 . . . . 0.76 111.085 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 58.4 m -60.44 -44.37 95.88 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.653 0.263 . . . . 0.69 110.423 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -61.53 -50.61 72.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.241 -0.436 . . . . 0.69 110.818 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 60.6 mt -58.28 -44.89 88.67 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.781 0.324 . . . . 0.95 110.534 179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.01 -57.65 11.87 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 116.222 -0.445 . . . . 0.82 110.59 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 71.6 mt -56.23 -37.96 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 122.821 0.076 . . . . 0.87 110.915 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 54.8 tp -58.9 -45.34 90.54 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.042 0.449 . . . . 1.09 110.281 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 70.7 t -78.62 -46.3 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.447 0.641 . . . . 1.21 111.34 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.009 -0.996 . . . . 1.41 112.69 -179.146 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' B' ' 12' ' ' ILE . 3.8 mm . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.562 0.22 . . . . 0.71 111.564 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.707 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 73.8 mt -54.61 -62.63 3.79 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.857 0.318 . . . . 0.62 111.857 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.501 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.3 Cg_endo -55.53 -39.9 88.46 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 121.73 1.62 . . . . 0.41 111.723 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 40.8 t -60.96 -50.75 72.12 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.103 -0.499 . . . . 0.58 111.448 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.437 HG12 ' O ' ' B' ' 13' ' ' ILE . 8.4 p -64.73 -41.79 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.9 -0.32 . . . . 0.5 111.177 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 60.0 mt -60.19 -51.14 70.84 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 122.276 -0.265 . . . . 0.53 110.605 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.8 mt -60.02 -44.04 93.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.536 -0.302 . . . . 0.6 110.718 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.496 ' O ' HG12 ' B' ' 23' ' ' ILE . 67.6 m -60.54 -45.01 95.47 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.405 -0.361 . . . . 0.58 110.625 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.3 t -60.7 -49.64 76.71 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.245 -0.434 . . . . 0.45 110.647 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 60.4 mt -59.71 -44.6 93.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.721 0.296 . . . . 0.63 110.556 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.77 11.42 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 116.418 -0.356 . . . . 0.6 110.641 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.496 HG12 ' O ' ' B' ' 19' ' ' THR . 45.4 mm -56.8 -36.91 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.282 0.087 . . . . 0.69 110.956 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.6 -44.44 96.27 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.952 0.406 . . . . 1.3 110.162 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 79.6 t -78.51 -47.54 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 121.444 0.64 . . . . 0.8 111.138 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 114.898 -1.046 . . . . 0.92 112.405 -179.285 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.6 mm . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 111.763 0.283 . . . . 0.7 111.763 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.514 HD12 ' H ' ' B' ' 13' ' ' ILE . 3.6 mp -57.99 -62.44 5.48 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 116.646 -0.252 . . . . 0.54 111.591 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.406 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.5 Cg_endo -56.03 -38.07 95.3 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.642 1.561 . . . . 0.33 111.821 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . 0.421 ' O ' HG13 ' B' ' 18' ' ' ILE . 42.0 t -60.86 -53.78 53.19 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.316 -0.402 . . . . 0.36 111.551 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.96 -37.85 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 120.684 -0.406 . . . . 0.52 110.623 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.422 HD13 ' O ' ' B' ' 13' ' ' ILE . 6.9 mp -61.5 -53.04 61.63 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.942 -0.117 . . . . 0.43 111.19 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.421 HG13 ' O ' ' B' ' 15' ' ' CYS . 2.6 pp -63.57 -34.27 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 120.707 -0.397 . . . . 0.41 110.831 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.481 ' O ' HG12 ' B' ' 23' ' ' ILE . 34.8 m -66.11 -48.07 72.1 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.811 0.338 . . . . 0.55 110.27 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -59.09 -48.53 81.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.012 -0.54 . . . . 0.6 110.504 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.41 HD13 ' O ' ' B' ' 17' ' ' LEU . 9.1 mp -60.78 -45.55 93.93 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.26 -0.427 . . . . 0.56 110.937 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.36 -56.33 23.54 Favored 'General case' 0 C--O 1.215 -0.731 0 C-N-CA 120.822 -0.351 . . . . 0.62 110.608 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.481 HG12 ' O ' ' B' ' 19' ' ' THR . 46.4 mm -56.73 -37.64 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 122.835 0.085 . . . . 0.73 110.779 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.91 -45.31 92.97 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.971 0.415 . . . . 0.78 110.407 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -77.33 -45.93 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.444 0.64 . . . . 0.78 111.312 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 . . . . . 0 C--N 1.326 -0.424 0 C-N-CA 124.306 1.042 . . . . 0.87 112.573 -179.051 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 51.3 mm . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 112.479 0.548 . . . . 1.98 112.479 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.439 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 84.1 mt -54.01 -61.37 5.43 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 111.878 0.325 . . . . 2.0 111.878 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.439 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.3 Cg_endo -54.87 -41.25 80.2 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 122.088 1.858 . . . . 1.56 111.605 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 41.2 t -60.2 -48.48 81.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.364 -0.38 . . . . 1.34 110.817 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 t -62.06 -46.61 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 120.696 0.284 . . . . 1.5 110.762 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' B' ' 17' ' ' LEU . 4.1 mm? -60.24 -51.49 69.35 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.456 -0.338 . . . . 1.55 111.816 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.37 -36.77 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 120.49 -0.484 . . . . 1.16 110.978 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.501 ' O ' HG12 ' B' ' 23' ' ' ILE . 80.4 m -65.9 -47.09 75.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.878 0.371 . . . . 1.03 110.039 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.519 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 41.0 t -58.81 -51.81 68.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.015 -0.539 . . . . 1.06 110.782 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -59.01 -44.65 91.73 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.654 -0.248 . . . . 1.24 110.786 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.72 -56.29 23.88 Favored 'General case' 0 C--O 1.211 -0.928 0 C-N-CA 120.852 -0.339 . . . . 0.73 110.585 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.501 HG12 ' O ' ' B' ' 19' ' ' THR . 50.0 mm -55.61 -40.13 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.288 0.09 . . . . 0.68 111.144 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' B' ' 20' ' ' SER . 87.9 mt -59.23 -43.78 92.35 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.779 0.323 . . . . 1.01 110.6 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 73.5 t -78.83 -45.6 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.528 0.68 . . . . 0.98 111.652 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 . . . . . 0 C--N 1.325 -0.46 0 C-N-CA 124.277 1.031 . . . . 0.93 112.975 -178.83 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.6 tp . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 120.581 0.229 . . . . 0.8 110.981 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.494 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 79.9 mt -58.18 -62.21 5.98 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 111.832 0.308 . . . . 0.66 111.832 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' PRO . . . . . 0.494 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.9 Cg_endo -55.91 -40.4 85.29 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 121.873 1.716 . . . . 0.54 111.671 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.3 t -59.76 -52.66 64.52 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.153 -0.476 . . . . 0.72 111.715 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.47 HG13 HD22 ' B' ' 17' ' ' LEU . 11.8 p -64.84 -41.23 91.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 120.805 -0.358 . . . . 0.8 111.332 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' LEU . . . . . 0.47 HD22 HG13 ' B' ' 16' ' ' VAL . 3.8 mm? -61.09 -52.16 66.07 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 121.144 -0.222 . . . . 0.86 111.023 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.426 HG12 ' O ' ' B' ' 14' ' ' PRO . 43.9 mm -60.16 -43.89 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.599 0.238 . . . . 0.7 110.675 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 75.5 m -60.6 -47.37 86.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.679 0.276 . . . . 0.82 110.669 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 48.1 t -59.44 -52.78 64.12 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.323 -0.399 . . . . 0.98 110.771 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -57.83 -45.58 85.98 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.576 -0.284 . . . . 1.01 110.918 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.99 -54.78 42.85 Favored 'General case' 0 C--O 1.212 -0.872 0 C-N-CA 120.922 -0.311 . . . . 0.77 110.164 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 34.2 mm -54.53 -45.88 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 122.932 0.145 . . . . 0.95 110.973 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' B' ' 20' ' ' SER . 93.3 mt -54.45 -41.55 69.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.821 0.343 . . . . 1.09 110.872 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 91.7 t -81.32 -36.02 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.374 0.607 . . . . 0.95 111.49 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.9 m-30 . . . . . 0 C--N 1.326 -0.44 0 C-N-CA 124.094 0.958 . . . . 0.96 113.389 -177.884 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.291 0.091 . . . . 1.17 110.806 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -88.31 -151.56 0.2 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.01 0.434 . . . . 1.22 110.697 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.615 ' H ' ' HD3' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -72.27 154.76 91.98 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 116.16 -0.473 . . . . 0.87 110.694 179.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.69 153.45 11.1 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.3 2.666 . . . . 0.95 113.857 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' B' ' 6' ' ' PHE . 3.9 mm? 68.1 97.31 0.06 Allowed 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.608 -0.724 . . . . 0.94 111.541 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.425 ' HB2' ' O ' ' B' ' 5' ' ' LEU . 5.2 m-85 72.18 108.49 0.07 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.572 -0.74 . . . . 1.11 111.718 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -80.98 -134.78 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.539 -0.755 . . . . 0.9 111.599 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 5.5 t -68.02 132.88 48.08 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.82 -0.55 . . . . 0.61 111.075 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 17.7 mm -77.3 59.12 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 112.681 0.623 . . . . 0.64 112.681 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -77.51 60.05 2.03 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.157 -0.339 . . . . 0.71 111.075 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 99.0 mt 59.8 35.71 22.04 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.962 -0.563 . . . . 0.69 111.004 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.0 tp -68.15 -41.0 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.748 -0.66 . . . . 0.7 111.988 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.485 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 78.3 mt -55.99 -61.98 5.49 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 111.767 0.284 . . . . 0.9 111.767 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.485 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.9 Cg_endo -55.23 -40.5 85.36 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 122.153 1.902 . . . . 0.54 111.852 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 t -59.76 -47.47 85.56 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.455 -0.339 . . . . 0.48 110.911 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 20.5 t -63.93 -46.88 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 116.555 -0.293 . . . . 0.71 110.895 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.663 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 9.4 mp -59.22 -50.56 73.56 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.455 -0.338 . . . . 0.81 111.125 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.6 mt -59.97 -44.68 95.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.567 0.222 . . . . 0.49 110.699 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.441 ' O ' HG12 ' B' ' 23' ' ' ILE . 51.3 m -60.63 -45.72 92.98 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.845 0.355 . . . . 0.53 110.339 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 43.3 t -58.82 -50.71 72.94 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.09 -0.505 . . . . 0.63 110.954 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 58.7 mt -60.0 -45.55 92.39 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.69 0.281 . . . . 0.7 110.793 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.24 -58.18 9.6 Favored 'General case' 0 C--O 1.212 -0.873 0 CA-C-N 116.39 -0.368 . . . . 0.4 110.784 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.441 HG12 ' O ' ' B' ' 19' ' ' THR . 52.0 mm -55.13 -39.56 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.39 0.138 . . . . 0.56 110.907 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 54.7 tp -57.78 -45.95 85.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.932 0.396 . . . . 0.71 110.504 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 78.6 t -78.76 -46.68 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.467 0.651 . . . . 0.67 111.639 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -61.63 -53.11 60.63 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.28 1.032 . . . . 0.81 113.171 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.415 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 2.7 m-85 -82.48 -36.81 26.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.477 -0.329 . . . . 0.9 111.493 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.528 ' O ' ' HE2' ' B' ' 35' ' ' LYS . 17.1 tp 57.82 68.0 2.09 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.086 -0.506 . . . . 0.66 112.15 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.05 55.51 1.82 Allowed 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.761 2.307 . . . . 0.74 113.614 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 87.5 p -79.14 146.29 33.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.761 0.315 . . . . 0.52 111.524 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -72.29 59.79 0.42 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.13 0.491 . . . . 1.37 111.843 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 40.9 t -158.34 135.83 10.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.101 -0.5 . . . . 0.93 110.472 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.54 46.88 1.76 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 115.335 0.894 . . . . 1.42 115.335 -178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.4 -33.36 19.14 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 118.046 0.923 . . . . 1.96 109.783 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.528 ' HE2' ' O ' ' B' ' 28' ' ' LEU . 9.2 ptpp? . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.36 -0.829 . . . . 1.54 111.737 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 111.504 0.187 . . . . 1.12 111.504 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -71.29 136.23 47.8 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.555 -0.293 . . . . 1.14 110.739 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -67.16 138.9 94.86 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.81 0.338 . . . . 0.96 110.604 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -61.02 125.3 16.75 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.235 1.957 . . . . 0.44 112.525 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.51 59.55 1.12 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.089 -0.505 . . . . 0.74 110.721 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 66.1 45.81 2.28 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.35 -0.841 . . . . 0.75 110.959 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -63.15 -35.41 80.18 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.921 -0.582 . . . . 0.97 112.343 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.459 HG23 HD21 ' B' ' 10' ' ' ASN . 3.3 t -148.97 134.76 18.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.192 0.52 . . . . 0.63 111.822 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.47 HD12 HD12 ' B' ' 13' ' ' ILE . 5.4 tp -79.4 125.16 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.767 -0.651 . . . . 0.52 111.697 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.482 ' OD1' HG22 ' B' ' 12' ' ' ILE . 11.0 p30 -173.64 -143.12 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.613 -0.722 . . . . 0.37 110.542 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.95 -23.96 44.23 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.488 0.921 . . . . 0.66 113.488 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.482 HG22 ' OD1' ' B' ' 10' ' ' ASN . 10.9 tp -63.25 -42.36 96.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 113.044 0.757 . . . . 0.49 113.044 -178.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.47 HD12 HD12 ' B' ' 9' ' ' ILE . 68.8 mt -59.34 -61.17 8.38 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.315 0.487 . . . . 0.44 112.315 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.418 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.1 Cg_endo -54.48 -40.03 85.29 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.864 1.709 . . . . 0.39 111.485 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.8 t -60.1 -51.93 67.51 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.22 -0.446 . . . . 0.36 111.671 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 34.7 m -65.22 -38.89 83.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 112.296 0.48 . . . . 0.36 112.296 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.481 HD12 ' N ' ' B' ' 18' ' ' ILE . 3.5 pp -69.97 -43.35 71.67 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 119.624 -0.83 . . . . 0.46 111.651 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.481 ' N ' HD12 ' B' ' 17' ' ' LEU . 2.6 pp -66.5 -38.04 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.276 -0.57 . . . . 0.42 110.312 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.486 ' O ' HG12 ' B' ' 23' ' ' ILE . 87.5 m -64.59 -47.22 79.49 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 110.126 -0.324 . . . . 0.39 110.126 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.48 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 48.7 m -59.17 -51.48 69.83 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.19 -0.459 . . . . 0.37 110.618 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.406 HD13 ' O ' ' B' ' 17' ' ' LEU . 8.6 mp -57.97 -45.22 87.05 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.63 -0.259 . . . . 0.53 110.847 178.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.95 -57.26 13.31 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 116.489 -0.323 . . . . 0.33 110.855 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.486 HG12 ' O ' ' B' ' 19' ' ' THR . 45.9 mm -55.3 -40.75 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 117.521 0.146 . . . . 0.48 111.208 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' B' ' 20' ' ' SER . 84.4 mt -58.31 -42.57 87.01 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.868 0.366 . . . . 0.42 110.485 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 76.9 t -80.61 -46.3 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.472 0.653 . . . . 0.39 111.667 179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -62.39 -61.36 2.5 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.412 1.085 . . . . 0.61 113.134 -178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -73.59 -32.4 64.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.273 -0.421 . . . . 0.7 110.931 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.511 HD11 ' HZ1' ' B' ' 35' ' ' LYS . 13.6 tp 59.98 61.53 3.83 Favored Pre-proline 0 CA--C 1.536 0.416 0 CA-C-N 115.464 -0.789 . . . . 0.49 111.877 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.418 ' HD3' ' N ' ' B' ' 28' ' ' LEU . 31.3 Cg_endo -85.63 41.67 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.517 2.145 . . . . 0.6 112.011 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.426 ' HB2' ' HA ' ' B' ' 34' ' ' GLU . 12.8 p -91.22 44.47 1.19 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.817 -0.628 . . . . 0.62 111.359 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 19.4 p30 -69.31 -49.09 59.06 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.223 -0.444 . . . . 1.26 111.674 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 41.2 t -64.19 -26.44 68.52 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.938 0.399 . . . . 1.48 111.33 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.27 126.89 1.39 Allowed Glycine 0 CA--C 1.521 0.417 0 C-N-CA 121.034 -0.603 . . . . 0.82 112.463 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' B' ' 30' ' ' SER . 41.8 mm-40 -74.24 64.04 1.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 113.114 0.783 . . . . 1.19 113.114 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.511 ' HZ1' HD11 ' B' ' 28' ' ' LEU . 3.9 mppt? . . . . . 0 C--O 1.252 1.187 0 CA-C-O 118.322 -0.847 . . . . 1.61 111.987 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 111.209 0.077 . . . . 3.07 111.209 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.473 ' HB3' ' H ' ' B' ' 3' ' ' LYS . 22.3 mmm180 56.48 -147.14 0.53 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.97 0.414 . . . . 2.08 111.703 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.519 ' HD2' ' HB2' ' B' ' 6' ' ' PHE . 59.2 pttt -169.82 146.9 2.81 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.001 -0.545 . . . . 0.93 110.617 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.449 ' HG2' ' CD1' ' B' ' 6' ' ' PHE . 56.2 Cg_endo -72.04 -140.66 0.02 OUTLIER 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.761 2.307 . . . . 1.09 112.724 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.422 ' H ' ' HB2' ' B' ' 4' ' ' PRO . 3.5 mm? -72.89 43.17 0.11 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.433 0.531 . . . . 1.8 112.433 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.519 ' HB2' ' HD2' ' B' ' 3' ' ' LYS . 3.5 m-30 -86.82 53.64 2.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.966 0.412 . . . . 1.59 111.166 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -81.92 32.7 0.37 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.021 0.439 . . . . 1.71 111.966 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 63.3 p -79.0 56.87 2.06 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.296 -0.411 . . . . 1.19 111.908 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 8.4 tp -83.07 -32.55 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.33 0.492 . . . . 0.96 112.33 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -70.86 56.25 0.18 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.945 0.721 . . . . 0.9 112.945 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 95.3 mt -64.53 -21.92 66.82 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.935 0.398 . . . . 1.19 111.843 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.1 tp -61.95 -34.76 64.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 116.282 -0.417 . . . . 0.88 111.974 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.518 ' O ' HG12 ' B' ' 16' ' ' VAL . 71.6 mt -61.72 -63.07 4.7 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 111.889 0.329 . . . . 0.7 111.889 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.491 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.4 Cg_endo -54.76 -40.48 84.58 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 121.863 1.709 . . . . 0.8 111.461 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 52.0 t -62.43 -48.66 78.71 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.093 -0.503 . . . . 0.77 111.564 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.518 HG12 ' O ' ' B' ' 13' ' ' ILE . 7.5 p -64.76 -39.45 85.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.029 0.381 . . . . 0.55 112.029 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.424 HD12 ' N ' ' B' ' 18' ' ' ILE . 3.0 pp -70.65 -42.8 70.33 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 119.842 -0.743 . . . . 0.58 111.561 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.424 ' N ' HD12 ' B' ' 17' ' ' LEU . 2.6 pp -65.9 -37.11 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 120.067 -0.653 . . . . 0.64 110.188 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 89.0 m -65.83 -46.26 79.24 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.805 0.336 . . . . 0.59 110.145 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.4 m -60.56 -51.51 69.13 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.124 -0.489 . . . . 0.35 110.904 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -59.89 -45.74 91.56 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.588 -0.278 . . . . 0.47 111.075 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.97 -57.98 10.15 Favored 'General case' 0 C--O 1.213 -0.862 0 C-N-CA 120.965 -0.294 . . . . 0.37 110.613 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.481 ' O ' ' HB2' ' B' ' 27' ' ' TYR . 74.8 mt -54.55 -39.95 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 120.351 0.12 . . . . 0.55 110.979 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 49.8 tp -56.81 -47.17 80.86 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 120.987 0.423 . . . . 0.59 110.607 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' B' ' 34' ' ' GLU . 77.9 t -79.93 -44.31 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.51 0.671 . . . . 0.5 111.962 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -64.62 -46.46 82.52 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.053 1.131 . . . . 0.62 114.053 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 3.8 m-85 -79.06 -41.94 27.6 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.211 0.819 . . . . 0.85 113.211 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.61 116.03 61.57 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-O 121.144 0.497 . . . . 0.88 112.09 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -83.39 50.65 3.32 Favored 'Trans proline' 0 CA--C 1.536 0.586 0 C-N-CA 122.939 2.426 . . . . 1.04 113.184 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 79.9 p -80.13 -45.29 18.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.978 0.418 . . . . 1.01 111.804 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -159.24 -122.14 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.924 -0.58 . . . . 0.83 111.175 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 38.8 t -161.62 25.31 0.12 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 111.806 0.299 . . . . 0.8 111.806 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.11 60.53 3.09 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.958 -0.639 . . . . 0.64 112.865 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.411 ' HA ' HG11 ' B' ' 25' ' ' VAL . 13.2 pt-20 -71.76 143.01 49.73 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.793 0.664 . . . . 0.74 112.793 -178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 12.3 mptt . . . . . 0 C--O 1.251 1.164 0 CA-C-N 115.362 -0.835 . . . . 0.94 112.14 179.468 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 42.6 ptt85 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.534 0.207 . . . . 1.43 111.243 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -80.36 133.03 35.87 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.058 0.456 . . . . 2.08 111.828 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.556 ' HG2' ' HB3' ' B' ' 7' ' ' TYR . 25.4 tptp -169.66 128.17 0.86 Allowed Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 115.929 -0.578 . . . . 1.12 109.875 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' B' ' 3' ' ' LYS . 18.2 Cg_exo -67.45 52.89 0.49 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.461 2.774 . . . . 1.11 114.188 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 62.5 mt 53.67 46.12 26.61 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.449 0.537 . . . . 1.83 112.449 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -145.2 49.18 1.27 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.167 0.508 . . . . 1.33 111.077 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.556 ' HB3' ' HG2' ' B' ' 3' ' ' LYS . 9.3 t80 -173.6 114.99 0.23 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.954 -0.566 . . . . 0.57 110.647 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 12.6 t -86.76 -175.17 5.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.641 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 6.2 tp -92.52 122.4 43.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.331 0.586 . . . . 0.65 111.153 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.518 ' O ' ' HD2' ' B' ' 14' ' ' PRO . 63.1 m-20 -73.25 129.52 38.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.455 . . . . 0.54 110.521 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -55.34 -31.69 61.91 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.566 0.58 . . . . 0.95 112.566 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.8 tp -63.0 -33.4 60.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 112.542 0.571 . . . . 0.81 112.542 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.484 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 72.3 mt -59.78 -63.91 3.65 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 112.279 0.474 . . . . 0.52 112.279 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' B' ' 10' ' ' ASN . 12.4 Cg_endo -55.95 -37.71 95.65 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.689 1.593 . . . . 0.66 111.453 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 40.8 t -60.85 -53.4 57.79 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.092 -0.503 . . . . 0.78 111.742 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.531 HG13 HD22 ' B' ' 17' ' ' LEU . 11.9 p -64.9 -40.68 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 120.824 -0.35 . . . . 0.6 111.509 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.531 HD22 HG13 ' B' ' 16' ' ' VAL . 3.8 mm? -62.82 -51.83 65.53 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.42 -0.175 . . . . 0.63 111.152 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 63.7 mt -60.79 -44.8 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.552 0.215 . . . . 0.79 110.904 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 64.0 m -60.07 -46.98 87.77 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.663 0.268 . . . . 0.65 110.775 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.1 m -60.23 -50.55 73.22 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.288 -0.414 . . . . 0.58 110.725 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.412 HD13 ' O ' ' B' ' 17' ' ' LEU . 8.8 mp -58.86 -45.18 90.71 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.44 -0.346 . . . . 0.76 110.68 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.58 -55.67 31.62 Favored 'General case' 0 C--O 1.208 -1.117 0 C-N-CA 120.894 -0.322 . . . . 0.58 110.329 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.416 HG23 ' CG ' ' B' ' 27' ' ' TYR . 74.1 mt -52.89 -41.68 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 O-C-N 122.967 0.167 . . . . 0.6 111.187 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.29 -46.96 87.14 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.927 0.394 . . . . 0.78 110.577 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.63 -36.32 27.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.474 0.654 . . . . 0.69 111.209 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.491 ' HB3' ' H ' ' B' ' 27' ' ' TYR . 3.2 m-30 -80.6 -132.14 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 124.107 0.963 . . . . 0.72 111.466 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.491 ' H ' ' HB3' ' B' ' 26' ' ' PHE . 3.3 m-85 34.03 47.8 0.21 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.42 -1.263 . . . . 0.96 113.585 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 93.7 mt -65.94 127.93 93.47 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.342 -0.39 . . . . 0.85 111.314 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.25 45.05 0.75 Allowed 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.882 2.388 . . . . 0.74 113.29 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 90.8 p -79.65 54.59 1.82 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.992 0.425 . . . . 0.66 111.117 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -75.87 54.82 0.84 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.631 0.729 . . . . 1.03 111.299 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 28.3 p -129.86 127.92 41.19 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.049 -0.523 . . . . 0.77 110.912 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.16 -132.89 2.63 Favored Glycine 0 C--O 1.228 -0.226 0 C-N-CA 120.932 -0.652 . . . . 1.08 111.883 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 44.2 mp0 -76.11 47.01 0.42 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.743 0.272 . . . . 1.93 111.347 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.455 -0.783 . . . . 1.54 111.35 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 77.8 mtp180 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.235 0.064 . . . . 1.83 110.847 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 19.5 tpp180 55.77 58.23 4.62 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.646 0.736 . . . . 1.13 111.141 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' B' ' 3' ' ' LYS . 31.3 mmtm -149.02 131.44 7.8 Favored Pre-proline 0 C--O 1.236 0.351 0 CA-C-N 115.582 -0.736 . . . . 0.68 111.022 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -63.89 119.31 6.31 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.498 2.132 . . . . 0.56 111.586 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 53.14 34.27 17.02 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.103 -0.499 . . . . 1.06 111.368 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 21.5 p90 43.67 39.65 2.54 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.834 0.854 . . . . 1.39 112.769 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -145.15 151.07 37.89 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.156 -0.474 . . . . 0.92 111.064 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 70.0 p -73.74 50.15 0.33 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.203 0.445 . . . . 0.84 112.203 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 8.4 tt -97.05 124.46 49.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 121.049 0.452 . . . . 0.36 111.45 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -82.66 44.34 0.89 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 111.956 0.354 . . . . 0.65 111.956 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 50.91 45.4 27.59 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.631 0.604 . . . . 0.51 112.631 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.2 tp -68.45 -40.7 82.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 112.332 0.493 . . . . 0.63 112.332 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.478 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 78.3 mt -56.62 -61.5 6.7 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 111.982 0.364 . . . . 0.7 111.982 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.478 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 14.1 Cg_endo -56.56 -39.74 89.26 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 121.788 1.659 . . . . 0.61 111.742 178.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 41.2 t -60.26 -53.05 62.3 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.343 -0.39 . . . . 0.6 111.792 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 14.0 p -65.49 -40.67 88.93 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 120.893 -0.323 . . . . 0.61 111.118 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 7.7 mp -60.89 -51.93 67.21 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.486 0.184 . . . . 0.82 110.776 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.5 mt -60.31 -44.0 94.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 120.699 0.285 . . . . 0.81 110.689 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 75.0 m -59.96 -45.23 93.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.423 -0.353 . . . . 0.61 110.48 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 40.9 t -60.3 -50.62 72.9 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.169 -0.469 . . . . 0.71 110.826 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 53.6 mt -59.23 -44.98 92.32 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.731 0.301 . . . . 0.88 110.844 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.27 -57.77 11.42 Favored 'General case' 0 C--O 1.213 -0.817 0 CA-C-N 116.326 -0.397 . . . . 0.67 110.712 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 64.4 mt -57.06 -36.56 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 121.415 -0.114 . . . . 0.65 110.978 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' B' ' 24' ' ' LEU . 1.5 tm? -59.83 -45.77 91.35 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 109.771 -0.455 . . . . 0.9 109.771 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.6 t -78.08 -46.28 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.424 0.631 . . . . 0.84 111.442 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -62.54 -50.4 71.49 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.183 0.993 . . . . 0.93 112.478 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -93.99 38.83 1.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.301 -0.409 . . . . 0.92 110.798 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.441 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 0.0 OUTLIER -65.04 140.95 98.23 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-O 121.223 0.535 . . . . 0.62 111.838 -179.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' B' ' 28' ' ' LEU . 16.3 Cg_exo -68.3 68.39 1.02 Allowed 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.289 2.66 . . . . 0.92 113.151 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 37.6 t -66.36 117.59 8.82 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.782 0.325 . . . . 0.46 111.371 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.529 ' HA ' ' NZ ' ' B' ' 35' ' ' LYS . 13.4 t0 -165.17 111.31 0.94 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.779 0.323 . . . . 1.08 111.576 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 51.2 t -172.81 -40.87 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.2 -0.454 . . . . 1.97 111.384 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 168.64 36.26 0.02 OUTLIER Glycine 0 CA--C 1.519 0.333 0 C-N-CA 121.189 -0.529 . . . . 2.07 112.072 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -107.72 -41.84 4.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.839 0.352 . . . . 2.02 111.612 -179.155 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.529 ' NZ ' ' HA ' ' B' ' 31' ' ' ASP . 33.4 mtmm . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.268 -0.872 . . . . 2.41 111.798 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.607 0.241 . . . . 1.91 111.393 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -77.13 139.3 39.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.762 0.315 . . . . 3.07 110.875 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.607 ' HD2' ' HD2' ' B' ' 4' ' ' PRO . 23.4 tptm -67.37 126.53 92.68 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.091 -0.504 . . . . 2.28 111.224 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.607 ' HD2' ' HD2' ' B' ' 3' ' ' LYS . 68.3 Cg_endo -73.27 53.6 2.59 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.139 2.559 . . . . 1.14 113.88 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 55.0 mt -79.18 47.35 0.78 Allowed 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.412 0.523 . . . . 1.26 112.412 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -79.07 41.75 0.45 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.095 0.474 . . . . 0.96 111.979 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -164.15 143.25 7.6 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.178 -0.464 . . . . 0.91 110.393 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.411 ' HB ' HD12 ' B' ' 11' ' ' LEU . 80.4 p -73.85 41.8 0.13 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.586 0.587 . . . . 0.88 112.586 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 7.9 tp -71.6 -35.59 56.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 121.115 0.483 . . . . 0.84 110.747 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.417 ' O ' ' HD2' ' B' ' 14' ' ' PRO . 6.8 p30 -64.33 -36.19 83.32 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.106 -0.497 . . . . 0.9 111.671 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.411 HD12 ' HB ' ' B' ' 8' ' ' THR . 92.4 mt -65.8 -22.59 66.57 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.308 0.484 . . . . 1.07 112.308 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 43.5 mm -61.88 -41.92 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 N-CA-C 112.07 0.396 . . . . 0.73 112.07 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.509 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 72.3 mt -55.98 -62.89 3.9 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.123 0.416 . . . . 1.2 112.123 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.509 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.1 Cg_endo -54.48 -40.16 84.67 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.97 1.78 . . . . 1.09 111.603 178.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 46.7 t -60.13 -51.43 69.66 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.932 -0.576 . . . . 0.81 111.664 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.12 -38.96 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.482 0.549 . . . . 0.78 112.482 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.446 HD12 ' N ' ' B' ' 18' ' ' ILE . 3.3 pp -69.1 -42.53 76.01 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 119.651 -0.82 . . . . 1.16 111.399 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.446 ' N ' HD12 ' B' ' 17' ' ' LEU . 2.6 pp -66.76 -36.88 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 C-N-CA 120.057 -0.657 . . . . 1.04 110.034 178.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.482 ' O ' HG12 ' B' ' 23' ' ' ILE . 86.5 m -65.51 -47.25 76.62 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 109.972 -0.381 . . . . 0.63 109.972 178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 48.3 t -58.68 -49.72 76.52 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.073 -0.512 . . . . 0.84 110.757 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.428 HD13 ' O ' ' B' ' 17' ' ' LEU . 8.4 mp -60.51 -45.4 93.93 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 116.326 -0.397 . . . . 1.19 111.044 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.18 -56.51 21.1 Favored 'General case' 0 C--O 1.214 -0.802 0 C-N-CA 120.871 -0.332 . . . . 0.65 110.752 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.482 HG12 ' O ' ' B' ' 19' ' ' THR . 47.7 mm -56.63 -37.93 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 110.774 -0.084 . . . . 0.53 110.774 178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -59.36 -46.63 88.11 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 109.886 -0.413 . . . . 0.95 109.886 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.1 t -76.51 -45.76 33.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.446 0.641 . . . . 0.84 111.591 179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -63.57 -50.92 67.56 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.121 0.968 . . . . 0.88 112.493 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -92.44 40.97 1.06 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.184 -0.462 . . . . 0.9 110.801 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.416 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 0.0 OUTLIER -70.45 148.17 95.28 Favored Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.271 -0.422 . . . . 0.55 111.58 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 28' ' ' LEU . 21.8 Cg_exo -66.08 67.11 0.44 Allowed 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.35 2.7 . . . . 1.02 113.2 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 42.3 t -70.33 -50.97 33.69 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.358 -0.383 . . . . 0.71 111.186 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 55.62 -125.65 2.1 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.71 -0.677 . . . . 1.33 112.315 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 50.7 t -70.05 134.56 48.38 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.058 0.456 . . . . 1.76 111.88 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.13 128.07 1.28 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.118 -0.563 . . . . 1.31 113.362 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 55.5 mp0 -69.2 71.32 0.26 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.995 0.518 . . . . 2.2 111.968 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.613 -0.708 . . . . 0.95 110.928 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 110.831 -0.062 . . . . 1.0 110.831 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 12.4 ptt85 -159.5 42.96 0.22 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.65 0.262 . . . . 0.73 111.221 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.682 ' HG3' ' HB2' ' B' ' 6' ' ' PHE . 23.7 ttmm 63.8 77.87 0.3 Allowed Pre-proline 0 CA--C 1.541 0.602 0 CA-C-O 121.318 0.58 . . . . 0.7 111.035 -179.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.11 69.94 1.8 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.419 2.746 . . . . 0.53 112.402 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' B' ' 9' ' ' ILE . 3.9 mm? 69.84 24.56 5.25 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.68 -0.691 . . . . 0.55 111.053 -178.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.682 ' HB2' ' HG3' ' B' ' 3' ' ' LYS . 3.1 m-85 -82.01 50.81 1.63 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.822 -0.626 . . . . 0.92 110.507 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.516 ' HB2' ' HD3' ' B' ' 3' ' ' LYS . 4.6 t80 -178.41 -130.49 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.338 -0.846 . . . . 0.78 108.811 -179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 80.6 p -82.4 139.02 34.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 0.41 110.823 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.403 ' HA ' HD12 ' B' ' 5' ' ' LEU . 42.1 mt -68.98 -37.5 77.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 120.915 0.388 . . . . 0.54 110.888 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.401 ' O ' ' HD2' ' B' ' 14' ' ' PRO . 69.0 m-20 62.57 49.48 3.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.727 -0.669 . . . . 0.47 112.369 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 93.9 mt -62.38 -23.33 66.75 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.883 0.373 . . . . 0.65 111.793 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 50.7 mm -60.75 -42.57 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 112.503 0.557 . . . . 0.57 112.503 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.497 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 72.8 mt -55.74 -63.12 3.5 Favored Pre-proline 0 CA--C 1.544 0.732 0 N-CA-C 112.233 0.457 . . . . 0.65 112.233 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.497 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.8 Cg_endo -55.47 -39.99 88.0 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.041 1.827 . . . . 0.56 111.899 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 50.2 t -59.65 -47.08 87.01 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.387 -0.369 . . . . 0.44 110.95 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 22.2 t -63.98 -47.57 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 116.617 -0.265 . . . . 0.5 111.133 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' B' ' 17' ' ' LEU . 4.2 mm? -59.46 -48.71 80.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.749 -0.205 . . . . 0.64 111.221 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.2 mt -61.24 -45.32 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 120.557 0.218 . . . . 0.62 110.757 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 38.4 m -61.43 -46.6 89.43 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.754 0.311 . . . . 0.34 110.796 178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 48.0 t -59.83 -50.88 72.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.176 -0.465 . . . . 0.45 110.942 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 9.1 mp -60.56 -44.35 96.26 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 120.63 0.252 . . . . 0.55 111.024 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.22 -59.6 5.05 Favored 'General case' 0 C--O 1.214 -0.809 0 CA-C-N 116.566 -0.288 . . . . 0.33 110.604 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' B' ' 27' ' ' TYR . 77.3 mt -54.46 -39.3 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.353 0.121 . . . . 0.35 110.907 178.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.521 ' O ' ' HB2' ' B' ' 28' ' ' LEU . 55.8 tp -57.47 -45.75 84.46 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.758 0.313 . . . . 0.47 110.631 178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 72.4 t -80.87 -43.66 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 121.642 0.734 . . . . 0.35 111.88 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -64.89 -46.57 81.17 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 124.281 1.032 . . . . 0.59 113.543 -178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 3.5 m-85 -86.67 -51.21 6.27 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.428 0.529 . . . . 0.57 112.428 -178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.521 ' HB2' ' O ' ' B' ' 24' ' ' LEU . 6.7 mp -83.03 135.95 44.43 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-O 120.788 0.327 . . . . 0.49 111.383 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.65 53.07 1.36 Allowed 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.056 2.504 . . . . 0.49 113.403 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 86.8 p 56.62 -124.62 1.87 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.232 0.613 . . . . 0.45 112.188 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -141.9 -49.32 0.38 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.04 0.447 . . . . 0.64 111.473 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 29.3 m -63.74 -39.51 94.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.759 -0.655 . . . . 0.6 111.93 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 178.5 -55.02 0.09 OUTLIER Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.648 -0.787 . . . . 0.5 112.673 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.07 157.97 18.87 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.214 0.531 . . . . 0.59 111.449 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-N 115.288 -0.869 . . . . 0.63 111.765 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 120.547 0.213 . . . . 1.3 111.303 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -165.83 128.25 2.02 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.452 -0.34 . . . . 1.46 110.687 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp 66.23 111.53 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.606 0 O-C-N 123.748 0.655 . . . . 0.84 112.06 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.32 139.6 50.38 Favored 'Trans proline' 0 CA--C 1.533 0.45 0 C-N-CA 122.761 2.308 . . . . 0.51 113.033 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.45 36.88 0.32 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.954 0.407 . . . . 0.62 111.787 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -87.17 55.03 3.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.98 0.419 . . . . 1.21 111.323 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -70.84 -50.54 34.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.7 111.658 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -176.35 -153.77 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.087 -0.506 . . . . 0.49 110.656 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.403 HG12 ' H ' ' B' ' 9' ' ' ILE . 21.0 pt -73.91 50.31 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.366 0.603 . . . . 0.85 112.316 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -117.61 45.65 1.89 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.357 -0.383 . . . . 0.94 110.908 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.3 45.27 0.28 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.937 0.399 . . . . 0.59 112.046 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 45.7 mm -72.58 -42.23 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 122.72 0.408 . . . . 0.58 111.524 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.469 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 80.6 mt -53.84 -60.74 6.54 Favored Pre-proline 0 CA--C 1.543 0.705 0 CA-C-N 116.151 -0.477 . . . . 0.87 112.177 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.469 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.0 Cg_endo -55.32 -40.69 84.3 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 121.928 1.752 . . . . 0.55 112.003 179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 48.3 t -61.04 -53.33 58.54 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.299 -0.409 . . . . 0.38 111.911 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.35 -38.03 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 120.701 -0.399 . . . . 0.51 111.191 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.418 HD13 ' O ' ' B' ' 13' ' ' ILE . 7.1 mp -61.92 -53.2 58.96 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 120.313 0.101 . . . . 0.79 111.204 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.97 -35.62 74.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 120.736 -0.386 . . . . 0.6 110.849 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 80.0 m -65.35 -47.0 77.97 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.97 -0.382 . . . . 0.41 109.97 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 39.9 t -59.83 -50.9 72.0 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.991 -0.55 . . . . 0.52 110.898 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -60.22 -44.87 94.81 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.651 -0.25 . . . . 0.72 111.099 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.54 -57.16 14.17 Favored 'General case' 0 C--O 1.215 -0.736 0 C-N-CA 120.866 -0.333 . . . . 0.51 110.566 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' B' ' 27' ' ' TYR . 65.4 mt -56.62 -37.1 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 121.49 -0.084 . . . . 0.52 110.957 178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.5 tp -59.86 -45.65 91.78 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.011 0.434 . . . . 0.66 110.269 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 73.8 t -77.5 -47.24 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.461 0.648 . . . . 0.79 111.316 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -61.71 -51.84 66.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.98 -1.009 . . . . 0.9 112.207 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 2.0 m-85 -92.01 55.08 2.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.059 -0.519 . . . . 0.99 110.562 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.559 HD23 ' H ' ' B' ' 28' ' ' LEU . 2.2 pt? -53.72 131.97 56.24 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-O 121.342 0.591 . . . . 0.9 111.916 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.37 127.44 18.2 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.589 2.193 . . . . 0.46 112.829 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 48.3 t -78.9 -46.8 17.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.204 -0.453 . . . . 0.84 110.854 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -104.69 -173.61 2.34 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.15 0.5 . . . . 1.15 111.48 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 39.8 m -80.6 131.21 35.48 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.072 -0.513 . . . . 1.23 111.86 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 59.67 38.37 93.7 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 121.305 -0.474 . . . . 1.15 112.548 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -78.64 -49.06 13.85 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.175 0.435 . . . . 1.04 112.175 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 40.8 mttp . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.423 -0.799 . . . . 1.52 110.85 -179.929 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 120.427 0.156 . . . . 1.55 111.324 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.36 145.03 44.16 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.58 -0.282 . . . . 2.5 110.778 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -54.0 131.84 58.71 Favored Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 116.191 -0.458 . . . . 1.44 112.208 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.39 46.85 0.78 Allowed 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.058 2.505 . . . . 1.19 113.492 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 69.9 mt -81.19 50.87 1.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.816 0.341 . . . . 0.85 111.72 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.02 31.31 0.55 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.064 0.459 . . . . 1.36 111.931 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -87.45 -38.16 16.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 1.72 111.076 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 8.8 t -167.48 -147.43 0.08 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 116.178 -0.465 . . . . 1.02 110.849 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 35.6 pt -65.07 144.03 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 121.213 0.53 . . . . 1.07 112.353 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -66.91 -40.69 87.75 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.03 -0.532 . . . . 0.8 111.439 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 95.8 mt -80.87 44.46 0.75 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.006 0.432 . . . . 1.0 111.814 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.7 tp -71.17 -37.37 66.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.402 -0.363 . . . . 0.78 111.591 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.468 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 82.1 mt -57.15 -61.11 7.7 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 111.933 0.346 . . . . 0.86 111.933 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.468 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.1 Cg_endo -55.37 -38.91 93.47 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.727 1.618 . . . . 0.78 111.641 178.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 40.9 t -59.69 -54.5 45.68 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.042 -0.526 . . . . 0.72 111.796 179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.421 HG23 HD22 ' B' ' 17' ' ' LEU . 27.5 m -65.1 -40.91 90.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 121.021 -0.272 . . . . 0.72 111.665 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.663 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 3.9 mm? -60.75 -53.03 62.39 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 121.173 -0.211 . . . . 0.76 111.019 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 43.5 mm -60.09 -43.74 93.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 120.508 0.194 . . . . 0.73 110.64 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 91.5 m -60.0 -45.5 92.53 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 120.625 0.25 . . . . 0.62 110.374 178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 47.7 t -60.09 -51.04 71.31 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.236 -0.438 . . . . 0.68 110.497 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 60.4 mt -58.11 -44.62 87.78 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-O 120.765 0.317 . . . . 0.68 110.48 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' B' ' 26' ' ' PHE . . . -59.0 -60.54 3.7 Favored 'General case' 0 C--O 1.204 -1.306 0 CA-C-N 116.296 -0.411 . . . . 0.46 110.237 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.619 ' O ' ' HB2' ' B' ' 27' ' ' TYR . 71.8 mt -50.95 -39.79 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-O 120.572 0.225 . . . . 0.57 111.147 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 52.6 tp -58.31 -47.78 82.6 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.684 0.278 . . . . 0.74 110.929 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.11 -39.6 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.671 0.748 . . . . 0.55 111.295 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' B' ' 22' ' ' ALA . 3.3 m-85 -79.73 -117.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.693 1.197 . . . . 0.52 111.812 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.619 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 0.4 OUTLIER 51.98 43.7 30.09 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 114.511 -1.222 . . . . 0.78 112.696 179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.94 113.15 45.88 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.439 -0.346 . . . . 0.99 111.128 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.14 50.46 2.86 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.637 2.225 . . . . 1.25 112.607 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 54.6 p -75.16 -61.11 2.01 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.983 0.421 . . . . 1.81 111.975 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.28 -143.94 0.08 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.904 -0.589 . . . . 2.5 111.761 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 25.8 p -77.13 118.6 19.83 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.921 0.391 . . . . 2.31 111.514 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 167.11 128.81 1.01 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.866 -0.683 . . . . 1.46 112.654 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 39.72 58.61 2.02 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.718 0.807 . . . . 1.21 113.079 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt . . . . . 0 C--O 1.251 1.166 0 CA-C-O 118.558 -0.734 . . . . 1.65 110.658 179.793 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 87.1 mtm-85 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.612 0.244 . . . . 1.58 111.408 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 76.6 mtp180 -75.96 60.04 1.34 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.265 0.469 . . . . 1.52 112.265 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.423 ' N ' ' HD3' ' B' ' 4' ' ' PRO . 19.0 ptpt 41.08 62.83 6.36 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.668 0.988 . . . . 1.66 113.668 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.423 ' HD3' ' N ' ' B' ' 3' ' ' LYS . 4.5 Cg_exo -73.08 136.87 25.45 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.974 2.449 . . . . 0.9 112.197 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' B' ' 5' ' ' LEU . 3.7 mm? -73.63 51.92 0.38 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.205 0.446 . . . . 1.46 112.205 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.99 42.51 0.32 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.094 0.473 . . . . 0.76 112.091 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -76.59 -35.71 57.96 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.123 -0.49 . . . . 1.58 111.402 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 42.3 p -76.41 -30.8 57.6 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.546 0.573 . . . . 0.84 112.546 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 15.2 tt -156.28 138.34 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 112.111 0.411 . . . . 0.87 112.111 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 t30 62.88 52.18 2.74 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.441 -0.8 . . . . 0.54 111.783 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.77 -65.4 0.7 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.814 -0.63 . . . . 1.49 112.109 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.4 HG23 ' N ' ' B' ' 13' ' ' ILE . 5.7 tp -159.78 -53.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.261 -0.427 . . . . 0.62 110.641 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.564 ' N ' ' HD2' ' B' ' 14' ' ' PRO . 87.5 mt -56.25 -55.09 45.78 Favored Pre-proline 0 CA--C 1.54 0.587 0 N-CA-C 110.63 -0.137 . . . . 0.76 110.63 178.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' B' ' 13' ' ' ILE . 19.7 Cg_endo -54.1 -44.82 45.85 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.882 2.388 . . . . 0.45 111.401 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.1 t -60.14 -43.73 95.47 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.965 -0.561 . . . . 0.47 110.856 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.28 -48.82 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 112.071 0.397 . . . . 0.55 112.071 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 pp -66.55 -43.56 84.74 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 120.401 -0.52 . . . . 0.55 111.397 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 31.6 mm -60.52 -45.15 97.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.666 0.269 . . . . 0.52 110.517 178.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.473 ' O ' HG12 ' B' ' 23' ' ' ILE . 47.6 m -62.57 -45.73 91.56 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.501 -0.318 . . . . 0.46 110.387 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.512 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 49.9 m -58.89 -52.47 65.58 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.19 -0.459 . . . . 0.48 110.894 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -58.72 -44.11 90.34 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 116.716 -0.22 . . . . 0.55 110.682 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.17 -56.13 26.05 Favored 'General case' 0 C--O 1.212 -0.893 0 C-N-CA 120.891 -0.324 . . . . 0.42 110.467 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.473 HG12 ' O ' ' B' ' 19' ' ' THR . 50.1 mm -55.06 -40.02 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 122.82 0.075 . . . . 0.54 111.15 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' B' ' 20' ' ' SER . 92.6 mt -60.11 -44.83 94.58 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.89 0.376 . . . . 0.52 110.795 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 92.3 t -77.69 -40.47 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.68 0.752 . . . . 0.53 111.649 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -70.34 -51.71 28.03 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.022 -0.99 . . . . 0.76 113.345 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 3.1 m-85 -80.65 49.01 1.12 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 113.571 0.952 . . . . 0.83 113.571 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 76.6 mt -82.58 127.49 70.28 Favored Pre-proline 0 C--N 1.329 -0.301 0 O-C-N 122.184 -0.322 . . . . 0.62 110.836 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.78 36.88 0.44 Allowed 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.798 2.332 . . . . 0.69 113.286 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 39.5 t -178.87 134.77 0.13 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.021 -0.536 . . . . 0.74 110.64 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 58.56 33.64 23.26 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.61 0.596 . . . . 0.8 112.61 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 46.2 t -174.46 -54.89 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.777 0.322 . . . . 0.51 111.367 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.87 61.39 2.1 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.242 -0.504 . . . . 0.7 114.166 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 1.051 ' HB2' ' HE2' ' B' ' 35' ' ' LYS . 27.1 mt-10 -63.04 -35.96 81.97 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.259 0.552 . . . . 0.94 111.145 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 1.051 ' HE2' ' HB2' ' B' ' 34' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.278 0 CA-C-O 118.079 -0.962 . . . . 1.09 110.863 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . 0.509 ' HG3' ' SG ' ' B' ' 15' ' ' CYS . 73.8 mtp180 . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 111.504 0.187 . . . . 0.41 111.504 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -81.99 47.85 1.16 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.687 0.28 . . . . 0.58 111.663 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' B' ' 3' ' ' LYS . 31.5 mmtm -155.1 133.99 7.4 Favored Pre-proline 0 N--CA 1.468 0.457 0 CA-C-N 116.329 -0.396 . . . . 0.62 110.808 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.22 48.88 1.26 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 122.916 2.411 . . . . 0.66 112.873 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 43.4 mt -145.15 62.38 1.29 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.505 . . . . 0.68 111.191 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -76.45 50.27 0.65 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 112.392 0.516 . . . . 0.55 112.392 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.467 ' CE1' HG23 ' B' ' 8' ' ' THR . 4.7 p90 -67.4 -25.25 65.86 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.995 0.368 . . . . 0.5 111.995 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.467 HG23 ' CE1' ' B' ' 7' ' ' TYR . 18.1 p -75.98 105.83 7.24 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.805 0.336 . . . . 0.47 111.709 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 14.5 tt -74.22 -30.0 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.107 -0.497 . . . . 0.67 111.36 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -57.62 113.19 1.7 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.356 -0.383 . . . . 0.66 111.428 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 97.1 mt 57.47 35.1 25.5 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.782 -0.645 . . . . 0.6 112.146 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.493 ' O ' HD13 ' B' ' 12' ' ' ILE . 0.0 OUTLIER -68.73 -38.39 78.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 116.612 -0.267 . . . . 0.37 111.147 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.69 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 4.8 mp -57.93 -62.21 5.91 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 111.454 0.168 . . . . 0.44 111.454 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.481 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.7 Cg_endo -55.01 -39.63 89.97 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 121.89 1.726 . . . . 0.31 111.855 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.509 ' SG ' ' HG3' ' B' ' 1' ' ' ARG . 53.7 t -60.28 -49.85 75.99 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.201 -0.454 . . . . 0.35 111.511 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.466 HG12 ' O ' ' B' ' 13' ' ' ILE . 7.3 p -66.0 -41.2 89.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 120.761 -0.376 . . . . 0.32 111.074 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 58.7 mt -59.65 -52.85 63.74 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 121.23 -0.188 . . . . 0.37 110.576 178.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.424 HG12 ' O ' ' B' ' 14' ' ' PRO . 45.4 mm -59.65 -42.81 89.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.622 -0.263 . . . . 0.41 110.572 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.553 ' O ' HG12 ' B' ' 23' ' ' ILE . 76.4 m -60.6 -46.46 90.16 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 110.151 -0.314 . . . . 0.32 110.151 178.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 48.4 t -59.22 -51.56 69.44 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.322 -0.399 . . . . 0.34 110.883 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 58.8 mt -58.63 -44.82 90.12 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.715 0.293 . . . . 0.47 110.889 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.87 -55.74 31.21 Favored 'General case' 0 C--O 1.213 -0.846 0 CA-C-N 116.441 -0.345 . . . . 0.35 110.756 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.553 HG12 ' O ' ' B' ' 19' ' ' THR . 43.9 mm -57.4 -37.39 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 121.266 -0.173 . . . . 0.44 110.724 179.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 52.7 tp -59.78 -46.01 90.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.965 0.412 . . . . 0.49 110.311 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.406 ' O ' HD22 ' B' ' 28' ' ' LEU . 68.9 t -76.97 -46.36 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.401 0.619 . . . . 0.44 111.36 178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -63.17 -52.3 62.96 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.175 0.99 . . . . 0.66 112.303 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -93.44 39.53 1.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.016 -0.538 . . . . 0.57 110.357 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.406 HD22 ' O ' ' B' ' 25' ' ' VAL . 2.4 pt? -65.25 143.28 98.75 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.154 -0.475 . . . . 0.46 111.742 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.86 -136.91 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 122.487 2.125 . . . . 0.57 112.367 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 96.7 p 54.97 34.43 22.35 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.511 0.725 . . . . 0.54 112.742 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 51.22 59.68 4.42 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.58 0.585 . . . . 0.74 112.58 178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 12.8 p -71.99 51.78 0.23 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.643 0.609 . . . . 0.48 112.643 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -76.39 130.13 10.52 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.98 -0.628 . . . . 0.66 112.917 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.78 -160.42 0.68 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.862 0.363 . . . . 1.86 111.054 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . . . . . . . . . 35.0 mtmm . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.348 -0.834 . . . . 2.13 111.477 179.741 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 111.981 0.363 . . . . 1.67 111.981 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 -76.6 121.93 23.9 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.52 0.2 . . . . 2.33 110.888 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm 55.89 66.88 3.26 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-N 116.106 -0.497 . . . . 1.78 111.664 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -79.42 47.4 2.5 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.456 2.104 . . . . 0.99 113.363 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' B' ' 5' ' ' LEU . 3.9 mm? -84.0 51.71 2.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.058 0.456 . . . . 1.14 111.351 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -148.55 36.15 0.8 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.046 0.45 . . . . 1.03 111.896 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.409 ' OH ' ' HA ' ' B' ' 10' ' ' ASN . 33.5 t80 -75.8 143.06 42.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.011 0.434 . . . . 0.77 111.17 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -162.47 -52.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 1.07 112.081 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 58.8 mt -81.0 115.63 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 1.05 111.149 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.409 ' HA ' ' OH ' ' B' ' 7' ' ' TYR . 77.0 m-20 -73.17 133.93 44.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.363 -0.38 . . . . 1.01 111.656 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 97.6 mt 59.67 37.49 22.33 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.682 -0.69 . . . . 1.17 111.649 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 6.9 tp -68.51 -40.6 82.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.106 -0.497 . . . . 1.18 111.636 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.473 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 79.6 mt -57.14 -61.22 7.51 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 111.756 0.28 . . . . 1.44 111.756 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.9 Cg_endo -55.36 -40.31 86.27 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.841 1.694 . . . . 1.05 111.869 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 42.9 t -61.68 -53.24 58.78 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.285 -0.416 . . . . 0.81 111.901 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 12.5 p -63.82 -38.4 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 120.601 -0.439 . . . . 1.07 110.83 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.641 ' O ' ' HG ' ' B' ' 21' ' ' LEU . 7.0 mp -61.66 -54.18 46.27 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.998 -0.092 . . . . 1.15 111.201 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.58 -35.83 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.838 -0.345 . . . . 0.71 110.882 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.442 ' O ' HG12 ' B' ' 23' ' ' ILE . 86.5 m -64.46 -45.77 85.99 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.841 -0.429 . . . . 0.8 109.841 178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.487 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 48.4 t -60.23 -52.28 65.99 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.882 -0.599 . . . . 0.92 110.528 178.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 59.8 mt -57.16 -44.61 83.66 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.74 0.305 . . . . 0.86 110.812 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.28 -58.15 9.77 Favored 'General case' 0 C--O 1.212 -0.914 0 CA-C-N 116.326 -0.397 . . . . 0.55 110.705 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.442 HG12 ' O ' ' B' ' 19' ' ' THR . 51.9 mm -54.61 -40.49 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 117.58 0.173 . . . . 0.92 111.113 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' B' ' 20' ' ' SER . 85.7 mt -58.99 -44.57 91.63 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 121.093 -0.243 . . . . 0.8 111.029 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -80.06 -43.26 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 121.67 0.748 . . . . 0.73 111.738 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -65.73 -48.64 71.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.951 -1.022 . . . . 0.97 113.399 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 3.0 m-85 -85.15 -50.15 7.65 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.368 0.507 . . . . 1.39 112.368 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 83.4 mt -92.66 137.41 24.26 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.743 0.306 . . . . 0.83 111.469 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.17 48.45 0.9 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.811 2.341 . . . . 0.62 113.226 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 38.2 t -85.0 157.17 20.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.966 0.412 . . . . 0.61 111.867 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.451 ' HA ' ' HE3' ' B' ' 35' ' ' LYS . 3.4 m-20 57.39 50.3 11.6 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.661 -0.699 . . . . 1.08 112.515 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 42.7 t -76.81 52.87 0.87 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 121.509 0.671 . . . . 1.94 110.947 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.64 152.19 7.98 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.564 -0.744 . . . . 1.84 111.357 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -75.54 102.87 5.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.126 0.463 . . . . 3.01 111.571 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' B' ' 31' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.614 -0.708 . . . . 1.6 110.5 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.584 0.23 . . . . 3.58 111.196 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -99.43 56.53 1.01 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.346 0.593 . . . . 0.87 112.067 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -160.34 133.36 4.66 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 0.77 111.226 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -80.51 -154.89 0.05 OUTLIER 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.578 2.185 . . . . 0.73 112.569 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 67.5 mt -90.82 -125.08 0.07 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.69 0.757 . . . . 1.75 111.86 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -80.61 54.19 2.04 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.963 -1.017 . . . . 1.85 111.893 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -129.78 -55.7 1.14 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.723 0.296 . . . . 1.97 111.468 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 26.5 p -143.95 157.33 44.41 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.421 -0.354 . . . . 1.33 111.308 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 33.3 pt -74.43 -166.5 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.082 0.468 . . . . 1.74 111.551 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -70.97 127.61 33.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.984 0.421 . . . . 0.79 110.441 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 85.4 mt -75.15 14.08 0.61 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.669 0.618 . . . . 1.68 112.669 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 9.0 tp -70.07 -39.83 77.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.331 0.11 . . . . 0.95 111.28 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.496 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 77.5 mt -60.29 -61.68 7.44 Favored Pre-proline 0 CA--C 1.541 0.6 0 N-CA-C 111.535 0.198 . . . . 1.03 111.535 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.496 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.4 Cg_endo -55.57 -39.39 91.33 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.853 1.702 . . . . 0.9 111.544 178.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.403 ' O ' HG13 ' B' ' 18' ' ' ILE . 50.3 t -64.21 -51.68 62.56 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.146 -0.479 . . . . 0.84 112.012 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 10.0 p -62.43 -38.26 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 120.403 -0.519 . . . . 0.65 110.401 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.419 HD13 ' O ' ' B' ' 13' ' ' ILE . 7.4 mp -62.32 -53.71 51.07 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.843 -0.162 . . . . 0.84 111.089 178.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.403 HG13 ' O ' ' B' ' 15' ' ' CYS . 2.6 pp -63.42 -35.36 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 120.782 -0.367 . . . . 0.8 111.189 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.455 ' O ' HG12 ' B' ' 23' ' ' ILE . 37.0 m -66.03 -44.09 85.68 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.563 -0.532 . . . . 0.63 109.563 178.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 46.6 t -61.16 -51.27 69.75 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.776 -0.647 . . . . 0.5 111.631 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.436 HD12 ' N ' ' B' ' 22' ' ' ALA . 3.2 pp -64.93 -38.86 92.35 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.45 -0.5 . . . . 0.7 111.039 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.436 ' N ' HD12 ' B' ' 21' ' ' LEU . . . -59.93 -57.7 11.75 Favored 'General case' 0 C--O 1.213 -0.841 0 C-N-CA 120.554 -0.458 . . . . 0.5 110.121 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.455 HG12 ' O ' ' B' ' 19' ' ' THR . 51.3 mm -56.32 -39.11 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 122.967 0.167 . . . . 0.45 110.756 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.3 tp -57.58 -45.15 85.57 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.865 0.364 . . . . 0.69 110.462 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 69.8 t -79.44 -45.15 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.457 0.646 . . . . 0.66 111.576 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -63.56 -47.56 81.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.908 -1.042 . . . . 0.67 113.012 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 2.7 m-85 -90.96 54.05 2.54 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.8 0.296 . . . . 0.58 111.8 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.65 HD23 ' H ' ' B' ' 28' ' ' LEU . 2.4 pt? -68.13 130.27 92.61 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-O 120.89 0.376 . . . . 0.74 111.004 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -61.49 129.72 29.11 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.71 2.273 . . . . 0.76 113.25 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 96.8 p -143.56 -37.38 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.056 -0.52 . . . . 0.87 111.443 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -157.48 -86.42 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.496 -0.32 . . . . 0.85 111.837 -179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 46.8 t -157.17 -14.79 0.09 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.911 0.337 . . . . 1.09 111.911 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -66.91 -38.55 92.96 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.627 -0.797 . . . . 0.76 112.517 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.98 ' HG2' ' HD3' ' B' ' 35' ' ' LYS . 17.9 pm0 -71.94 -36.46 69.92 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.72 0.408 . . . . 0.56 111.599 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.98 ' HD3' ' HG2' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.514 -0.755 . . . . 0.9 110.548 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 110.703 -0.11 . . . . 4.31 110.703 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 62.09 44.85 7.6 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.643 0.377 . . . . 2.93 110.911 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' B' ' 4' ' ' PRO . 57.1 mtpt 64.82 114.79 0.02 OUTLIER Pre-proline 0 N--CA 1.473 0.702 0 CA-C-N 115.842 -0.617 . . . . 1.65 111.492 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' B' ' 3' ' ' LYS . 13.4 Cg_endo -57.22 111.64 0.87 Allowed 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.779 2.32 . . . . 1.79 113.494 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' B' ' 5' ' ' LEU . 3.6 mm? 53.1 35.06 18.68 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.52 -0.764 . . . . 1.71 112.373 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -156.87 54.75 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.122 0.487 . . . . 1.13 110.579 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.64 51.69 0.14 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.803 -0.635 . . . . 1.44 112.519 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 1.6 t -156.83 149.15 23.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.033 -0.531 . . . . 0.57 111.101 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 57.7 mt -60.81 -43.84 96.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.036 0.446 . . . . 0.69 110.835 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . 0.412 ' HB2' ' H ' ' B' ' 11' ' ' LEU . 16.7 p30 -161.28 -151.01 0.21 Allowed 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.937 -0.574 . . . . 0.67 111.218 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.412 ' H ' ' HB2' ' B' ' 10' ' ' ASN . 95.8 mt -87.23 -20.51 26.81 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.195 0.813 . . . . 1.15 113.195 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 39.9 mm -64.25 -45.71 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 112.408 0.522 . . . . 0.98 112.408 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.473 HD12 ' H ' ' B' ' 13' ' ' ILE . 3.1 mp -54.21 -59.98 8.68 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 111.905 0.335 . . . . 0.78 111.905 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.431 ' O ' HG12 ' B' ' 18' ' ' ILE . 12.1 Cg_endo -56.29 -41.31 77.79 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 121.967 1.778 . . . . 0.87 112.065 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.1 t -58.75 -48.08 82.44 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.733 0.301 . . . . 0.93 110.868 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 41.6 t -64.03 -47.14 91.65 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-N 116.37 -0.377 . . . . 0.98 110.967 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . . . . . . . . . 8.6 mp -58.54 -50.68 72.9 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.661 -0.245 . . . . 1.28 111.417 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.431 HG12 ' O ' ' B' ' 14' ' ' PRO . 46.4 mm -61.36 -44.89 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 120.448 0.166 . . . . 1.31 110.835 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 44.7 m -60.87 -47.19 87.51 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.715 0.293 . . . . 0.88 110.69 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 44.4 t -60.38 -50.98 71.46 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.272 -0.422 . . . . 1.22 110.929 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 8.8 mp -59.03 -45.82 89.76 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 116.553 -0.294 . . . . 1.65 110.768 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.64 -57.57 12.4 Favored 'General case' 0 C--O 1.207 -1.174 0 N-CA-C 110.044 -0.354 . . . . 0.99 110.044 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.525 HG23 ' CD1' ' B' ' 27' ' ' TYR . 30.7 mm -53.21 -38.35 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.481 0.181 . . . . 0.89 111.458 178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.9 tp -60.67 -45.86 92.55 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.836 0.35 . . . . 1.63 110.654 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -80.58 -37.92 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.547 0.689 . . . . 1.49 111.392 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.433 ' HB3' ' H ' ' B' ' 27' ' ' TYR . 2.8 m-85 -78.79 -119.71 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 124.401 1.08 . . . . 1.55 111.913 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.525 ' CD1' HG23 ' B' ' 23' ' ' ILE . 0.0 OUTLIER 51.2 46.47 26.4 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 114.858 -1.064 . . . . 1.41 112.458 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 16.5 tp 59.33 70.1 1.18 Allowed Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.074 -0.512 . . . . 1.52 111.935 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.17 50.62 1.9 Allowed 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.831 2.354 . . . . 0.92 112.967 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 95.5 p 53.98 46.26 25.92 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.261 0.624 . . . . 0.88 111.702 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -56.24 116.88 3.3 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.234 -0.439 . . . . 1.39 111.381 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 71.7 m 60.42 29.19 18.82 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.748 -0.66 . . . . 2.09 111.96 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.3 53.02 2.68 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.332 -0.461 . . . . 1.73 113.139 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -80.91 75.48 7.86 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.067 0.46 . . . . 2.67 111.546 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.454 ' N ' ' HD2' ' B' ' 35' ' ' LYS . 11.1 mptt . . . . . 0 C--O 1.251 1.156 0 CA-C-O 118.397 -0.811 . . . . 3.33 112.198 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.219 0.057 . . . . 1.83 111.053 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 59.42 45.76 13.28 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.129 0.49 . . . . 1.35 110.737 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 ttpp 60.2 92.0 0.07 OUTLIER Pre-proline 0 N--CA 1.469 0.506 0 CA-C-N 115.487 -0.779 . . . . 0.78 112.22 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -69.72 -142.17 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.143 2.562 . . . . 0.59 112.987 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.11 45.75 0.16 Allowed 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.305 0.483 . . . . 0.99 112.305 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -86.48 53.58 2.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.894 0.378 . . . . 1.08 111.251 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.65 -46.9 67.94 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.105 0.409 . . . . 0.98 112.105 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 67.4 p 50.14 39.86 20.44 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.544 0.572 . . . . 1.04 112.544 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.403 HG12 ' H ' ' B' ' 9' ' ' ILE . 17.7 pt -75.18 50.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 112.888 0.699 . . . . 1.14 112.888 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 58.93 57.72 3.48 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.298 0.481 . . . . 1.39 112.298 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.446 ' HB3' ' HG2' ' B' ' 14' ' ' PRO . 3.4 mm? -74.4 49.26 0.37 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.883 0.373 . . . . 0.82 111.749 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 7.4 tp -69.93 -38.98 76.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 111.875 0.324 . . . . 0.94 111.875 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.718 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 74.4 mt -58.38 -62.48 5.53 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 111.854 0.316 . . . . 0.72 111.854 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.502 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.4 Cg_endo -54.42 -40.13 84.5 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 121.882 1.722 . . . . 0.59 111.834 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 51.6 t -61.93 -50.29 72.75 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.014 -0.539 . . . . 0.71 111.558 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.471 HG12 ' O ' ' B' ' 13' ' ' ILE . 7.2 p -64.14 -39.0 83.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 120.6 -0.44 . . . . 0.53 110.947 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.718 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 60.3 mt -62.78 -53.39 54.99 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 122.451 -0.156 . . . . 0.53 111.275 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.83 -36.69 76.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 120.762 -0.375 . . . . 0.57 111.15 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 88.1 m -64.78 -46.38 82.32 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.826 0.346 . . . . 0.57 110.126 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 50.5 m -60.14 -50.96 71.64 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.051 -0.522 . . . . 0.45 110.626 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -59.62 -44.46 93.45 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 116.592 -0.276 . . . . 0.7 110.629 178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' B' ' 26' ' ' PHE . . . -59.16 -60.57 3.66 Favored 'General case' 0 C--O 1.205 -1.287 0 CA-C-O 119.259 -0.401 . . . . 0.47 110.131 178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.667 ' O ' ' HB2' ' B' ' 27' ' ' TYR . 36.6 mm -51.04 -38.67 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 117.817 0.281 . . . . 0.6 111.289 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 53.7 tp -59.54 -47.54 85.14 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.755 0.312 . . . . 0.81 110.927 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 60.8 t -83.37 -39.94 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 121.771 0.796 . . . . 0.78 111.373 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' B' ' 22' ' ' ALA . 3.9 m-85 -80.15 -114.96 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.895 1.278 . . . . 0.77 111.947 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.667 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 0.6 OUTLIER 57.69 79.55 0.2 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 114.497 -1.228 . . . . 0.92 113.187 179.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.4 mm? -65.94 133.07 94.79 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.096 -0.502 . . . . 1.18 110.586 178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 28' ' ' LEU . 23.5 Cg_exo -65.36 67.0 0.33 Allowed 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.431 2.754 . . . . 1.36 113.792 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 47.3 t -145.94 44.31 1.26 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.153 0.502 . . . . 1.63 111.071 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -66.03 131.03 45.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.965 -0.562 . . . . 0.91 111.3 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 54.0 t -72.02 115.31 11.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.284 -0.416 . . . . 1.59 111.216 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.39 129.4 19.9 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.803 -0.713 . . . . 1.52 112.714 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -74.88 121.36 21.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.828 0.347 . . . . 2.84 111.045 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.925 ' H ' ' HD3' ' B' ' 35' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.459 0 CA-C-O 118.444 -0.788 . . . . 3.61 111.298 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 111.57 0.211 . . . . 1.84 111.57 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -74.4 129.42 37.75 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 121.219 -0.192 . . . . 4.41 110.83 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.456 ' HD2' ' HD2' ' B' ' 4' ' ' PRO . 26.7 tptp 67.54 109.33 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.538 0 O-C-N 123.717 0.636 . . . . 2.21 110.947 -178.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.456 ' HD2' ' HD2' ' B' ' 3' ' ' LYS . 33.6 Cg_exo -59.52 115.94 2.94 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.446 2.097 . . . . 2.19 112.741 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 54.1 mt -82.04 56.94 3.31 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.118 -0.492 . . . . 1.83 111.433 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.28 34.78 0.06 Allowed 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.272 0.842 . . . . 2.07 113.272 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -81.54 -30.36 33.15 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.327 0.584 . . . . 2.17 110.177 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 9.0 t -166.28 -160.84 0.44 Allowed 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.523 -0.762 . . . . 1.66 110.157 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 20.1 pt -78.46 46.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.108 0.48 . . . . 2.08 112.225 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -76.95 67.33 2.94 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.427 -0.352 . . . . 1.2 111.175 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.501 ' HB3' ' HG2' ' B' ' 14' ' ' PRO . 93.2 mt 53.32 41.15 32.14 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.222 -0.445 . . . . 0.94 111.753 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 7.7 tp -63.73 -42.53 96.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 112.089 0.403 . . . . 0.89 112.089 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.67 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 73.9 mt -59.49 -62.71 5.32 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 111.709 0.263 . . . . 1.0 111.709 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.504 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.2 Cg_endo -54.51 -37.2 90.11 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 121.735 1.623 . . . . 0.64 111.604 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 41.3 t -61.24 -51.3 69.51 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.198 -0.455 . . . . 0.56 111.56 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 35.5 m -65.77 -39.08 83.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 120.684 -0.406 . . . . 0.69 111.225 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 57.3 mt -61.84 -53.97 48.5 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 121.165 -0.214 . . . . 0.82 110.73 178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 45.0 mm -60.15 -43.36 92.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.642 -0.254 . . . . 0.76 111.085 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 58.4 m -60.44 -44.37 95.88 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.653 0.263 . . . . 0.69 110.423 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -61.53 -50.61 72.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.241 -0.436 . . . . 0.69 110.818 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 60.6 mt -58.28 -44.89 88.67 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 120.781 0.324 . . . . 0.95 110.534 179.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.01 -57.65 11.87 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 116.222 -0.445 . . . . 0.82 110.59 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 71.6 mt -56.23 -37.96 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 122.821 0.076 . . . . 0.87 110.915 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 54.8 tp -58.9 -45.34 90.54 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.042 0.449 . . . . 1.09 110.281 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 70.7 t -78.62 -46.3 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.447 0.641 . . . . 1.21 111.34 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -62.74 -49.0 76.74 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.009 -0.996 . . . . 1.41 112.69 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -93.12 47.12 1.25 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.859 0.361 . . . . 1.4 110.873 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.52 HD23 ' H ' ' B' ' 28' ' ' LEU . 2.6 pt? -62.85 134.69 95.67 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-O 120.93 0.395 . . . . 1.05 111.546 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.24 126.0 14.97 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 122.56 2.173 . . . . 1.16 112.888 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 40.5 t -71.38 141.62 50.36 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.194 -0.457 . . . . 1.03 111.8 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -54.78 -39.81 68.79 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.103 -0.499 . . . . 1.87 111.653 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 25.6 p -89.48 19.13 4.71 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 111.989 0.366 . . . . 1.62 111.989 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.51 -59.53 2.88 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.327 -0.464 . . . . 1.64 113.587 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.433 ' HB3' ' H ' ' B' ' 35' ' ' LYS . 19.1 mm-40 59.37 -142.2 0.62 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.453 0.538 . . . . 2.27 112.453 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.463 ' N ' ' HD3' ' B' ' 35' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.259 1.57 0 CA-C-O 117.868 -1.063 . . . . 2.91 109.915 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 25.0 mmt85 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 111.043 0.016 . . . . 0.86 111.043 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -78.64 131.55 36.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.792 0.33 . . . . 0.81 111.204 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.435 ' HB2' ' HD2' ' B' ' 4' ' ' PRO . 13.9 pttp -73.72 157.94 86.81 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.134 -0.485 . . . . 0.88 111.06 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.603 ' HD3' HD21 ' B' ' 11' ' ' LEU . 29.0 Cg_endo -62.76 135.05 50.12 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.382 2.055 . . . . 0.63 112.457 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.79 54.11 2.94 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.264 -0.425 . . . . 0.99 111.898 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 58.96 52.12 6.68 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.213 0.53 . . . . 1.45 111.584 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -150.87 145.86 25.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.948 -0.569 . . . . 0.99 110.306 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 5.2 t -72.92 45.91 0.16 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.515 0.674 . . . . 0.75 112.498 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.529 HG23 ' H ' ' B' ' 11' ' ' LEU . 9.1 tp -75.46 -28.5 20.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 116.119 -0.491 . . . . 0.64 110.413 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 60.18 36.32 20.99 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.763 -0.653 . . . . 0.57 111.984 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.603 HD21 ' HD3' ' B' ' 4' ' ' PRO . 95.7 mt 53.36 46.84 25.51 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.104 0.779 . . . . 0.58 113.104 178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.427 HG12 ' O ' ' B' ' 9' ' ' ILE . 3.8 mm -66.83 -43.95 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 120.562 0.22 . . . . 0.71 111.564 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.707 ' O ' ' HG ' ' B' ' 17' ' ' LEU . 73.8 mt -54.61 -62.63 3.79 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.857 0.318 . . . . 0.62 111.857 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.544 ' HG2' ' HB3' ' B' ' 11' ' ' LEU . 12.3 Cg_endo -55.53 -39.9 88.46 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 121.73 1.62 . . . . 0.41 111.723 178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 40.8 t -60.96 -50.75 72.12 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.103 -0.499 . . . . 0.58 111.448 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.437 HG12 ' O ' ' B' ' 13' ' ' ILE . 8.4 p -64.73 -41.79 93.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.9 -0.32 . . . . 0.5 111.177 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.707 ' HG ' ' O ' ' B' ' 13' ' ' ILE . 60.0 mt -60.19 -51.14 70.84 Favored 'General case' 0 C--N 1.342 0.255 0 O-C-N 122.276 -0.265 . . . . 0.53 110.605 178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 64.8 mt -60.02 -44.04 93.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.536 -0.302 . . . . 0.6 110.718 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.496 ' O ' HG12 ' B' ' 23' ' ' ILE . 67.6 m -60.54 -45.01 95.47 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.405 -0.361 . . . . 0.58 110.625 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 45.3 t -60.7 -49.64 76.71 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.245 -0.434 . . . . 0.45 110.647 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' B' ' 17' ' ' LEU . 60.4 mt -59.71 -44.6 93.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.721 0.296 . . . . 0.63 110.556 178.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.77 11.42 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 116.418 -0.356 . . . . 0.6 110.641 178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.496 HG12 ' O ' ' B' ' 19' ' ' THR . 45.4 mm -56.8 -36.91 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.282 0.087 . . . . 0.69 110.956 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.6 -44.44 96.27 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 120.952 0.406 . . . . 1.3 110.162 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 79.6 t -78.51 -47.54 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 121.444 0.64 . . . . 0.8 111.138 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -61.27 -48.6 80.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 114.898 -1.046 . . . . 0.92 112.405 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' B' ' 23' ' ' ILE . 2.1 m-85 -95.7 48.47 1.14 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.402 -0.363 . . . . 0.96 110.558 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.501 HD23 ' H ' ' B' ' 28' ' ' LEU . 2.6 pt? -61.01 131.23 91.79 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-O 121.218 0.532 . . . . 0.87 112.116 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -73.85 75.22 3.2 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.869 2.379 . . . . 0.99 113.068 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 68.0 m -156.25 128.92 7.76 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.78 0.324 . . . . 0.75 111.257 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.51 123.87 20.36 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.136 -0.484 . . . . 1.24 111.511 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 17.6 t 56.63 45.31 22.33 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.286 0.565 . . . . 1.34 111.128 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.5 -23.51 77.53 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.62 -0.718 . . . . 1.1 114.003 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -38.86 85.59 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 117.042 0.421 . . . . 1.62 111.918 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.567 ' NZ ' ' HB3' ' B' ' 35' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.497 -0.763 . . . . 1.91 111.152 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.457 0.17 . . . . 1.02 110.91 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -142.69 140.68 31.62 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.736 0.303 . . . . 0.94 111.144 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.482 ' HB2' ' HB2' ' B' ' 6' ' ' PHE . 13.3 mmmm -68.59 134.73 90.53 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 116.253 -0.43 . . . . 0.43 111.309 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.31 28.98 0.26 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.741 2.294 . . . . 0.55 113.364 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . 0.443 ' H ' ' C ' ' B' ' 3' ' ' LYS . 17.3 mt -158.81 27.64 0.22 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.428 -0.805 . . . . 0.43 110.099 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . 0.482 ' HB2' ' HB2' ' B' ' 3' ' ' LYS . 12.8 t80 -106.35 54.0 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.61 -0.723 . . . . 0.8 110.476 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.582 ' HB2' ' HG ' ' B' ' 11' ' ' LEU . 6.0 m-85 -79.65 -44.52 20.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.051 -0.522 . . . . 1.07 111.677 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.439 ' O ' HG12 ' B' ' 12' ' ' ILE . 9.0 t -168.94 -161.34 0.32 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.34 -0.391 . . . . 0.76 111.067 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.49 ' O ' ' HB ' ' B' ' 12' ' ' ILE . 49.4 mm -62.59 -46.9 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 111.992 0.368 . . . . 0.95 111.992 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -58.9 -39.23 80.86 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.952 0.406 . . . . 0.79 111.768 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . 0.582 ' HG ' ' HB2' ' B' ' 7' ' ' TYR . 4.3 mm? -74.44 -14.35 60.83 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.795 0.665 . . . . 0.62 112.795 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' B' ' 9' ' ' ILE . 8.6 mm -60.11 -39.33 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 111.763 0.283 . . . . 0.7 111.763 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.514 HD12 ' H ' ' B' ' 13' ' ' ILE . 3.6 mp -57.99 -62.44 5.48 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 116.646 -0.252 . . . . 0.54 111.591 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.406 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.5 Cg_endo -56.03 -38.07 95.3 Favored 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 121.642 1.561 . . . . 0.33 111.821 179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.421 ' O ' HG13 ' B' ' 18' ' ' ILE . 42.0 t -60.86 -53.78 53.19 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.316 -0.402 . . . . 0.36 111.551 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.96 -37.85 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 120.684 -0.406 . . . . 0.52 110.623 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.422 HD13 ' O ' ' B' ' 13' ' ' ILE . 6.9 mp -61.5 -53.04 61.63 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.942 -0.117 . . . . 0.43 111.19 178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.421 HG13 ' O ' ' B' ' 15' ' ' CYS . 2.6 pp -63.57 -34.27 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 120.707 -0.397 . . . . 0.41 110.831 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.481 ' O ' HG12 ' B' ' 23' ' ' ILE . 34.8 m -66.11 -48.07 72.1 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.811 0.338 . . . . 0.55 110.27 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -59.09 -48.53 81.26 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.012 -0.54 . . . . 0.6 110.504 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.41 HD13 ' O ' ' B' ' 17' ' ' LEU . 9.1 mp -60.78 -45.55 93.93 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.26 -0.427 . . . . 0.56 110.937 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.36 -56.33 23.54 Favored 'General case' 0 C--O 1.215 -0.731 0 C-N-CA 120.822 -0.351 . . . . 0.62 110.608 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.481 HG12 ' O ' ' B' ' 19' ' ' THR . 46.4 mm -56.73 -37.64 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 O-C-N 122.835 0.085 . . . . 0.73 110.779 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.91 -45.31 92.97 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.971 0.415 . . . . 0.78 110.407 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -77.33 -45.93 28.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.444 0.64 . . . . 0.78 111.312 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 4.0 m-30 -63.52 -50.88 67.83 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.306 1.042 . . . . 0.87 112.573 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -92.89 46.63 1.23 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.193 -0.458 . . . . 1.01 110.764 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.483 HD23 ' H ' ' B' ' 28' ' ' LEU . 2.6 pt? -63.68 133.12 95.42 Favored Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 121.09 0.472 . . . . 1.01 111.945 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -72.86 59.04 3.45 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.95 2.434 . . . . 1.1 112.889 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 56.2 p -87.19 -13.47 43.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 1.3 112.101 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.93 128.9 38.34 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.273 0.559 . . . . 1.92 111.67 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 51.8 t -139.85 141.15 36.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.32 0.581 . . . . 2.41 111.507 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 170.41 -46.42 0.2 Allowed Glycine 0 C--N 1.322 -0.241 0 N-CA-C 110.282 -1.127 . . . . 1.87 110.282 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.457 ' OE1' ' HG2' ' B' ' 35' ' ' LYS . 0.0 OUTLIER -93.49 -37.49 11.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.632 -0.784 . . . . 3.09 109.229 177.294 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.457 ' HG2' ' OE1' ' B' ' 34' ' ' GLU . 20.5 pttm . . . . . 0 C--O 1.25 1.107 0 CA-C-N 115.24 -0.891 . . . . 3.7 111.051 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 111.563 0.209 . . . . 3.84 111.563 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 58.14 38.56 26.42 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.677 0.61 . . . . 3.42 111.649 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' B' ' 3' ' ' LYS . 43.8 mtmt 67.41 118.78 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 122.878 0.471 . . . . 1.49 111.567 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.12 107.73 0.31 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.429 2.086 . . . . 1.51 112.099 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 54.42 29.48 11.11 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.857 -0.61 . . . . 2.65 111.41 -178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 55.03 32.49 18.3 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.892 -0.594 . . . . 2.2 111.742 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -87.6 -44.34 11.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.018 0.437 . . . . 2.44 111.552 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 60.2 p -73.94 63.08 0.9 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.322 0.49 . . . . 0.81 112.322 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 49.8 mm -75.43 126.27 36.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.358 -0.383 . . . . 1.25 111.459 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -70.79 110.45 5.57 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.906 0.384 . . . . 2.06 110.4 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 93.8 mt -87.07 -20.12 27.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 1.92 111.299 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 51.3 mm -61.8 -50.3 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 112.479 0.548 . . . . 1.98 112.479 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.439 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 84.1 mt -54.01 -61.37 5.43 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 111.878 0.325 . . . . 2.0 111.878 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.439 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 11.3 Cg_endo -54.87 -41.25 80.2 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 122.088 1.858 . . . . 1.56 111.605 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 41.2 t -60.2 -48.48 81.55 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.364 -0.38 . . . . 1.34 110.817 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 t -62.06 -46.61 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 CA-C-O 120.696 0.284 . . . . 1.5 110.762 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' B' ' 17' ' ' LEU . 4.1 mm? -60.24 -51.49 69.35 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.456 -0.338 . . . . 1.55 111.816 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 2.6 pp -63.37 -36.77 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 120.49 -0.484 . . . . 1.16 110.978 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.501 ' O ' HG12 ' B' ' 23' ' ' ILE . 80.4 m -65.9 -47.09 75.97 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.878 0.371 . . . . 1.03 110.039 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.519 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 41.0 t -58.81 -51.81 68.42 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.015 -0.539 . . . . 1.06 110.782 178.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -59.01 -44.65 91.73 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.654 -0.248 . . . . 1.24 110.786 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.72 -56.29 23.88 Favored 'General case' 0 C--O 1.211 -0.928 0 C-N-CA 120.852 -0.339 . . . . 0.73 110.585 178.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.501 HG12 ' O ' ' B' ' 19' ' ' THR . 50.0 mm -55.61 -40.13 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-O 120.288 0.09 . . . . 0.68 111.144 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' B' ' 20' ' ' SER . 87.9 mt -59.23 -43.78 92.35 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.779 0.323 . . . . 1.01 110.6 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 73.5 t -78.83 -45.6 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.528 0.68 . . . . 0.98 111.652 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -64.18 -56.5 14.33 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 124.277 1.031 . . . . 0.93 112.975 -178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -79.71 -35.46 38.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.27 -0.423 . . . . 1.04 111.42 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 tp 56.7 64.08 4.95 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.852 -0.613 . . . . 1.25 111.974 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.14 52.82 1.93 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.856 2.371 . . . . 0.95 113.338 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 28.7 t -72.01 -45.23 61.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.038 -0.528 . . . . 1.75 111.565 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -140.17 137.62 34.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.967 -0.56 . . . . 2.13 111.102 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 52.5 t -151.91 -36.69 0.12 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.383 0.512 . . . . 2.36 112.383 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . 172.42 39.98 0.04 OUTLIER Glycine 0 CA--C 1.517 0.176 0 C-N-CA 121.017 -0.611 . . . . 2.7 111.671 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.426 ' OE1' ' HG3' ' B' ' 35' ' ' LYS . 0.0 OUTLIER -141.89 -168.75 2.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.35 -0.425 . . . . 2.51 111.927 -178.592 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.426 ' HG3' ' OE1' ' B' ' 34' ' ' GLU . 34.1 mtmm . . . . . 0 C--O 1.252 1.217 0 CA-C-O 118.373 -0.823 . . . . 3.16 112.148 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 111.82 0.304 . . . . 1.27 111.82 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 61.13 -151.04 0.4 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.193 -0.458 . . . . 1.93 111.215 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.44 ' N ' ' HD3' ' B' ' 4' ' ' PRO . 21.7 pttp -170.77 60.18 0.33 Allowed Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 112.309 0.485 . . . . 1.28 112.309 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' B' ' 7' ' ' TYR . 18.5 Cg_exo -64.75 110.35 1.44 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.236 1.957 . . . . 1.17 111.824 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' LEU . . . . . . . . . . . . . 66.3 mt 56.12 40.43 30.17 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.529 -0.305 . . . . 1.42 111.731 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 63.68 38.28 9.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.081 -0.508 . . . . 1.07 112.105 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.454 ' HB3' ' HD2' ' B' ' 4' ' ' PRO . 24.5 t80 -76.98 127.21 32.29 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.439 -0.346 . . . . 1.09 111.372 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 61.2 p 53.11 38.06 26.49 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 112.95 0.722 . . . . 0.63 112.95 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . . . . . . . . . 16.5 tt -91.22 145.65 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-O 120.695 0.283 . . . . 0.65 111.212 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -72.38 50.08 0.22 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.114 0.483 . . . . 0.71 111.755 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -144.08 -48.21 0.28 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.112 -0.495 . . . . 0.76 109.752 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 8.6 tp -69.37 -36.68 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.109 -0.496 . . . . 0.8 110.981 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.494 ' HB ' ' CD ' ' B' ' 14' ' ' PRO . 79.9 mt -58.18 -62.21 5.98 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 111.832 0.308 . . . . 0.66 111.832 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . 0.494 ' CD ' ' HB ' ' B' ' 13' ' ' ILE . 12.9 Cg_endo -55.91 -40.4 85.29 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 121.873 1.716 . . . . 0.54 111.671 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 43.3 t -59.76 -52.66 64.52 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.153 -0.476 . . . . 0.72 111.715 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.47 HG13 HD22 ' B' ' 17' ' ' LEU . 11.8 p -64.84 -41.23 91.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 120.805 -0.358 . . . . 0.8 111.332 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' LEU . . . . . 0.47 HD22 HG13 ' B' ' 16' ' ' VAL . 3.8 mm? -61.09 -52.16 66.07 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 121.144 -0.222 . . . . 0.86 111.023 178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.426 HG12 ' O ' ' B' ' 14' ' ' PRO . 43.9 mm -60.16 -43.89 94.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.599 0.238 . . . . 0.7 110.675 178.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . . . . . . . . . 75.5 m -60.6 -47.37 86.49 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.679 0.276 . . . . 0.82 110.669 178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' B' ' 24' ' ' LEU . 48.1 t -59.44 -52.78 64.12 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.323 -0.399 . . . . 0.98 110.771 179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' B' ' 21' ' ' LEU . 4.1 mm? -57.83 -45.58 85.98 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.576 -0.284 . . . . 1.01 110.918 178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.99 -54.78 42.85 Favored 'General case' 0 C--O 1.212 -0.872 0 C-N-CA 120.922 -0.311 . . . . 0.77 110.164 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 34.2 mm -54.53 -45.88 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 O-C-N 122.932 0.145 . . . . 0.95 110.973 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' B' ' 20' ' ' SER . 93.3 mt -54.45 -41.55 69.56 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.821 0.343 . . . . 1.09 110.872 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 91.7 t -81.32 -36.02 14.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.374 0.607 . . . . 0.95 111.49 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.417 ' HB3' ' H ' ' B' ' 27' ' ' TYR . 4.9 m-30 -75.87 -120.34 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.094 0.958 . . . . 0.96 113.389 -177.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' TYR . . . . . 0.417 ' H ' ' HB3' ' B' ' 26' ' ' PHE . 0.0 OUTLIER 21.83 47.87 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.078 1.751 . . . . 1.12 115.281 -178.439 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.781 HD23 ' H ' ' B' ' 28' ' ' LEU . 1.9 pt? -67.89 130.86 92.65 Favored Pre-proline 0 N--CA 1.455 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.88 110.961 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.59 48.64 1.34 Allowed 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 122.709 2.273 . . . . 1.23 113.153 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 81.7 p -79.88 53.62 1.7 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.005 0.431 . . . . 0.88 111.15 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -83.39 136.38 34.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.259 0.552 . . . . 1.88 111.177 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 25.6 p -83.87 -13.77 52.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.684 -0.689 . . . . 1.68 111.143 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' GLY . . . . . . . . . . . . . . . -75.02 53.2 2.58 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 114.332 0.493 . . . . 2.21 114.332 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.435 ' HB3' ' H ' ' B' ' 35' ' ' LYS . 0.0 OUTLIER 60.29 -151.41 0.41 Allowed 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.415 0.524 . . . . 3.17 112.415 179.534 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' LYS . . . . . 0.435 ' H ' ' HB3' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.624 -0.703 . . . . 2.77 110.886 -179.584 . . . . . . . . 2 2 . 1 stop_ save_